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INTRODUCTION
This thesis addresses the effect of certain environmental pollutants on respiratory health 
of Ecuadorian children, and studies the influence of public policy aimed at controlling the 
vehicular emissions in Quito on respiratory health. The investigations are based on studies 
carried out at both the community level and in a hospital setting in Quito, Ecuador. 
This introduction provides a general view of air pollution and respiratory illnesses in 
Quito; evidence on the effects of several pollutants on respiratory health with an emphasis 
on the innate immune response; and finally an overview of potential solutions and measures 
to improve air quality.
AIR POLLUTION CONDITIONS AND RESPIRATORY 
INFECTIONS IN QUITO, ECUADOR
Air pollution conditions
Quito, the capital of Ecuador is a developing city with ~ 2.700.000 inhabitants of relative 
homogeneous ethnicity (1). The city is situated on the equatorial line on average 2828 
meters above sea level in the Andean Region. While the general climate of Ecuador is hot 
and subtropical, the climate of the city of Quito is defined by its mountainous location. The 
monthly temperatures are stable throughout the year averaging 15°C (59°F) (2) and the 
seasons are defined by precipitation. The dry (summer) season generally extends from June 
to September, with the rest of the months reserved for rainy (winter) season (2). The city 
sits on a long, narrow valley and is surrounded by high mountains that impede wind flow 
that could disperse pollutants, causing them to remain in the environment for a long time. 
The altitude of the city results in greater solar radiation that photochemically transforms the 
pollutants into oxidants (3). Its topography also favors thermal inversions where a hot air 
roof traps and concentrates pollutants within the city. Furthermore, some of the surrounding 
mountains are active volcanoes (Guagua Pichincha and Reventador) that from time to time 
intensify their activity with the emission of large amounts of volcanic ash. For example, In 
October of 1999 and April of 2000 the stratovolcano Guagua Pichincha located 13 km west of 
Quito became active after 340 years of dormancy. Concluding, due to its geographic location, 
topography, and climatology, Quito is very vulnerable to stagnant air and high air pollution.
In addition, the rapid urban development of the city in the last two decades has deteriorated 
the quality of the air due to an increase of pollutants from industry, deforestation, and 
vehicle exhaust. It is important to mention that vehicle exhaust is the most significant source 
of pollutants in Ecuador. In fact, the number of circulating vehicles in Quito has increased by 
7% per year or ~ 30,000 vehicles per year between 1998 and 2014 (4), and that residential 
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population has grown in the peripheral areas. This growing number of commuters entails a 
steady increase in heavy vehicular circulation, especially public transportation buses that run 
on diesel (5) are making Quito the most polluted city in Ecuador. 
No routine regular monitoring of air pollution was conducted in Quito before 2004. 
Based on ad hoc official report, ambient carbon monoxide (CO) concentration levels in five 
consecutive months (August to December) of the years 2001 and 2002 were higher than 
those in 2003. In 2002, such concentrations exceeded the national standard (Figure 1) (6). 
The monitoring system started in 2004 through the Metropolitan Atmospheric Monitoring 
Network of Quito (REMMAQ). It consists of eight online and one additional backup station. 
These stations are equipped with automatic analyzers for particulate matter (PM)2.5, carbon 
monoxide (CO), Ozone (O3), nitric oxide (NOX), and sulphur dioxide (SO2) with the capacity 
to operate permanently and continuously 24 hours a day, 365 days a year (7). Between 
2004 and 2017, the annual averages of PM2.5, CO, O3, and NO2, show a downward trend with 
measures below the national standard for all except PM2.5 (Table 1) (8). The high levels of 
PM2.5 could be related to an increase in the number of cars in Quito during that period since 
vehicular exhaust is the principal source of this pollutant. 
Within this situation, the residents of Quito, especially children, may be prone to multiple 
health problems including respiratory illness.
Respiratory infections in Ecuadorian children related to air pollution
One of the main public health problems globally is environmental air pollution, which has 
been gradually deteriorating air quality in most cities of the world. Air quality deterioration is 
due to the rapid urbanization and industrialization of cities, forest fires (9), volcanic eruptions 
(10), and particularly the increase of circulating vehicles (11, 12), which produce irritating 
substances and toxic gases. 
Figure 1. Annual comparison of average concentrations of 8 h carbon monoxide (CO), Quito
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According to the World Health Organization (WHO), globally 570,000 children under the 
age of five die every year as a result of respiratory infections caused by indoor and outdoor 
air pollution and exposure to environmental tobacco smoke (13). Although in Ecuador 
respiratory infections, mainly pneumonia, remain the leading cause of morbidity and death in 
young children (14, 15), accurate data on the effects of air pollution on respiratory infections 
in children are scarce. 
In this thesis we present evidence on the relationship between exposure to different air 
pollutants and the presence of respiratory infection in children of Quito. In chapter 2 we 
compare the incidence of acute respiratory infections (ARIs) in school-age children living 
in three communities that differ in traffic intensity in urban and suburban areas of Quito, 
and examine the relationship between ARI occurrence and individual carboxyhemoglobin 
(COHb) concentrations, as a measure of CO exposure. In chapter 3 we document the rates of 
emergency room visits for acute upper and lower respiratory infections and asthma-related 
conditions in children living in Quito, Ecuador associated with the eruption of the Guagua 
Pichincha volcano in April of 2000. In chapter 4, we assess the simultaneous effects of traffic 
air pollution and anemia as risk factors for pneumonia in Ecuadorian children.
AIR POLLUTION AND RESPIRATORY SYSTEM: IMMUNOLOGI-
CAL ASPECTS
There is accumulating evidence to suggest that people chronically exposed to gaseous 
pollutants (CO, SO2, O3, and NOX ) and PM have a higher risk of developing respiratory 
infections (16-20), and asthma (21-24). These respiratory conditions may be mediated 
through effects of air pollutants on different immune lung cells, among them a novel group 
of cells named the innate lymphoid cells (ILCs). 
Although ILCs play an important role in pathogen containment and airway 
hyperresponsiveness, the effects of air pollutants on them are poorly understood. In chapter 
5 of this thesis we conduct a systematic review to evaluate available evidence on the effect 
Table 1. Annual average concentration of pollutants in Quito 2004 and 2017
Ambient Pollutant 2004 2017 National 
standard 
CO      (mg/m3)* 5.5 2.4 10 
PM2.5  (ug/m3)** 22.5 17 15 
O3       (ug/m3)* 29.5 27 40 
NO2    (ug/m3)** 26 23 40 
 
*annual octo-hour average
**annual average
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of the major air pollutants on the lung ILC subsets, specifically type 1 (ILC1) and type 2 ILCs 
(ILC2).
In order to a better understanding of how pollutants affect other lung immune cells in 
human, a brief review is presented below:
Particulate matter 
Particulate matter is a complex and heterogeneous mixture of solid particles and liquid 
matters suspended in the atmosphere. Its composition varies according to region, season, and 
time (25, 26). The most deleterious are the smallest inhalable particles capable of depositing 
throughout the airways up to the alveoli. Inhaled particles with diameters between 2.5 and 
10 micrometers (μm) (PM10) are deposited mainly in the nose and large conducting airways; 
fine particles (0.1-2.5 μm) with a diameter of 2.5 μm, but larger than 0.1 (PM2.5) can reach 
the small airways and alveoli; and ultrafine PM (UFPM) fraction PM0.1 (particles < 0.1μM) 
can deposit in the pulmonary tissue and even translocate from the alveoli to the pulmonary 
circulation (27). All of these particles have been associated with impairment of the innate 
immune respiratory system in humans, with effects varying across size, mass, composition 
of the particles. Exposure to PM alters the function of several lung innate immune cells, as 
outlined in more detail below and in figure 2. 
- Effects on lung epithelial cells (EC): PM exposure causes oxidative stress and activation 
of multiple cell death pathways (28), deregulates the ability to express the antimicrobial 
peptides human β-defensin 2 (HBD-2) and HBD-3 (29), increases interleukin (IL)-6 and 
IL-8 production (30, 31) as well as matrix metalloproteinase (MMP)-9 and cyclooxygenase 
(COX)-2 (31). More recently, it has been shown that PM2.5 exposure alters the mitochondrial 
structure, including mitochondrial dynamic, DNA biogenesis and morphological alteration of 
bronchial epithelial cells via reactive oxygen species (ROS) formation (32). 
- Effects on Alveolar macrophages (AMs): AMs are activated by PM to produce increased 
proinflammatory cytokines (IL-6 and TNF-α), and to generate a pro-oxidant state (33-35). 
Paradoxically, these particles have also been reported to lower the capacity of pulmonary 
macrophages to secrete IL-6 and interferon beta (IFN-β) (36) as well as IL-8, TNF-α and PGE2 
(37). In addition, a decrease in cell viability (33, 38), suppression of phagocytic activity (39) 
and reduction of antibacterial function (40) have been reported.
- Effects on Dendritic cells (DC): Human DCs exposed to PM improve their maturation and 
activation (41); increase cell-surface expression of co-stimulatory molecules (CD40), major 
histocompatibility complex (MHC) class II, and vascular endothelial growth factor (VEGF) 
(42); and enhance the production of TNF-α, IL-6, IFN-γ, IL-12 (41, 42),IL-13, Granzyme A and 
Granzyme B (41). 
- Effects on adaptive lymphocytes (AL): PM from diesel exhaust can act directly on T 
Helper (Th) 1 reducing cytokine production, and inducing autophagic lysosomal blockage and 
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mitochondrial membrane perturbations (43). PM also affects AL indirectly through activation 
of DC and macrophages. For example, PM-activated DCs produce great quantity of IL-6 which 
enhance CD4+ T cell proliferation with low IFN-γ secretion (44). In addition, DCs enhance 
priming of naive CD8+ T lymphocytes, and induce resting memory CD4 T cells to secrete 
IFN-γ and IL-13, and to expand into Th1, Th2, and Th17 inflammatory effector cells (45). 
These Th17 cells co-express IL-17A with IFN-γ, GM-CSF, and granzyme B (46). PM-exposed 
macrophages induce human CD4+ and CD8+ T cells to upregulate protein levels of interferon 
IFN-γ, interleukin IL-10, IL-17, and IL-21 production as well as granzyme A and granzyme 
B expression (47). In the reviewed literature, no studies on the effect of pollutants on B 
lymphocytes were found.
Carbon monoxide
Carbon monoxide (CO) is a gas that results from incomplete combustion whenever 
carbon-containing material is burning (48). In general, high CO concentrations result from 
natural events such as volcanic eruptions or wild forest fires (49). In urban settings, high CO 
concentrations primarily occur due to incomplete fuel combustion and in areas with heavy 
traffic congestion. The main indoor sources of environmental CO are smoking and domestic 
fuel combustion with inadequate stoves and furnace ventilation (48). A direct effect of 
high CO exposure on innate immune cells has not been reported, but it is known that CO 
binds tightly to hemoglobin to form Carboxyhemoglobin (COHb), a compound that prevents 
hemoglobin from delivering oxygen throughout the body (50), which causes several effects 
on subsets of innate immune cells (Figure 2). 
- Effects on macrophages and lung epithelial cells: A hypoxic environment has been 
associated with an inhibitory effect on the recruitment, differentiation, and phagocytic 
activity of AMs (51, 52) as well as with the upregulation of monocyte/macrophage pro-
inflammatory responses (53, 54). In addition, hypoxia induces the alveolar epithelium to 
increase surfactant production, causes disruption of cytoskeleton integrity, and triggers 
apoptosis in these cells (55). 
- Effects on Dendritic cells: It has been reported that hypoxic immature DCs exhibit 
low bacterial phagocytosis and increased migratory capacity towards secondary lymphoid 
organs (56), and that hypoxic mature DC showed raised gene expression of pro-inflammatory 
cytokines and chemokines (57). 
Ozone
Ozone (O3) is a pale blue reactive gas comprised of three oxygen atoms. It is found 
naturally in the earth’s stratosphere where it creates a protective layer that shields the 
planet from UV rays. However, Ozone can also occur at ground level. This tropospheric ozone 
is not emitted naturally into the air but rather created by chemical reactions between oxides 
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of nitrogen (NOx), volatile organic compounds (VOCs) and CO in the presence of sunlight (58, 
59). This newly-formed trophospheric ozone can reach the lining of the respiratory tract and 
react with several molecules causing inflammation (Figure 2). 
- Effects on epithelial cells: The principal harmful effects of O3 is the disruption of the 
airway epithelial integrity (60) which facilitates access of different external antigens, and 
the impairment of microbial phagocytosis (61). On human bronchial epithelial cells O3 
induces an increased expression of inflammatory marker genes (IL-8 and COX-2) (62), and 
production of IL-8, IL-6, IL-1α, IL-1β (63-67), TNF-α, E-selectin and PGE2 (68). O3 exposure 
also induces oxidative stress (64), DNA damage, apoptosis and cytotoxicity of epithelial cells 
(69). Furthermore, O3 exposed bronchial epithelial cells play an important role in driving 
signals in macrophages to increase markers of alternative activation, enhance cytotoxicity, 
and reduce phagocytosis (70). 
- Effects on phagocytic cells: Human alveolar macrophages exposed to O3 exhibit 
impaired phagocytosis, superoxide production, and increased levels of pro-inflammatory 
cytokines (61, 70, 71). Ozone also induces neutrophilic inflammation of the lower airways 
but with defective neutrophil phagocytosis, intracellular killing and production of superoxide 
radicals (61). High levels of polymorphonuclear cells (PMN), elevated expression of IL-1β and 
IL-8, increased innate immune function and minimal activation of the immune cell trafficking 
pathways are seen in responders to O3, while opposite changes are seen in non-responders 
(72).
- Effects on Lymphocytes: Little has been published on the effect of O3 exposure on human 
lymphocytes. One study showed that lymphocyte numbers of human bronchoalveolar (BAL) 
fluid decreases by 3.1-fold after ozone exposure compared to air exposure (73) while other 
found suppression of IgG production in O3-exposed mitogen-stimulated lymphocytes (74). 
Nitric oxide 
Nitrogen is released during fuel combustion and it combines with oxygen to create nitric 
oxide (NO), which in a new reaction with oxygen forms nitrogen dioxide (NO2) (75). In areas 
of high motor vehicle traffic, such as in large cities, the amount of nitrogen oxides emitted 
into the atmosphere as air pollution can be significant. Similarly to CO, NOx (particularly NO), 
reduces oxygen saturation through the formation of methemoglobin (76, 77). While high 
concentration of NO2 is considered to cause inflammation of the airways (78, 79), few reports 
demonstrate its effects on lung innate immune cells. For example, it has been shown that 
NO2 interacts with the lung epithelial fluid and epithelial cell membranes to produce reactive 
oxygen and nitrogen species (80). The epithelial cells exposed to NO2 undergo apoptotic 
cell death at an early stage and exhibit cell membrane damage at a later time as well as 
changes in expression levels of adhesion molecules with the consequent increase of cell 
interaction with PMN (81). It has been described that the percentage of macrophages in 
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sputum increases depending on the exposure level, but no changes in cytokine production 
have been seen (82). 
Volcanic emissions
The composition of volcanic emissions varies depending on the geochemistry of the 
individual volcano. Nevertheless, in general, they contain a mixture of fine particle matter 
of pulverized rock (mainly silica, aluminum, and iron) and superheated gases (mainly water 
vapor, CO2, and SO2) (83).
- Effects on epithelial cells: Volcanic gases, especially SO2, induce the respiratory 
epithelium to produce mucus and secrete the pro-inflammatory cytokine IL-13 (84). Volcanic 
ash induces human alveolar type-1 like epithelial cells (TT1) to release MCP-1, IL-6, and IL-8, 
produces acute cytotoxicity of those cells (85), but does not induce alveolar epithelial cell 
death even at high concentrations (86). 
- Effects on macrophages: Human AMs exposed to volcanic ashes increase the release 
of lactate dehydrogenase, β- glucuronidase, and β-N-acetylglucosaminidase enzymes (87); 
decrease production of TNF-α mRNA with a subsequent decrease of killing ability (86). 
Additionally, volcanic ashes activate the NLRP3 Inflammasome (88), induce cytotoxicity of 
AMs (87), and interfere with the autophagy process (86). Furthermore, volcanic ash has been 
proved to be highly reactive in the lung since the fracture of crystalline silica produces surface 
radicals and also can generate reactive oxygen species (ROS) in aqueous suspensions such 
as the superoxide radical (O2-.) and hydroxyl radical (HO.), but the main cause of reactivity 
is the removable divalent iron (Fe2+), which is present in abundance on the surfaces of the 
particles (89). 
POTENTIAL SOLUTION TO IMPROVE AIR QUALITY 
According to WHO, ambient air pollution affects developed and developing countries 
alike, but low- and middle-income countries experience the highest burden of disease (90). 
Mortality and morbidity related to environmental exposures could be diminished if countries 
reduce the principal sources of ambient pollution through the establishment of regulatory 
policies and strong investments in energy efficacy projects or sustainable practices; surely, 
it is most likely that developed countries could meet this goal sooner than developing ones. 
In developed countries, limited trials are demonstrating a benefit of air pollution reduction 
policies, and other actions implemented to improve air quality on the respiratory health 
of children. Overall, declining trends in several air pollutants were associated with large 
reductions in respiratory infections and asthma cases (91-93), as well as with an improvement 
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Figure 2. Effects of main contaminants on immune cells. 
Particulate Matter (PM), Ozone (O3), and carbon monoxide (CO) through carboxyhemoglobin (COHb) formation 
decrease some functions (in blue) and increase others (in orange) of epithelial cells (EC), macrophages (Mφ), natural 
killer cells (NK) and dendritic cells (CD). Decreased phagocytosis, and antibacterial function of Mφ, DC, and EC, and 
cytotoxic function of NK result in susceptibility to infections. Inflammatory pathology is due to increased cytokines 
(IL-1, IL-6, IL-8, IL-12, TNF-α), chemokines (IL-8), and reactive oxygen species (ROS) production. Increased activation 
of DC results in CD4+ T cell activation and differentiation.
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of lung function (94-96) among children. However, other studies did not show definitive 
effects of air pollution regulation on respiratory illnesses in children (97, 98). 
Although some Latin American countries have established air pollution abatement 
policies, there are no studies evaluating the impact on respiratory health in children. In Quito, 
the first policy for air pollution abatement started in 2002 and consisted in controlling the 
emission of exhaust gas from gasoline engine vehicles, and the gradual removal of outdated 
carburetor–containing vehicles from the circulation; however, its effectiveness has not been 
assessed. 
We aimed to evaluate the effect of air pollution control on the occurrence of acute 
respiratory illnesses in school children five years later by comparing two studies conducted 
at the same location in Quito. Findings from this study are presented in chapter 6 of this 
thesis.
THE AIMS OF THIS THESIS 
In summary the aims of this thesis are:
1. To study the relation between carbon monoxide exposure and respiratory diseases in 
children.
2. To document the elevated rates of emergency room visits for acute upper and lower 
respiratory infections and asthma-related conditions in children living in Quito, Ecuador 
associated with the eruption of the Guagua Pichincha volcano in April of 2000.
3. To assess the simultaneous effects of traffic air pollution and anemia as risk factors for 
pneumonia in Ecuadorian children.
4. To conduct a systematic review to evaluate available evidence on the effect of the major 
air pollutants on the lung ILC subsets, specifically type 1 (ILC1) and type 2 ILCs (ILC2).
5. To evaluate the effect of a citywide 5-year air pollution control program on the occurrence 
of acute respiratory illness in children.
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ABSTRACT
Outdoor carbon monoxide comes mainly from vehicular emissions, and high 
concentrations occur in areas with heavy traffic congestion. CO binds to hemoglobin, forming 
carboxyhemoglobin (COHb), and reduces oxygen delivery. We investigated the link between 
the adverse effects of CO on the respiratory system using COHb as a marker for chronic CO 
exposure. We examined the relationship between acute respiratory infections (ARIs) and 
COHb concentrations in school-age children living in urban and suburban areas of Quito, 
Ecuador. We selected three schools located in areas with different traffic intensities and 
enrolled 960 children. To adjust for potential confounders we conducted a detailed survey. 
In a random subsample of 295 children, we determined that average COHb concentrations 
were significantly higher in children attending schools in areas with high and moderate traffic, 
compared with the low-traffic area. The percentage of children with COHb concentrations 
above the safe level of 2.5% were 1, 43, and 92% in low-, moderate-, and high-traffic areas, 
respectively. Children with COHb above the safe level are 3.25 (95% confidence interval (CI), 
1.65–6.38) times more likely to have ARI than children with COHb < 2.5%. Furthermore, with 
each percent increase in COHb above the safety level, children are 1.15 (95% CI, 1.03–1.28) 
times more likely to have an additional case of ARI. Our findings provide strong evidence of 
the relation between CO exposure and susceptibility to respiratory infections.
Keywords: acute respiratory infections, carbon monoxide exposure, carboxyhemoglobin, 
children, Ecuador, traffic-related pollution.
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INTRODUCTION
Numerous studies have found a strong association between respiratory illness and 
exposure to traffic-related air pollution (Choudhury et al. 1997; Hajat et al. 2002; Polosa 
et al. 2002; Romieu et al. 2002; Shamsiiarov et al. 2002; Spinaci et al. 1985). Traffic-related 
nitrogen monoxide, nitrogen dioxide, black fumes, and ammonia particulate have been linked 
to an increase in respiratory symptoms and a decrease in pulmonary function in school-age 
children (Boussin et al. 1990; Keiding et al. 1995; Lercher et al. 1995; Lwebuga-Mukasa et al. 
2003; Quian et al. 2000; Steerenberg et al. 2001; van Vliet et al. 1997; Wjst et al. 1993; Yang 
et al. 1998, 2002). Carbon monoxide, a toxic product of incomplete combustion, can also 
impair respiratory function. High CO concentrations may occur in areas with heavy traffic 
congestion, especially in urban settings with insufficient emission regulation. The main indoor 
sources of environmental CO are smoking and domestic fuel combustion with inadequate 
stoves and furnace ventilation (Collings et al. 1990; Kleinman 2000; Puente-Maestu et al. 
1998). Although the physiology and adverse effects of acute CO poisoning on the respiratory 
system are well documented, very few studies have been conducted to understand the 
effects of chronic low-dose CO exposures on susceptibility to respiratory infections.
Carboxyhemoglobin (COHb), a marker for CO exposure, reflects the binding of CO to the 
hem portion of hemoglobin capturing oxygen. A concentration of COHb < 2.5% is currently 
considered safe (Kleinman 2000). The lowest level of COHb, at which adverse effects are 
observed, ranges from 2.9 to 3% (U.S. Environmental Protection Agency (EPA) 2000). COHb 
concentrations of 5–10% serve as an indicator of acute CO poisoning and are associated with 
impaired visual function, task performance, and maintaining alertness (Raub and Benignus 
2002). Even a relatively low CO exposure may increase COHb levels in human peripheral 
blood (Raub and Benignus 2002). Higher levels of COHb have been observed in smokers 
compared with nonsmokers (Behera et al. 1991). In addition, children living in households 
with smokers or wood/coal/gas heating systems exhibit slight increases in COHb levels 
(Vazquez et al. 1997).
The effects of CO exposure at high altitudes may be more detrimental than exposure at sea 
level. In the presence of high CO concentrations, a compensatory mechanism of adaptation 
to low oxygen saturation in high altitude that leads to increased production of red blood cells 
may be insufficient. High-altitude residents have a greater initial body burden of COHb and 
may attain the COHb level associated with the U.S. National Ambient Air Quality Standard for 
CO more quickly than sea-level residents (McGrath 1989). The respiratory effects of chronic 
exposure to CO in high-altitude populations have not been explored.
The objectives of this pilot study were a) to compare the incidence of acute respiratory 
infections (ARIs) in school-age children living in three communities that differ in traffic 
intensity in urban and suburban areas of Quito, b) to examine the relationship between ARI 
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occurrence and individual COHb concentrations, and c) to examine the joint effect of COHb 
levels (a measure of CO exposure) and hematocrit levels (a measure of a compensatory 
oxygen-delivery function) on the incidence of ARI. To achieve these goals, we conducted a 
12-week prospective study of 960 children attending elementary schools in the early spring 
of 2000 in Quito, the capital of Ecuador. Quito is a rapidly developing city with > 1 million 
residents of relatively homogeneous ethnicity. It is located 2,825 m above sea level and 
enjoys a mild climate year round, but is challenged by heavy air pollution, 82% of which is 
due to vehicle exhaust. Substantial human morbidity and mortality in Quito are likely linked 
to environmental factors.
MATERIALS AND METHODS
Study design
From January through April of 2000, we conducted a prospective study in young children 
attending Quito’s public elementary schools. First, three schools were selected that were 
comparable with respect to the type of school building (with concrete walls and roofs and 
cemented playgrounds) and the number of children per class (~ 45 children, p = 0.56) but 
differed by traffic intensity in sur- rounding areas. One school was located north of Quito, in 
the suburban area of Nayon and represents a low-traffic area (LT-school). The second school 
was located in a moderate-traffic area of Quito (MT-school). The third school was located in a 
heavy-traffic area in down-town Quito (HT-school). Next, an initial screening was performed 
in each school to identify a pool of children eligible for the study. During the screening period, 
detailed information about the study was delivered to the teachers and to the parents of 
each child. Children with chronic respiratory illnesses and major congenital and/or chest 
deformities interfering with the respiratory tract were excluded from enrollment. In each 
school, 320 children, 6–11 years of age (age was con- firmed by birth certificate), who had 
formal written consent freely signed by their parents, were randomly selected and enrolled 
in the study. Finally, from the total 960 children enrolled 295 were randomly selected to 
obtain blood measurements.
Primary outcome, ARI
During the 12-week study period, each child was visited in the school twice weekly by 
a pediatrician who examined the child’s respiratory signs and symptoms to determine the 
presence of upper and lower ARIs. For each child, the number of episodes of upper and 
lower ARIs observed over the study period was determined, considering a 2-week period 
to be free of infections. We adapted ARI case definitions proposed by Sempértegui et al. 
(1999). Upper ARI was defined as the presence of two or more of the following signs/
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symptoms: cough, nasal secretion, fever > 37.5°C (auxiliary temperature), inflammation of 
pharynx, and anterior cervical lymphadenitis. Presence of otitis (local pain, aural pus, and 
eardrum congestion) was also considered as upper ARI. Lower ARI was defined as tachypnea 
(respiratory rate > 20) and/or lower respiratory tract secretions (alveolar or bronchoalveolar) 
assessed by thoracic auscultation, with one or more of the following: fever, cough, and chest 
retractions.
Anthropometric measurements
On the first day of the study, weight and height for all enrolled children was measured 
by standard procedures using the instruments calibrated by the Ecuadorian Institute of 
Normalization (Quito, Ecuador). Weight was measured with a DETECTO balance (DETECTO, 
Webb City, Missouri, USA) and recorded to the nearest 0.1 kg. Height was obtained with a 
calibrated scale using a fiberglass tape measure and recorded in centimeters. Weight-for-
age Z-score (WAZ), height-for-age Z-score (HAZ), and body mass index (BMI) values were 
calculated.
Survey
Baseline measurements for confounders, including household heating and cooking 
conditions (the use of kerosene or wood), the presence of smokers, and house- hold 
crowdedness (number of persons/number of rooms), were collected via household surveys. 
On the first week of the study, a sur- vey was sent to the parents of each child. After 2 weeks, 715 
surveys (77%) were returned.
Blood measurements
COHb and hematocrit levels were measured on the first day of the study. Venous blood 
was drawn with plastic syringes and placed into EDTA-treated tubes. Blood was immediately 
transported for analysis. COHb was measured by spectrometry and expressed as a percentage 
of plasma hemoglobin. Hematocrit was obtained by centrifuging whole blood in microtubes 
and expressed as a percentage.
Statistical analysis
Data entry and management were performed using Epi-Info 6.04c software (CDC, Atlanta, 
Georgia, USA). SPSS 11.5 (Lead Technologies Inc. SPSS Inc., Chicago, Illinois, USA) and S-plus 
6.0 (Insightful Inc., Seattle, Washington, USA) were used for statistical analysis.
For each child, we estimated the number of ARI episodes observed during the study period 
and the number of weeks a child had attended the school. The primary health outcome—the 
annual ARI rate—was expressed as the number of ARI episodes per year per 1,000 children. 
Descriptive statistics for the primary health outcome, the blood measurements, all baseline 
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measurements, and variables collected via surveys were calculated. Because the blood 
measurements were not available for all children, we compared descriptive statistics in both 
subsets, with and without the blood measurements, using t-test or test of proportions as 
appropriate.
To examine the effect of traffic-related pollution on COHb and ARI, we estimated the 
average COHb concentration and the average rate of ARI for each school and assessed the 
differences using analysis of variance, hypothesizing that children attending the school 
located at in the high-traffic area would have the highest level of COHb and the highest 
incidence of ARI compared with children attending LT- or MT-schools.
To test the hypothesis that children with COHb concentrations above the safe level of 2.5% 
are more susceptible to ARI, we created two binary variables: one to reflect the occurrence of 
ARI (0, no ARI; 1, at least one case of ARI), and the second variable to reflect the level of COHb 
(0, COHb ≤ 2.5%; 1, COHb > 2.5%). A logistic regression model including a set of confounders 
for adjustment (age, sex, HAZ, WAZ, type of domestic fuel (kerosene or wood), smoking, 
crowdedness, and hematocrit level) was then applied. Because the household information 
was not available for all the children in the study, we repeated this model excluding variables 
on household confounders. The results of modeling were expressed as risk ratios with their 
confidence intervals (CIs).
To assess the association between the recurrence of ARI episodes and high COHb 
concentrations, we employed a log-linear Poisson regression model. In this model we 
predicted the observed number of ARI in a given child by an individual COHb measurement 
that exceeds the safety level. The model included the same set of confounders as the logistic 
model. Results were expressed as an adjusted relative risk with its CIs.
To examine interactions between COHb concentration, hematocrit level, and the 
incidence of ARI, we applied a generalized additive model (GAM) with nonparametric spline 
smoothing (Hastie and Tibshirani 1990). In this nonlinear model, we regressed the number 
of cases of ARI against individual levels of COHb and hematocrit. The result of the model was 
dis- played using a three-dimensional surface with x- axes reflecting COHb concentration, 
y-axes reflecting hematocrit level, and axes reflecting the predicted numbers of ARI episodes.
RESULTS
Of 960 enrolled children, 910 (95%) completed the study (294 in the LT-school, 303 in 
the MT-school, and 313 in the HT-school). Fifty children were lost in the follow-up because 
of local migration. A total of 10,729 child-weeks of observation were accumulated in the 
study (3,382 child-weeks in the LT-school, 3,560 child-weeks in the MT-school, and 3,777 
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child-weeks in the HT-school). Of 910 children, 715 (78%) completed the household survey. 
The blood tests were avail- able for a subset of 295 children.
Over the 12-week study period, 848 cases of ARI were detected. Twenty-four percent of 
the children suffered recurrent ARIs. The over- all incidence rate of ARIs was 78.6 cases per 
1,000 child-weeks of observation or 4.05 cases per 1,000 children annually.
We estimated the descriptive statistics for ARI rates, baseline characteristics, survey 
responses, and COHb and hematocrit measurements for the entire study population and for 
the two subsets, with and without the blood measurements (Table 1). The ARI incidence and 
all other measurements, except the percentage of stunted children, did not differ between 
the two subsets.
Next, we estimated and compared the descriptive statistics for ARI incidence and other 
measurements by school (Table 2). The schools were comparable in nutritional status as 
measured by the proportion of underweight children. However, children attending the 
Table 1. The incidence of ARIs and exposure measurements for the entire study population as well for the COHb 
substudy contrasted with the remaining study participants
  
Total 
(n=910)  
   COHb Substudy  
(n=295)  
Remaining 
(n=615) 
Measure    
Children with ARI (%)                    49.56                      50.50            50.40 
No. of ARI episodes 848 285 563 
Annual Rate of ARI                4.05                       4.19             3.98 
Baseline characteristics (n) 910 295 615 
Age (years (Mean ±SD))  8.5±1.2 8.4±1.2 8.6±1.2 
Females (%) 43.3 40.68 44.6 
Weight (kg (Mean ±SD)) 26.3±5.8 25.9±1.0 26.4±5.7 
Underweight children, WAZ < -2SD (%) 3.4 4.2 3.1 
Height (cm (Mean ±SD)) 125.2±9.2 124.6±9.4 125.6±9.1 
Stunted, HAZ < -2SD (%)  16.1 20.7* 13.8 
BMI (Mean ±SD) 16.6±2.3 16.6±2.2 16.6±2.3 
Survey response (n) 715 233 482 
Completed Survey (%) 78.6 78.4 79 
Crowdedness (Mean ±SD)  1.29±1.1 1.28±0.85 1.29±0.83 
Households with kerosene use (%) 2.6 1.8 3.1 
Households with firewood use (%) 5.3 5.4 5.2 
Smokers(%) 25.5 23.5 26.5 
Children with history of asthma (%) 2.5 2.6 2.5 
Blood tests (n)  295  
COHb (% (Mean±SD))   2.81±2.19  
COHb > 2.5%(%)  46.4  
Hematocrit (% (Mean±SD))    43.26±2.6   
 
The blood tests were performed only for 295 children (our substudy). To avoid redundancy we provided the values 
only for the substudy. The total will have identical values.
*Significant difference at p = 0.02 between groups with and without COHb measurements
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LT-school were significantly more stunted than were children in the other areas. Crowdedness 
and the use of firewood fuel were significantly higher, and the average hematocrit level was 
significantly lower, in the suburban than in the urban area. The HT-school had fewer girls 
than did the other schools. The presence of smokers in the households was significantly 
higher in the MT-school, and children in this school were slightly older than the rest of the 
children.
The incidence of ARI was also significantly different among three schools (p < 0.01). The 
highest incidence rate of ARI of 6.89 cases per 1,000 child-years was observed in children 
attending the HT-school. Children attending the MT-school had the lowest incidence rate of 
ARI of 1.63 cases per 1,000 child-years. Children attending the LT-school had an incidence 
rate of ARI of 3.49 cases per 1,000 child-years.
The average COHb concentrations were also significantly different among three schools 
(p < 0.001). Children attending the HT-school had the highest COHb level (5.1 ± 1.7%), 
and 92% of those children had COHb levels above 2.5%. Children from the MT-school had 
significantly lower levels of COHb (2.5 ± 1.1%), although 43% of children had high COHb. The 
lowest average concentration of COHb (0.7 ± 1.2%) was observed in children attending the 
LT-school, where only one child had a COHb concentration exceeding the safety level. The 
significant differences in COHb concentrations among the schools indicate a strong gradient 
of CO exposure in the studied areas.
Table 2. Incidence of ARIs and exposure measurements for children attending LT-, MT-, and HT-schools.
  
 Low-Traffic 
    Moderate-
Traffic 
High-Traffic 
Significance 
(n=294) (n=303) (n=313) 
Measure     
Children with ARI (%)                   48.6 29.7 69.6 *, ** ,*** 
No. of ARI episodes 238 114 496 *, ** ,*** 
Annual Rate of ARI               3.49 1.63 6.89 *, ** ,*** 
Baseline characteristics (n) 294 303 313  
Age (years (Mean ±SD))  8.3±1. 6 8.9±0.8 8.3±1 *, *** 
Females (%) 51.7 49.5 29.4  
Weight (kg (Mean ±SD)) 23.9±5.5 27.7±5.2 27.0±5.9 *, ** 
Underweight children, WAZ < -2SD (%) 4.4 2.3 3.2  
Height (cm (Mean ±SD)) 120.4±9.5 128.5 ±7.6 126.4±8.5 *, ** ,*** 
Stunted, HAZ < -2SD (%)  28.2 9.6 8.6 *, ** 
BMI (Mean ±SD) 16.4±1.8 16.7±2.4 16.8±2.3 *, ** 
Survey response (n) 176 301 258  
Completed Survey (%) 60 99 76 *, **, *** 
Crowdedness (Mean ±SD)  1.9±1.1 1.2±0.6 0.8±0.4 *, **, *** 
Households with kerosene use (%) 4.1 1.7 2.9  
Households with firewood use (%) 18.1 1.3 0.5 *, ** 
Smokers(%) 25.5 30.5 17.6 *** 
Children with history of asthma (%) 1.1 3.6 2.1  
Blood tests (n) 99 90 106  
COHb (% (Mean±SD))  0.70±1.17 2.52±1.12 5.09±1.7 *, **, *** 
COHb > 2.5%(%) 1 43 92 *, **, *** 
Hematocrit (% (Mean±SD))  41.6±2.0 44.4±2.4 43.8±2.5 *, ** 
 
aSignificance at p < 0.05: *LT-school versus MT-school; **LT-school versus HT-school; ***MT-school versus HT-school
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Next, we examined the effects of household smoking and cooking fuel use on the average 
COHb concentration. In each school, we compared average COHb levels in children living 
in households with and without smokers (Table 3), as well as in households with kerosene 
and firewood cooking fuel. Neither smoking nor cooking fuel significantly altered the area-
related COHb concentration pattern.
The results of the logistic regression models suggest that children with COHb > 2.5% 
are 3.25 (95% CI, 1.65–6.38; adjusted) or 2.06 (95% CI, 1.3–3.2; crude) times more likely 
to have ARI than children with COHb < 2.5%. Except for COHb level, the included variables 
(age, sex, weight, height, BMI, hematocrit levels, and child’s previous history of asthma) as 
well as the presence of smokers, kerosene and/or firewood use for cooking, and the level 
of crowdedness at households did not exhibit significant associations with ARI occurrence. 
Furthermore, the results of the log-linear model indicate that with each percent increase in 
COHb above the safety level of 2.5%, children are 1.15 (95% CI, 1.03–1.28) times more likely 
to have an additional case of ARI.
The interactive effect of COHb and hematocrit level on occurrence of ARI examined by the 
GAM model is shown in Figure 1. Low COHb concentrations (< 2.5%) were associated with a 
low rate of ARI (0.6 episodes per child per 12 weeks). As COHb level increases, there is a steep 
increase in the likelihood of occurrence of ARI. COHb concentrations that exceeded 5% were 
associated with at least 1.5 ARI episodes per child per 12 weeks of observation. Hematocrit 
level did not affect the observed relationship between individual COHb concentration and 
ARI occurrence.
Table 3. Average COHb concentrations in children attending LT-, MT-, and HT-schools and living in households with 
or without smokers, and with or without  firewood/kerosene use.
  n 
COHb  
(% (mean ± SD)) 
% COHb > 2.5% 
LT-school    
Households with smokers 15 0.76±0.59 0.00 
Households without smokers 44 0.60±0.29 2.27 
MTschool    
Households with smokers 26 2.52±1.1 42.3 
Households without smokers 62 2.55±1.25 41.93 
HT-school    
Households with smokers 11 4.55±1.75 90.9 
Households without smokers 63 5.27±1.62 93.6 
LT-school    
Households with firewood/kerosene use 13 0.59±0.26 0.00 
Households without firewood/kerosene use 47 0.75±0.58 2.21 
MT-school    
Households with firewood/kerosene use 1 2.15 0.00 
Households without firewood/kerosene use 86 2.49±1.15 41.9 
HT-school    
Households with firewood/kerosene use 1 3.24 100 
Households without firewood/kerosene use 73 5.19±1.64 93.2 
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DISCUSSION
The main finding of the study was that COHb concentrations elevated because of traffic 
pollution correlate with the occurrence of ARIs in young children. A high COHb level was 
associated with at least one additional case of ARI in a 12-week period or a 3-fold increase 
in the annual rate of ARI incidence. These associations remain after adjusting for age, sex, 
weight, height, BMI, hematocrit level, previous history of asthma, presence of smokers, 
kerosene and/or wood use for cooking, and level of crowdedness. Our findings imply that 
exposure to a high level of CO, the primary reason for increased COHb concentration, 
may lead to increased susceptibility to ARIs. Information on chronic CO exposure and the 
incidence of respiratory disease in a sensitive subpopulation such as children residing in 
areas with high micronutrient and oxygen deficiency is novel.  
The observed COHb level in the studied population was very high. Even the average 
concentrations exceeded a safe level of 2.5%, mostly due to elevated COHb in children from 
the area with high traffic volume. Almost half of those children had a COHb level consistent 
with acute CO poisoning. Unfortunately, routine monitoring for CO in Quito was not conducted 
at the time of the study. The absence of ambient CO measurements did not allow direct 
assessment of the relations between COHb concentrations and exposure to CO in the studied 
 
Figure 1. The GAM-predicted joint effect of COHb concentration (x-axes) and hematocrit level (y-axes) on the 
occurrence of ARIs during the 12-week study period in young school-age children in Quito, Ecuador
Carboxyhemoglobin and acute respiratory infections
37
population. The sparse CO and particle matter monitoring, performed by the Departmento 
de Control de la Calidad del Aire (Department of Air Quality Control, Quito) in the central 
part of Quito in 1995–1999, has demonstrated that the median monthly concentrations 
of both pollutants consistently exceeded U.S. and European standards (Southgate et al. 
1995). Furthermore, in December and January, CO concentrations exceeded the standards 
three times. It is plausible that the study inception in early January 2000 coincided with the 
seasonal peak in CO exposure, which contributed to elevated COHb levels.
Indoor CO comes predominantly from smoking and heating/cooking fuel combustion. A 
gradient of COHb levels in children with different type of heating systems has been observed, 
0.88 ± 1.34% for wood and coal heating, 0.58 ± 0.97% for gas heating, and 0.28 ± 0.4% for 
electric system, although it was not significant (Vazquez et al. 1997). It has been demonstrated 
that CO inhaled during cooking in high-altitude conditions results in a 1% increase in COHb 
concentration but does not reach clinically unsafe levels (Keyes et al. 2001). Because of the 
warm climate of Quito, with air temperature ranging from 10°C (50°F) at night to 25°C (77°F) 
at noon averaging at 15°C (64°F) year around, the heating systems are not necessary. In 
our study, we did not observe significant effects of smoking or kerosene and/or wood use 
for cooking on individual COHb concentrations. Therefore, we concluded that the dominant 
factor for the significant COHb gradient observed in the study was traffic-related pollution, 
which was different in the three school locations. 
It is important to note that children attending the school located in the central historical 
district of Quito with the heaviest traffic had the highest levels of COHb and the highest 
incidence rate of ARIs. Surprisingly, children from the area with low traffic had the lowest 
COHb levels but did not experience the lowest incidence of ARI. This finding could be 
explained by the potential influence of other factors that we were not able to consider, such 
as anemia, immune status, or the presence of local outbreaks of infection. Although the 
regression analysis demonstrated that the con- founders considered were not associated 
with ARI, it is possible that other factors might influence health outcomes for these suburban 
children. It is also possible that the slight “ridge” of ARI incidence in Figure 1 at very low 
COHb levels occurred because the children who had low COHb concentrations (most of them 
were attending the LT-school) were also more chronically malnourished (stunted) than the 
children from the two other schools (28 vs. 9 and 8%, respectively) (Table 2). The observed 
differences in stunting might be indicative of frequent diarrheal diseases and/or malnutrition 
that occurred in early childhood (Freire et al. 1988). Despite our effort to select schools 
with similar socioeconomic status, we suspect that the students in the suburban area came 
from families with lower literacy levels (considering the lowest percentage of completed 
surveys) and poorer household´s conditions (considering the high rate of crowdedness and 
more frequent use of firewood, the cheapest cooking fuel) than the rest of the students. 
Nevertheless, the subanalysis of potential interactions between stunting and COHb levels 
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in children residing in the low-traffic area revealed that the risk of ARI in children who were 
stunted and had high COHb level was 3.37 (95% CI, 1.001–11.26), but the sample size was 
too small to draw a strong conclusion. Therefore, more detailed studies are needed to 
disentangle the effect of CO exposure from the effect of malnutrition and socioeconomic 
conditions on ARI.
Although we did not find reports on susceptibility to respiratory infections and elevated 
COHb, similar associations between COHb level and inflammatory pulmonary diseases has 
been described (Yasuda et al. 2002). A biologic plausibility for the effect of high CO exposure 
on bronchial-alveolar sys- tem impairing local immune reactivity has been proposed (McGrath 
2000); however, direct investigations of CO effects on innate and adaptive immunity are 
scarce. The following mechanism might explain a local defect of immunoreactivity leading to 
a high susceptibility to respiratory infection. Given that the mobility of immune cells and the 
motility of a ciliar epithelium that lines bronchial-alveolar system are highly ATP- dependent 
processes, the high CO content might directly compete with free radicals for the binding 
site on cytochrome C during oxidative phosphorylation. This might deprive dendritic cells, 
B-cells, and T-cells of ATP- dependent cytokine production, immuno- globulin synthesis, and 
the killing of virus- infected cells (Bona et al. 1999; Caldwell et al. 2001; Loeffler et al. 1990). 
Considering hemoglobin dependency, the oxygen binding might affect the proliferation 
of dendritic cells and T- and B-cell reactivity in the lymphoid organs (Shimizu et al. 1996; 
Taneja et al. 2000). The division of immune cells, primed in bronchial lymph nodes, might be 
affected because of their high sensitivity to hypoxia even when the inhibitory effect CO on 
the neural system is not yet detected.
Our pilot study contributes to the body of literature that demonstrates the harmful 
effect of traffic-related pollution in urban settings. In the last decade, the air quality has 
been rapidly decreasing in Quito because of urbanization and increasing exhaust from public 
transportation. According to the Dirección Nacional de Tránsito, Quito, the number of cars 
registered in Quito rose from 174,875 in 1995 to 209,757 in 1998. Diesel is used in the vast 
majority of trucks and buses and in 6% of the cars (Jurado 1991). The city lies in a narrow 
valley with a north–south orientation of encircling mountains and environmental conditions 
challenged by high volcanic activity and El Niño effects. The polluted air in the city is often 
stagnant, and its clearance depends mainly on prevailing wind and precipitation. Strict 
emission regulations, as much as economic development, are crucial to the nation of Ecuador. 
Unfortunately, economic capacities to address the issues of health and the environment at 
the municipal and national levels, are severely constrained by harsh economic situations 
and shifting political factors. Nonetheless, receptivity to environmental concerns is evolving 
rapidly. 
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ABSTRACT
Background: This study documented elevated rates of emergency room (ER) visits for 
acute upper and lower respiratory infections and asthma-related conditions in the children 
of Quito, Ecuador associated with the eruption of Guagua Pichincha in April of 2000.
Methods: We abstracted 5169 (43% females) ER records with primary respiratory 
conditions treated from January 1 – December 27, 2000 and examined the change in 
pediatric ER visits for respiratory conditions before, during, and after exposure events of 
April, 2000. We applied a Poisson regression model adapted to time series of cases for three 
non-overlapping disease categories: acute upper respiratory infection (AURI), acute lower 
respiratory infection (ALRI), and asthma-related conditions in boys and girls for three age 
groups: 0–4, 5–9, and 10–15 years.
Results: At the main pediatric medical facility, the Baca Ortiz Pediatric Hospital, the rate of 
emergency room (ER) visits due to respiratory conditions substantially increased in the three 
weeks after eruption (RR = 2.22, 95%CI = (1.95, 2.52) and RR = 1.72 95%CI = (1.49, 1.97) for 
lower and upper respiratory tract infections respectively. The largest impact of eruptions on 
respiratory distress was observed in children younger than 5 years (RR = 2.21, 95%CI = (1.79, 
2.73) and RR =2.16 95%CI = (1.67, 2.76) in boys and girls respectively). The rate of asthma 
and asthma-related diagnoses doubled during the period of volcano fumarolic activity (RR = 
1.97, 95%CI = (1.19, 3.24)). Overall, 28 days of volcanic activity and ash releases resulted in 
345 (95%CI = (241, 460)) additional ER visits due to respiratory conditions.
Conclusion: The study has demonstrated strong relationship between ash exposure and 
respiratory effects in children.
Keywords: emergency room, respiratory conditions, Guagua Pichincha, eruption
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INTRODUCTION 
The danger of living near active volcanoes has been well documented since ancient 
times, from the ruins of Pompeii to the recent satellite images of volcano eruptions. 
Volcanic activity is typically associated with toxic emissions; pyroclastic flows (the mixture 
of rock fragments and superheated gases, which can achieve speeds over 100 km/hr and 
temperatures over 300°C); the release of ash; volcanic gases containing carbon dioxide, 
water vapor, sulfur dioxide, hydrogen chloride, hydrogen sulphide, hydrogen fluoride, etc.; 
and polycyclic aromatic hydrocarbons produced whenever any complex organic material is 
burned by hot pyroclastic flows (1,2). Although approximately 455 million people worldwide 
live within potential exposure range of an active volcano, information on the acute and 
chronic respiratory health effects of volcanic emissions is sparse (3,4).
The 1980 eruption of Mt. St. Helens (5) led to numerous studies of health effects of 
volcanic emissions. The acute effects of volcanic ash fall and gases on respiratory conditions 
vary from undetected to well-defined (2,3). Transient acute irritant effects of volcanic ash 
and gases on the mucous membranes of upper respiratory tract and exacerbation of chronic 
lung diseases during and shortly after eruptions with heavy ash fall have been documented 
(6,7). Such relationships have been found following the more recent eruption in Cerro Negro, 
Nicaragua in 1992 (8), Mt. Sakurajima in Japan (9), and Mt. Tungurahua in Ecuador (10).
Quito, the capital of Ecuador, located 2800 m above sea level, is surrounded by four active 
volcanoes: Guagua Pichincha, Cotopaxi, Antisana, and Tungurahua (11). The stratovolcano 
Guagua Pichincha is located 13 km (7 mi) west of Quito and became active in 1998 after 
340 years of dormancy with emissions of vapor, ashes, and fumes. In the spring of 2000, 
volcanic ashes containing silica, sulfurs, and particulate matter were again reported and 
yellow alerts were issued for the city of Quito. Nestled in a long, narrow valley between 
the base of the mountain range to the west and the precipitous canyon of the Machángara 
River to the east, Quito possesses an unmatched setting: a dangerous chamber created 
by the nature and enhanced by humans (Figure 1). Over the last two decades, the rapid 
urbanization and sprawl has resulted in hazardously high levels of air pollutants (12,13). 
Quito’s unique geographical location, with its topology and the pattern of prevailing wind, 
traps stagnant contaminated air. At that altitude, where the demand for oxygen is high, even 
a small increase in air pollution may trigger a substantial increase in ER visits for respiratory 
conditions. In fact, our own studies indicate strong effects of air pollution on respiratory 
health in Quito’s children (14).
Recent work has emphasized a complex spectrum of health problems associated with 
direct and indirect effects of displacement, disruptions in infrastructure (15,16), soil, 
air, and water contamination (17,18). Studies stress the need for implementing efficient 
surveillance systems to monitor the health effects associated with various environmental 
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and socio-economic factors, especially in the most vulnerable populations (8). In the absence 
of such surveillance systems, we have made an attempt to characterize the respiratory 
health outcomes that often reflect the most severe conditions requiring urgent ER visits 
and hospitalization. In the presented study we describe the change in pediatric ER visits for 
respiratory conditions before, during, and after ash falls in Quito due to Pichincha volcano 
eruptions which occurred in April, 2000. We believe that the results of this study provide 
important information for environmental public health policy and better understanding of 
the short term effects of environ- mental exposure to volcanic ashes on human health.
DATA AND METHODS
Study population and outcomes
This study was conducted at the Baca Ortiz Children’s Hospital, Quito’s largest government-
subsidized facility, which provides care to approximately 307,000 children under 15 years of 
age residing in the Quito Metropolitan area and surrounding communities (19). During 2000, 
72,039 children were treated at the hospital’s outpatient departments, 22,353 children 
were assisted at the hospital’s emergency room, and about six per cent of children visited 
ER were treated for respiratory illnesses, mainly pneumonia (Department of Statistics, Baca 
Ortiz Hospital, 2000, unpublished data). The Ethical Committee of Ecuador and the Tufts IRB 
granted permission for abstraction of de-identified records.
We abstracted 5169 (43% females) ER records with primary respiratory conditions treated 
from January 1 – December 27, 2000. For each case the following information was recorded: 
age, sex, residential location (barrios), admission date, temperature, weight, respiratory rate, 
Figure 1. Aerial photograph of Quito, the capital of Ecuador. 
Foot- notes: The Pichincha volcano located west of Quito is in the central background of the picture. Along its base 
is the narrow strip with an air pollution haze stretching from left to right (south to north) across the city
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and primary diagnosis. For 4416 (85%) children nutritional status was determined using EPI/
Info software (20) and classified as underweight if the weight-for-age z-score was more than 
two standard deviations below the age adjusted mean and normal otherwise. Based on the 
primary diagnosis given in the ER and similar to previous study (14) we classified records 
into three non-overlap ping categories: acute upper respiratory infection (AURI), which 
includes conditions coded as pharyngitis, tonsillitis, sinusitis, rhinitis, laryngitis, and their 
combinations; acute lower respiratory infection (ALRI), which includes conditions coded 
as pneumonia, bronchopneumonia, traqueobronchitis, bronchitis; and asthma-related 
conditions (2392, 2319, and 431 cases in each group respectively). We estimated the annual 
incidence rate for ER visits (per 1000 children) in boys and girls for three age groups: 0–4, 
5–9, and 10–15 years using the estimates of population served calculated from census data 
(18).
The timing of eruption
We abstracted information on Guagua Pichincha activity from various sources, including 
Instituto Geofisico de la Escuela Politecnica Nacional, Volcano Ash Advisory Archive, 
maintained by the NOAA Satellite and Information Service (21), and the main local news 
media, and created a timeline of exposure-related volcanic activity. Figure 2 illustrates the 
compiled timeline superimposed on the time series of daily counts of respiratory infections in 
the studied population. In the spring of 2000 Pichincha was active; in February, plumes rose 
to 1–2 km often carrying noticeable ash, and a few ash falls were seen near the vent. During 
January to April, fumarolic activity was moderate but variable, often most noticeable a week 
before eruptions (shown as a pink bar in Figure 2). Between April 9 and12 (days 99–102 in 
the Figure 2), the volcano erupted approximately 18 times. Ash clouds rose 0.8 km into the 
air. More than 100 seismic tremors were recorded during the eruptions. A yellow alert was 
issued for the city on April 12. On April 16, the volcano sent clouds of vapor 0.5 km into the 
sky over Quito. We defined four periods for analysis: fumarolic activity period – Period 1, one 
week post eruption – Period 2, two weeks post eruption – Period 3, and three weeks post 
eruption – Period 4. We also abstracted daily measures for temperature and precipitation, 
obtained from the Instituto Nacional de Meteorología e Hidrología of Ecuador (22).
Models and analysis
Six time series of daily counts of ER visits were compiled based on the date of admission: 
for males and females in each of the three age categories. In 52 (1%) records, a missing day 
was replaced with a mid-month value. Pair- wise Spearman correlations between time series 
for boys and girls ranged from 0.4 to 0.7 (all significant) indicating similarity of temporal 
patterns. Three time series of daily counts of ER visits for each diagnostic group for all 
children were created.
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We also compiled a set of binary time series to indicate the timing of volcano eruptions 
including one, two, and three-week post-eruption periods (shown as red bar in Figure 2) 
and one week prior eruption (shown as pink bar in Figure 2). To examine the relationship 
between the timing of the volcanic eruption and ER visits we applied a Poisson regression 
model adapted to time series data adjusted for effects of the day of the week, official 
holidays and potential effect of replaced missing dates, and meteorological factors: log (Y(t)) 
= β0+ β1E+ β2D+ β3H+ β4P+ε(t), where Y(t) is a time series of cases, and bs are regression 
parameter for the variables reflecting presence of exposure (E), weekly cycle (D), holidays 
and mid-month indicator (H), and weekly precipitation level (P). The predicted daily rate of 
ER visits per 1000 children; the relative risks (RR), and their 95% confidence intervals (95%CI) 
were estimated for boys and girls in three age groups for all ER visits and for three diagnostic 
groups in all children. To examine if the higher rate of ER visits in malnourished children was 
associated with exposure we performed the χ2-test.
To characterize the spatial distribution of ER cases we geocoded 4786 (93.4% of all 
records) and categorized patients’ residential locations into three regions: the City of Quito, 
the city suburbs, and the area outside the city metropolitan boundaries. Locations of Quito 
residents were further subdivided into sixteen parishes and five large suburban areas. The 
spatial distribution of cases and its change during the eruption period were examined.
 
Figue 2. The time line of the Guagua Pichincha volcano activity, daily ER visits, and weekly precipitation. 
Footnotes: Time series of daily cases of ER visits for first 200 days are shown. The most noticeable fumarolic activity 
was observed a week prior eruptions (shown as a pink bar). On April 10th and 11th (days 100 and 101), the volcano 
erupted approximately 18 times. More than 100 seismic tremors were recorded during the eruptions. Ash clouds 
rose 0.8 km into the air on April, 10th and then another cloud of vapor was seen on April 16th. A yellow alert was 
issued for the city Quito. The study periods (2, 3, and 4) are indicated as a red bar.
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RESULTS
The descriptive characteristics of population served by the Baca Ortiz Hospital and annual 
incidence rates of ER visits due to respiratory infections are shown in Table 1. The mean age 
for girls and boys was 3.23 ± 3.10 years and 3.18 ± 3.08 years, respectively. The annual rates 
of infections were consistently higher in males in every age category.
Based on the results of the regression model we estimated the daily means of ER visits 
for a period that include time before and three weeks after the eruption (344 days). We also 
estimated the relative risks of the increase in the daily mean ER visits during the four defined 
periods of volcanic activity (28 days). These estimates are shown in Table 2. Overall, children 
under 4 years of age were treated at the ER three times more often than older children. At 
base- line, the daily mean ER visits was significantly higher in the youngest children compared 
to children older than 5 y.o. (0.092; 95%CI = (0.088, 0.098) vs. 0.024; 95%CI = (0.021, 0.027), 
p < 0.0001). The daily means of ER visits in the youngest children were two times higher 
during all four defined periods of volcanic activity than pre and post eruption after adjusting 
for the baseline differences. The relative risks for ER visitations were similar in boys and girls 
(e.g. during one-week post eruption: RR = 2.21, 95%CI = (1.79; 2.73) and RR = 2.16, 95%CI = 
(1.69; 2.76), respectively). These findings indicate that increases in daily cases relative to the 
annual average (e.g. Figure 2– red horizontal line) were significant for all ER visits and each 
disease group.
Table 1. Annual incidence rates of ER visits for three specific diagnostic groups
    Age groups 
    0 – 4 5 – 9 10 – 15 all ages 
Population serveda      
 females 49860 50964 61267 162091 
 males 51332 52160 61709 165201 
Annual rateb      
 females 32.83c 8.37 2.57 13.70 
 males 42.43 11.38 2.88 17.85 
Annual rate of AURI c      
 females 16.02 3.21 0.92 6.28 
 males 21.39 4.37 0.78 8.32 
Annual rate of ALRI      
 females 15.53 3.36 1.00 6.21 
 males 19.47 4.72 1.19 7.98 
Annual rate of 
Asthma      
 females 1.11 1.78 0.64 1.14 
  males 1.43 2.24 0.90 1.49 
 
a Values are estimated from the Census 2000, Ecuador. 
b Annual rates are estimated per 1000 children served by the Baca Ortiz Hospital.
c Estimated as: (number of cases/population served) × 1000
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On average, the predicted rates of ER visits for acute upper and lower respiratory tract 
infections were significantly higher (from 1.65 to 2.32 times) during all four predetermined 
periods compared to the rates in pre and post eruption periods (Table 3). The rate of 
asthma and asthma- related diagnosis was two times higher during the period of fumarolic 
activity RR = 1.97, 95%CI = (1.19, 3.24), but not during other time periods. Eight percent of 
children admitted to ER were underweight. No difference in the rates of ER visits between 
underweight and normal children associated with exposure was observed (χ2-test; p = 0.24).
An observed 2.25-fold increase in daily ER visits was present in all parts of the city (Table 
4 and Figure 3). The suburb residents accounting for 20% of ER visits experienced a 3-fold 
increase (3.05) in daily counts of ER visits during the volcano eruption period. Overall, during 
28 days of volcanic activity and ash releases on average 138 girls 95%CI = (104, 207), and 206 
boys 95%CI = (137, 252), were treated in ER in addition to typically observed level of 6.17 and 
8.18 cases per day in girls and boys respectively.
Table 2. Predicted daily rates of ER visits and the relative risks associated with the volcanic activity
Age Groups   Males     Females   
  estimate LCI UCI estimate LCI UCI 
Daily ratesa       
0–4 0.104 0.099 0.110 0.080 0.076 0.086 
5–9 0.027 0.024 0.030 0.020 0.018 0.023 
10–15 0.007 0.006 0.009 0.007 0.005 0.008 
All 0.043 0.041 0.045 0.040 0.039 0.042 
Relative Risksb 
Fumarolic activity period – Period 1 
0–4 2.008 1.610 2.504 1.953 1.509 2.527 
5–9 1.698 1.075 2.681 1.358 0.746 2.472 
10–15 1.180 0.438 3.180 1.681 0.690 4.098 
All 1.927 1.587 2.339 1.799 1.458 2.220 
One week post eruption – Period 2 
0–4 2.212 1.791 2.732 2.156 1.685 2.758 
5–9 1.331 0.797 2.222 1.106 0.571 2.140 
10–15 2.102 0.987 4.476 0.996 0.318 3.121 
All 1.965 1.621 2.381 1.799 1.458 2.220 
Two weeks post eruption – Period 3 
0–4 1.995 1.699 2.344 2.280 1.913 2.718 
5–9 1.434 1.004 2.048 1.108 0.691 1.777 
10–15 1.820 1.013 3.270 0.488 0.156 1.530 
All 1.795 1.552 2.076 1.894 1.632 2.199 
Three weeks post eruption – Period 4 
0–4 2.056 1.799 2.350 2.096 1.798 2.442 
5–9 1.579 1.188 2.100 1.067 0.717 1.586 
10–15 1.625 0.972 2.716 0.879 0.431 1.790 
All 1.891 1.678 2.130 1.807 1.591 2.052 
 
a Estimated baseline together with 95% confidence interval (LCI, UCI) for cases per day per 1000 served population 
before and after volcanic eruption.
b Relative  risks together with  95% confidence interval (LCI, UCI) for cases per day per 1000 served population for 
effects of the day of the week, official holidays and weekly precipitation.
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Table 3. The relative risks associated with the volcanic activity for three diagnostic groups.
  ALRI (n = 2392) AURI (n = 2319) ASTHMA (n = 431) 
 RRa LCI UCI RR LCI UCI RR LCI UCI 
Period 1b 2.056 1.665 2.538 1.654 1.314 2.082 1.966 1.193 3.239 
Period 2c 2.318 1.899 2.830 1.677 1.334 2.107 1.586 0.913 2.754 
Period 3d 2.125 1.827 2.473 1.808 1.541 2.122 1.089 0.679 1.746 
Period 4e 2.221 1.959 2.518 1.716 1.497 1.968 0.963 0.638 1.453 
 
a The relative risks and their 95% confidence intervals (LCI, UCI for all ages combined) of an increase in the daily 
mean ER visits during the defined periods for three diagnostic groups.
b Fumarolic activity period – Period 1
c One week post eruption – Period 2 
d Two weeks post eruption – Period 3
e Three weeks post eruption – Period 4
Table 4. Geographical distribution of residential locations of patients visited emergency room visits at two periods
  
  
Pre and post 
eruption  
(334 days) 
During eruption  
(28 days)     
Region Parishes 
Total 
cases 
Cases 
per day 
Total 
cases 
Cases 
per day 
Ratio 
Percent
age 
City of Quito (n = 405,206)a        
Turubamba (South) 443 1.33 85 3.04 2.29 11 
 Guamani 64 0.19 8 0.29 1.49 2 
 Chillogallo 219 0.66 43 1.54 2.34 5 
 Las Cuadras 120 0.36 26 0.93 2.58 3 
 El Beaterio 40 0.12 8 0.29 2.39 1 
Urinsaya (South Central) 902 2.70 173 6.18 2.29 22 
 Villaflora 333 1.00 69 2.46 2.47 8 
 La Magdalena 140 0.42 25 0.89 2.13 3 
 Chimbacalle 141 0.42 24 0.86 2.03 3 
 Eloy Alfaro 288 0.86 55 1.96 2.28 7 
Yavirac (North Central) 1095 3.28 234 8.36 2.55 28 
 San Roque 321 0.96 64 2.29 2.38 8 
 Santa Prisca 180 0.54 36 1.29 2.39 5 
 EL Batan 66 0.20 14 0.50 2.53 2 
 San Blas 528 1.58 120 4.29 2.71 14 
Anansaya (North) 936 2.80 162 5.79 2.06 23 
 La Concepcion 168 0.50 24 0.86 1.70 4 
 Cotocollao 201 0.60 43 1.54 2.55 5 
 Carcelen 333 1.00 53 1.89 1.90 8 
 El Inca 234 0.70 42 1.50 2.14 6 
Quito suburbs (n = 136,466)a 422 1.26 108 3.86 3.05 11 
 
Valle Tumabco 
(East) 79 0.24 24 0.86 3.62 2 
 San Antonio (North) 48 0.14 11 0.39 2.73 1 
 
Calderon (North 
East) 159 0.48 41 1.46 3.08 4 
 
Valle de los Chillos 
(South East) 136 0.41 32 1.14 2.81 4 
 Amaguana (South) 10 0.03 2 0.07 2.39 0.3 
Outside of Quito Metropolitan 
Area 169 0.51 45 1.61 3.18 4 
Total geocoded cases 3977 11.91 809 28.89 2.43 100 
 
a The numbers in parenthesis represent the population of children under 15 years of age.
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DISCUSSION
This study documented elevated rates of ER visits for acute upper and lower respiratory 
infections and asthma-related conditions in the pediatric population of Quito associated 
with the eruption of Guagua Pichincha in April of 2000. Although Pichincha activity during 
 
Figure 3. A schematic map of the city of Quito. 
Footnotes: Names of parishes from where geocoded residential locations of patients that visited the emergency 
room of the Baca Ortiz Hospital in 2000 correspond to Table 4.
 
Figure 4. A composite map of ash deposition from Pichincha eruptions (October 1999 – July 2000) demonstrating 
the extensive area affected by ashfalls. 
Footnotes: The map has been modified from the images of the Volcano Ash Advisory Archive (21), courtesy of Dr. 
Yepes, the Geophysical Institute of Ecuador.
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the year 2000 was generally more moderate than in 1999, the rate of pediatric ER visits due 
to respiratory conditions following volcanic eruptions in April of 2000 doubled. The rate of 
asthma and asthma-related diagnosis was two times higher during the period of fumarolic 
activity of Pichincha. The largest increase in ER visitations was observed in the youngest 
children.
We demonstrated the potential of ER record utilization for monitoring the health 
effects associated with volcanic activity. Our study illustrates a set of analytical tools useful 
as the basis for pre-disaster planning and preparedness in areas where explosive and 
effusive volcanic eruptions are relatively common in proximity to vulnerable populations. 
Observed associations imply a potential scenario for compositions of immediate and delayed 
health effects following single or multiple exposure releases (23). The onset of respiratory 
symptoms can manifest as three distinct waves. The first wave is composed of symptoms 
associated with the transient acute irritant effects of volcanic ash and gases on the mucous 
membranes of the eyes and upper respiratory tract, evidenced by the increase in asthma-
related diagnosis which doubled during the period of fumarolic activity. The second and the 
third waves reflect conditions apparent with a specific delay and include acute upper and 
lower respiratory infections.
Volcanic ash is capable of inducing acute respiratory problems in susceptible people 
especially children and those with history of respiratory illness such as asthma or bronchitis 
(6,3,24,25). The precise mechanism of those respiratory problems has not been well defined; 
however, its complexity has been outlined (3,26). The basic etiology of lung inflammation 
begins with deposition of the particles into the lung. The location of the particle’s deposition 
can be influenced by breathing pattern, the branched morphology of the airways, particle size 
and shape (1). If a particle lodges in the main airways, it is cleared by the mucociliary escalator 
(27). If it penetrates into the non-ciliated alveolar level, it may be cleared by the phagocytic 
alveolar macrophages. However, in the latter scenario, the particles may impair macrophage-
mediated removal and these particles are not cleared. Some particles may directly penetrate 
the alveolar epithelium and reach the lung’s deep lymph node drainage. Macrophages have 
also been shown to become inundated with inert particles, which subsequently halt the 
clearance of all particles at the alveolar level (28). Macrophages release toxins which are 
utilized to destroy particles; however the released IL-1, IL-6, tumor necrosis factor (TNF), 
fibroblast growth factor, and the affluence of polymorphonuclear neutrophils damage the 
host’s lung tissue (1). The short-term effect of the above processes is lung inflammation, 
which manifests itself as difficulty in breathing and increased susceptibility to respiratory 
infections. Long-term prognoses include possibly fibrosis and carcinogenesis (29).
The irritant effect of volcanic ash on human airways depends on the physical and chemical 
proprieties of the ash including particulate size (6,30), the concentration of respirable ash 
particles, mineralogical composition, and duration of exposure (3). It also depends on main 
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features of the respiratory tract such as ventilation rate, the nasal filtration efficiency, and 
the mucocilliary clearance rate (30). Several in vitro and in vivo experiments on different 
lung cells and animals suggest that inhaled volcanic ash is less toxic to the lung than other 
compounds like fine and coarse ambient particulate matter, quartz, or free crystal line 
silica. Some observations support the notion that volcanic ash is not a potent stimulus 
to lung inflammation since it does not stimulate the release of IL-8, a quimiotactic factor 
for neutrophils, nor does it depress g-interferon and TNF-± secretion from either human 
alveolar macrophages or normal human bronchial epithelial cells (31,32). However, it has 
been shown that physical immunologic barriers such as cilliary beating frequency and 
mucous lining can be altered after a short exposure to volcanic ash (33). It has been reported 
that humoral immunologic parameters can also be affected by volcanic ash; for instance, 
workers exposed to volcanic ash had significantly lower C3 and C4 levels as well as marked 
decrease in serum IgG levels when compared to unexposed controls (34). Immunological 
assays have shown that IgA, IgG, and albumin, airways proteins, play a protective role in 
mediating the effect of inhaled dust in human lungs (30). Therefore, we hypothesize that 
young and malnourished children with pre-existing low levels of immunoglobulins, could be 
at higher risk for respiratory problems than healthy children. We did not find a difference 
in respiratory distress between underweight and nor- mal children, potentially due to low 
sensitivity of weight- for-age measures in older children, but the age difference was well 
pronounced.
Moreover, some rodent models suggest that exposure to different particulate air 
pollutants including volcanic ash, stimulates immunocompetent cells, e.g. monocytes, 
more strongly than alveolar macrophages, to produce oxidative response (35). Exposure 
to volcanic ash was also found to be related to an impairment of stimulated superoxide 
production while resting superoxide anion production is normal suggesting that volcanic ash 
might pose a risk for infection by compromising phagocyte antibacterial functions (36). Such 
mechanisms may explain why individuals with underlying lung impairment including chronic 
inflammation are more susceptible to harmful effect of air pollution than healthy individuals. 
At Quito’s altitude, where the demand for oxygen is high, even a small increase in CO, SO2, 
CO2, and similar compounds that might affect hematocrit level (and are already known to 
be associated with asthma exacerbation) may trigger a substantial increase in ER visits for 
asthma exacerbation especially during volcano’s fumarolic activity.
Very little is known on the effects of “fresh” fractured silica particles on the developing 
lung tissue in young children. One may speculate that rough edges of silica particles due 
to micro-abrasion may damage the epithelial lining and promote pathogen colonization. 
Together with the high susceptibility for viral infections, which often followed by bacterial 
pneumonia, this may explain an increase in acute lower respiratory infections of bacterial 
origin in young children.
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We believe that the observed effect most likely reflects the increase in severity of acute 
respiratory infections and exacerbation of preexisting asthma-related conditions. In the 
absence of surveillance systems that can continuously and efficiently monitor the health 
effects associated with various environmental and socio-economic factors, we were using 
health outcomes that often reflect the most severe conditions, which require urgent ER visits 
and hos- pitalizations. We also anticipate that young children with pneumonia and asthma-
related conditions are more likely to be hospitalized than older children or children with 
acute upper respiratory infection. In our recently completed four-year longitudinal study 
of Quito’s children aged from 6 to 36 months, we recorded 4,450 cases of AURI and 518 
physician-diagnosed cases of pneumonia, out which six (1.2%) cases required hospitalization 
(Sempertegui et al, in preparation). Furthermore, of all the AURI episodes, 102 (2.3%) 
progressed into ALRI. Therefore, we anticipate that for one episode of hospitalization due to 
pneumonia there are approximately 86 cases of mild pneumonia. This observation helped us 
to assert the severity of respiratory conditions. In fact the observed effect was very similar 
with reported increase in AURI (2.6 times), ALRI (2.5 times) and asthma (2.1 times) eruptions 
of Tungurahua in 1999 (37).
The observed increase in respiratory infections in April of 2000 was most likely triggered 
by aerosols and ash falls produced by Pichincha eruptions. However, we recognize that 
the main limitation of our analysis is the absence of direct measures of exposure. It is also 
plausible that ash particles deposited during 1999 ash falls can be re-suspended in the air 
without elevated volcanic activity. Unfortunately, in Quito, systematic monitoring of air 
quality for critical air pollution was initiated after 2000, so we can only rely on indirect proxies 
such as satellite imagery records for ash emissions and daily records on seismic activity of 
Pichincha to establish the timing of high exposure (21). We assessed the relations between 
ER visits and timing of high exposure in a manner of ecological analysis, limitations of which 
pose caution on our conclusions. First of all, health effects of volcanic aerosols and ambient 
traffic-related pollution are difficult to disentangle. Secondly, volcanic activity is a continuous 
process, in which the delayed health effects of one event may over- lap with others. Thirdly, 
a seasonal elevation in incidence of respiratory infections and pneumonia could coincide 
with the eruption and therefore bias the results. Finally, temporal variations in ER visits could 
be prompted by a number of social factors (e.g. weekends, holidays, strikes) as well as by 
changes in perception associated with volcano alerts. Although potential confounding by air 
pollution, continuous volcanic activity, seasonal infection rates and reporting bias could have 
affected our study, we believe that their role is not substantial.
Volcanic ashes worsened the already poor air quality in Quito (14). Typically, the chemical 
composition of ashes could be distinguished from by-products of man-made air pollutants in 
urban settings. However, one of the most predominant and routinely measured components, 
particular matter of 10 micron in diameter and larger (PM10), are in both volcanic ashes 
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and traffic-related products of incomplete combustion. In fact, a few samples of PM10 
concentrations collected in urban Quito in the late-fall of 1999 demonstrated an extremely 
high level of PM10 in both the northern and southern parts of the city. For instance, during 
the 1999 Pichincha eruption PM10 increased progressively from 58 μg/m3 in September 
30, to 407 μg /m3 in October 6–7, to 1487 μg /m3 in November 26, 1999, exceeding the 
allowed level by 8 to 28 times (25). Unfortunately, specific information of ash composition, 
transport, and deposition is limited, especially for eruptions prior to 2000 (39). It has been 
reported that the ash contained substantial respirable material and an elevated cristobalite 
content (26,40). An elementary description of Guagua Pichincha ash given by Baxter (26) for 
three consecutive eruptions in November 1999, July 2000, and February 2002, is based on 
percentage of PM10 in ash that ranged from 7.9 to 13.6, not too dissimilar to Mount St Helens 
1980 ash composition (5). The data from two other Ecuadorian eruptions of Tungurahua 
and El Reventador volcanoes in 2001 suggested that in Quito area the ash layer was mainly 
composed of medium to fine ash particles with about 20% free crystals (41). This study also 
indicates that the ash re-suspended during the windy afternoons caused ocular irritation, 
respiratory troubles, and other health problems.
Quito was affected by several episodes of ash emission in October – December of 1999, 
April 2000, and July 2000 (see Figure 4). It is possible that our estimates of the ER rates 
before and after the eruptions in April could have been elevated by these prior eruptions, 
and then we probably underestimated the effect. It is also plausible, that we were able to 
detect the effect of volcanic activity due to little or no rain, which would have cleansed the 
air during the days of eruption (see Figure 1). Again, additional studies are needed to better 
quantify the effect of ash fallouts and related pollutants.
The seasonal variations in respiratory infections in Ecuador, and specifically in Quito, 
are poorly documented. In our own research, we noticed that the incidence of acute upper 
respiratory infections has no pronounced seasonal variations. The incidence of pneumonia 
however had a defined seasonal peak in December, January, and February with the lowest 
level in May, June, and July (Naumova, unpublished data). We believe that an increase of 
ER visits observed in late April and early May is unlikely to be obscured by typical seasonal 
variations in the incidence of respiratory infections.
This study was conducted in a government-subsidized hospital, easily accessible by public 
transportation, pro- viding free care exclusively for children. Although, the quality of medical 
care utilization may depend on socio- economic status, the main routines of ER visitations 
are fairly standard in city hospitals. The change in attitudes and perceptions of potential risks 
associated with volcano eruption in patients, their parents, and physicians could potentially 
affect the pattern of ER visitations (38). However, little is known about behavioral aspects of 
medical service utilization in Quito. Important studies performed by the University of South 
Florida suggest that attitudes of high resilience, e.g. the ability to withstand stresses are 
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quite dominant in small Ecuadorian towns affected by volcanic activity of Tungurahua and 
Chimborazo (10). Furthermore, before the April eruptions, a series of yellow alerts (which 
assumed to be prepared to close schools and businesses and to evacuate when necessary, 
to know the plan of alternative and evacuation routes, locations of shelters and hospitals) 
(11) could have warned both physicians and families disrupted by the disaster, and therefore 
over-utilization is somewhat implausible. Strikes of medical personnel or closing of hospitals 
(events that could artificially lower the rate of ER visits) can occur in Quito, however the 
days with extremely low counts are not systematic and no records of strikes in Baca Ortiz or 
any city hospitals before or after the April eruption of 2000 are known. We believe that the 
observed increase in ER visits at the Baca Ortiz Hospital after the volcano eruption reflect a 
plausible health effect on children from families with low and moderate income living in all 
communities of Metropolitan Quito.
CONCLUSION
We documented significantly increased levels of respiratory disease in Quito children 
after a volcanic eruption using hospital records. Sound environmental decisions require 
estimates of the burden of disease or other externalities suffered by the population. In 
Ecuador, continuous monitoring of air quality is in its infancy, population based surveillance 
data relevant to environmentally linked diseases are scanty, and often not usable except 
for descriptive purposes. The quality of passively reported information obtained by the 
authorities is variable. Quito hospitals do not collect data from emergency room visits 
or hospitalizations in a manner suitable for detailed analysis electronically and records 
abstraction was performed manually. Nevertheless, the fraction of missing data in the 
compiled database is ~5%). It is feasible to prospectively collect highly specific information in 
ER of Baca Ortiz Hospital in electronic format and at low cost. The next natural steps of this 
study are to abstract historical ER records that will cover a longer time span including dramatic 
volcanic eruptions of 1999, the period of volcano dormancy and initiate prospective data 
collection with the emphasis on linking health and environmental information. We believe 
that at this stage remote sensing data can provide highly valuable information regarding the 
characterization of ash deposition (42). However, remotely sensed data on ash transport 
and deposition might have some limitations. For example, current techniques are not 
uniformly effective in classifying volcanic ash and may falsely interpret meteorological clouds 
as volcanic ash clouds and conversely (43). Future interdisciplinary studies are required to 
convert remote sensing data and other data related to volcanic activity into information 
relevant to public health needs. The efforts to prospectively acquire human health and 
disease information from sentinel populations, or from representative populations, will build 
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disease surveillance capacity which will greatly improve our knowledge and decision making 
at many levels.
ABBREVIATIONS
particular matter (PM), emergency room (ER), acute upper respiratory infection (AURI), 
acute lower respiratory infection (ALRI), relative risks (RR), confidence intervals (CI), lower 
boundary of confidence interval (LCI), upper boundary of confidence interval (UCI), tumor 
necrosis factor (TNF).
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ABSTRACT
Background: Ambient air pollution and malnutrition, particularly anemia, are risk factors 
for pneumonia, a leading cause of death in children under five. We simultaneously assessed 
these risk factors in Quito, Ecuador.
Methods: In 2005, we studied two socioeconomically similar neighborhoods in Quito: 
Lucha de los Pobres (LP) and Jaime Roldos (JR). LP had relatively high levels of air pollution 
(annual median PM2.5 = 20.4 μg/m3; NO2 = 29.5 μg/m3) compared to JR (annual median 
PM2.5 = 15.3 μg/m3; NO2 = 16.6 μg/m3). We enrolled 408 children from LP (more polluted) 
and 413 children from JR (less polluted). All subjects were aged 18-42 months. We obtained 
medical histories of prior physician visits and hospitalizations during the previous year, 
anthropometric nutrition data, hemoglobin levels, and hemoglobin oxygen saturation via 
oximetry.
Results: In anemic children, higher pollution exposure was significantly associated with 
pneumonia hospitalization (OR = 6.82, 95%CI = 1.45-32.00; P = 0.015). In non-anemic children, 
no difference in hospitalizations by pollution exposure status was detected (OR = 1.04, NS). 
Children exposed to higher levels of air pollution had more pneumonia hospitalizations (OR 
= 3.68, 1.09-12.44; P = 0.036), total respiratory illness (OR = 2.93, 95% CI 1.92-4.47; P < 
0.001), stunting (OR = 1.88, 1.36-2.60; P < 0.001) and anemia (OR = 1.45, 1.09-1.93; P = 
0.013) compared to children exposed to lower levels of air pollution. Also, children exposed 
to higher levels of air pollution had significantly lower oxygen saturation (92.2% ± 2.6% vs. 
95.8% ± 2.2%; P < 0.0001), consistent with air pollution related dyshemoglobinemia.
Conclusions: Ambient air pollution is associated with rates of hospitalization 
for pneumonia and with physician’s consultations for acute respiratory infections. 
Anemia may interact with air pollution to increase pneumonia hospitalizations. 
If confirmed in larger studies, improving nutrition-related anemia, as well as 
decreasing the levels of air pollution in Quito, may reduce pneumonia incidence. 
Keywords: anemia, pneumonia, air pollution, children
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INTRODUCTION 
Pneumonia is the leading cause of childhood death (1, 2).  The pathogenesis of pneumonia 
includes environmental and host factors, such as air pollution and malnutrition (2). Air 
pollutants are respiratory irritants and increase susceptibility to acute respiratory infections 
(ARI) (3, 4). Air pollution increases morbidity and mortality largely from respiratory diseases 
(5), and reducing ambient air pollution increases lifespan (6). Particulate air pollution (PM), 
especially particles < 10 μm (PM10) and < 2.5 μm (PM2.5) in aerodynamic diameter, and 
nitrogen oxides (NOx) are specifically linked to childhood ARI (7-9). Outdoor (ambient) air 
pollution, and indoor pollution from biofuel use, have been identified as major pneumonia 
risk factors (2, 3).
Globally, many malnourished children are exposed to high levels of air pollution. Also, 
because malnourished children are known to be at increased risk for pneumonia (1, 2,10,11), 
a synergistic relationship between ambient air pollution and malnutrition has been postulated 
(2). Previous studies of pneumonia have examined either air pollution or malnutrition (e.g. 
(12-15)) but not both risk factors simultaneously. We explored the relationship between 
air pollution and malnutrition in Quito, Ecuador where both risk factors are prevalent. Our 
primary objective was to determine if interaction between malnutrition and air pollution 
was evident. To our knowledge this is the first study of possible interaction effects between 
ambient air pollution and malnutrition as risk factors for pneumonia in children.
METHODS
Ethics Approval
This study was approved by the Tufts University Institutional Review Board and the Ethical 
Committee of the Corporación Ecuatoriana de Biotechnología (CEB).
Study Site
Quito is a high-altitude (2830 m) city with significant ambient air pollution largely due to 
vehicular traffic and combustion (16). The city is flanked by volcanic mountains that act to 
trap air pollutants by reducing atmospheric mixing (17). Quito’s urban slums have high rates 
of pneumonia and malnutrition (15,18,19). We identified two neighborhoods, Jaime Roldos 
(JR) and Lucha de los Pobres (LP), of closely comparable socioeconomic status (SES) (Figure 
1, Table 1), but which differ in levels of ambient air pollution. The Instituto Nacional de 
Estadistica y Censos (INEC) provided SES and census data for 2001 and the Corporación Para 
el Mejoramiento del Aire de Quito (CORPAIRE) provided hourly air pollution measurements 
for 2005 for two monitoring stations located adjacent to the studied neighborhoods.
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Figure 1. Map of Quito showing the two neighborhoods (Jaime Roldos and Lucha de los Pobres) where the study 
was conducted.
El Condado and El Camal are sites adjacent to the two study areas where hourly air monitoring data were collected by 
CORPAIRE during 2005.
Table 1. Socioeconomic indicators in LP (higher air pollution) and JR (lower air pollution).
Indicator LP JR OR (95%CI) P-value 
Population 11751 9009   
Area (hectares) 95 74   
Male 5888 4451 1.03 (0.97-1.09) 0.32 
Female 5863 4558 0.97 (0.92-1.03) 0.32 
Illiterate (%) 5.3 5.2 1.02 (0.90-1.16) 0.73 
Educationa     
None (%) 37.7 36.6 0.97 (0.83-1.13) 0.72 
Primary (%) 37.7 36.6 1.05 (0.99-1.11) 0.10 
Secondary (%) 37.7 37.9 1.05 (0.99-1.11) 0.10 
Superior and above (%) 4.3 4.0 1.08 (0.94-1.24) 0.28 
Household electricity (%)b 98.0 98.0 1.00 (0.82-1.22) 0.99 
Absence of poverty (%) 4.7 5.2 0.90 (0.79-1.02) 0.14 
Working age population (%) 72.6 72.5 1.01 (0.94-1.07) 0.88 
Employment by economic 
sector (persons)c   X
2 = 3.23 (2df) 0.20 
Primary 125 87   
Secondary 1437 1226   
Tertiary 3296 2633   
 
Data provided by INEC. OR, X 2, and P-values indicate differences between higher and lower air pollution neighbor-
hoods.
a Educational achievement as reported by INEC; unknown or unreported status for 16.9% of residents of LP and 
18.0% of JR.
b Based on 3231 households in LP and 2379 households in JR.
c Primary sector = agriculture, secondary sector = industry, tertiary sector = services. 
81 of 8885 individuals were not assigned by INEC to employment sectors.
Air pollution and anemia as risk factors for pneumonia in Ecuadorian children
67
Study Design
Between February and May 2006 we enrolled 408 and 413 children aged 18-42 months 
in LP and JR, respectively, after using a neighborhood census to identify eligible children. For 
each child we obtained a medical history using a standardized, pre-tested questionnaire for 
parents asking if the child was hospitalized or received medical attention for a respiratory 
illness in the prior year, including diagnoses and treatments. Anthropometric measurements 
included height, weight, and mid-upper arm circumference (MUAC). Length (age < 24 months) 
or height (age ≥24 months) was measured (nearest millimeter) using a nondistensible plastic 
tape glued to a rigid board. Weight was measured (closest 0.1 kilogram) using Detecto® 
Health-o-meters balances and scales (Webb City, IA, USA). MUAC was measured using 
a nondistensible plastic tape (closest millimeter). Height and weight were converted into 
weight-for-age (WAZ) and height-for-age (HAZ) Z-scores using Centers for Disease Control 
(CDC) reference values in the EpiInfo software package (20). A sterile lancet was used to 
draw fingerstick blood into a microcuvette analyzer (Hemocue AB, Angelholm, Sweden). 
Pulse-oximetry blood hemoglobin oxygen saturation (SpO2) was assessed via an index finger 
sensor (opposite hand from fingerstick) after sensor readings stabilized. Anemic children 
were offered iron supplements. Altitude was measured at each house using a GPS receiver 
(Garmin, Olathe, KS, USA).
Analyses
Statistical analysis was performed using EpiInfo (CDC, EpiInfo for Windows, version 3.4.1) 
and SPSS for Windows (SPSS Incorporated, SPSS Release 14.0). Demo- graphic and illness data 
were compared using Pearson c2 analysis and Fisher’s exact test. Logistic regression models 
were used for the multivariate analyses of both outcomes: hospitalization due to pneumonia 
and outpatient consultations due to acute respiratory illness (ARI). Associations were 
assessed by calculation of the odds ratio (OR) with 95% confidence intervals (CI). Following 
international conventions, children with height for age (HAZ) z-scores ≤ 2 standard deviations 
below the mean age and gender adjusted means were termed stunted. Anemia was defined 
as an adjusted blood hemoglobin < 11.0 g/dL after subtracting 1.9 g/dL to adjust for altitude 
(21). In order to quantitatively check our assumption of significant air pollution differences 
by neighborhood, median air pollution levels were tested using the Mann- Whitney test.
RESULTS
There were no significant differences in population density, educational achievement, 
illiteracy, overall poverty, and other SES indicators between Lucha de los Pobres and Jamie 
Roldos (Table 1). There was a total of 7808 hourly NO2 measurements from LP and 8065 from 
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JR, while for PM2.5 there were 8449 measurements from LP and 6157 from JR. The annual 
median NO2 level for LP was 29.5 μg/m3 and for JR it was 16.6 μg/m3. The annual median 
concentration of PM2.5 for LP was 20.4 μg/m
3 and for JR it was 15.3 μg/m3. Box plots of the 
data are shown in Figure 2. The nonparametric Mann-Whitney test for equal median levels 
demonstrated highly significant (P <0.001) differences for both pollutants. We considered 
Lucha de los Pobres to be a community with relatively higher air pollution levels compared 
to Jamie Roldos, a community with relatively lower air pollution levels. 
Complete demographic and anthropometric data were available for 798 (97%) children 
(Table 2). Neither enrollee age nor gender proportions differed by neighborhood. Children in 
LP were significantly more mal- nourished (lower HAZ, WAZ, and hemoglobin) than children 
in JR (Table 2). Likewise, stunting and anemia were significantly more prevalent in LP children 
than in JR children (Table 2), with odds ratios (ORs) of 1.88 and 1.45, respectively.
High exposure children had significantly lower SpO2 than low exposure children (92.2% ± 
2.6% vs. 95.8% ± 2.2%; P < 0.001; Figure 3). The high exposure house- holds were at a greater 
mean altitude than the low exposure households (2979 ± 79 versus 2852 ± 47 m, P< 0.001), 
corresponding to 527.2 and 535.7 Torr of atmospheric pressure, respectively. However, this 
minor pressure difference is not enough to account for the SpO2 difference (22).
Hospitalizations due to pneumonia, physician consultations for ARI, and air 
pollution exposure 
All 22 hospitalizations were for pneumonia. Of the hospitalized children, 7 resided in 
the lower air pollution exposure neighborhood while 15 resided in the higher air pollution 
 
Figure 2. Median PM
2.5 
in μg/m
3
 and median NO
2
 in μg/m
3
 during 2005 at the air pollution monitoring sites adja-
cent to the study neighborhoods.
Median PM2.5 and NO2 levels were each significantly lower (P<0.001) at El Condado than at El Camal. El Condado is 
adjacent to JR, the lower air pollution site, and El Camal is adjacent to LP, the higher air pollution site.
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exposure neighborhood. Parents were able to recall a specific diagnosis for 97% of 
physician consultations for all ailments in 2005 and this percentage did not vary between 
neighborhoods. The most common outpatient diagnoses were asthma, bronchitis, cough, 
influenza, pharyngitis, pneumonia, sinusitis, and tonsillitis. A total of 172 of 397 children 
(43%) with lower air pollution exposure required one or more consultations versus 224 of 
401children (56%) with higher air pollution exposure.
Children with higher air pollution exposure were significantly more likely to have had a 
pneumonia hospitalization (Table 3) or ARI requiring physician consultation (Table 4) than 
children exposed to lower air pollution exposure. In logistic regression analysis controlling for 
age, gender, HAZ, WAZ, hemoglobin, and residential altitude, higher air pollution exposure 
was significantly associated with pneumonia hospitalization (OR = 3.68, 95% CI 1.09-12.44; 
P = 0.036; Table 3).
There were no significant differences in age, gender, or nutritional parameters (HAZ, 
WAZ, MUAC, hemoglobin) between previously ill and healthy children. However, SpO2 was 
significantly lower in previously ill children compared to healthy children (93.6 ± 3.0% vs. 94.5 
± 3.0%; P < 0.001). In chi-square and regression analyses, neighborhood SES factors were not 
associated with any nutritional, environmental, or illness characteristics or outcomes.
Table 2. Demographic, nutritional, and environmental information for children exposed to higher (LP), and lower 
(JR), air pollution.
  LP JR  
 N = 401 N = 397  
  mean (sd) mean (sd) P 
Demographic characteristics    
Age (months) 31.25 (7.51) 31.25 (7.51) 0.94 
Males (number, %) 209 (50.6) 224 (54.5) 0.26 
Nutritional characteristics    
HAZ (height-for-age) -1.46 (1.00) -1.28 (0.87) 0.006 
Presence of stuntinga 125/397 78/401 < 0.001 
WAZ (weight-for-age) -1.31 (1.09) -1.12 (0.97) 0.010 
MUAC (cm) 15.44 (1.09) 15.43 (1.07) 0.900 
Adjusted hemoglobin (g/dL)b 10.45 (1.39) 10.74 (1.14) 0.002 
Presence of anemiac 253/401 214/397 0.013 
Environmental measures    
SpO2 (%) 92.2 (2.60)d 95.8 (2.20) < 0.001 
Mean household altitude (m) 2979 (72)e 2852 (47) < 0.001 
 
P-values represent the significance level of t-test comparisons unless otherwise noted.
a
Stunting was defined as a HAZ z-score ≤ -2 (i.e., 2 standard deviations below the mean age- and sex-adjusted 
height).
b
Hemoglobin was adjusted for altitude by subtracting 1.9 g/dL from the measured value (21).
c
Anemia was defined as an adjusted blood hemoglobin < 11.0 g/dL.
d
n = 400 for the high exposure children (LP), and 397 for lower exposure children (JR).
e
n = 398 for the high-exposure children (LP), 397 for lower exposure children (JR)
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Figure 3. Pulse-oximetry oxygen saturation (SpO
2
) values by residential ambient air pollution exposure.
SpO2 are significantly lower in the high air pollution neighborhood, compared to the lower air pollution neighbor-
hood, P < 0.001
Table 3. Hospitalization for pneumonia: Logistic regression analysis controlling for cofactors.
  All children Not anemic Anemic (N = 792) (N = 331) (N = 461) 
Cofactors OR 95%CI P OR 95%CI P OR 95%CI P 
Age 1.11 1.03-1.19 0.004 1.06 0.94-1.18 0.36 1.14 1.04-1.26 0.007 
Gender 1.02 0.43-2.44 0.96 0.60 0.13-2.90 0.52 1.35 0.46-4.02 0.59 
HAZ 1.48 0.76-2.89 0.25 1.50 0.46-4.85 0.45 1.54 0.66-3.57 0.32 
WAZ 0.86 0.48-1.54 0.60 0.81 0.30-2.22 0.69 0.83 0.40-1.73 0.63 
Hemoglobin 0.92 0.65-1.31 0.65 0.63 0.20-1.97 0.43 0.76 0.38-1.54 0.45 
Air pollution exposure* 3.68 1.09-12.4 0.036 1.04 0.08-13.9 0.98 6.82 1.45-32.0 0.015 
Altitude 1.00 0.99-1.01 0.21 0.99 0.98-1.01 0.25 1.01 1.002-1.02 0.017 
 
Table 4. Medical consultations for respiratory illness: Logistic regression analysis controlling for cofactors.
  All children Not anemic Anemic 
  (N = 792) (N = 331) (N = 461) 
Cofactors OR 95%CI P OR 95%CI P OR 95%CI P 
Age 1.01 0.99-1.03 0.23 1.02 0.99-1.05 0.26 1.01 0.98-1.04 0.49 
Gender 1.04 0.78-1.38 0.81 0.86 0.52-1.28 0.38 1.24 0.85-1.80 0.26 
HAZ 0.97 0.79-1.20 0.78 0.86 0.61-1.20 0.60 1.08 0.82-1.42 0.58 
WAZ 0.94 0.78-1.14 0.53 1.09 0.80-1.48 0.60 0.84 0.65-1.08 0.63 
Hemoglobin 1.08 0.96-1.20 0.22 1.01 0.71-1.42 0.97 1.11 0.88-1.39 0.38 
Air pollution 
exposure* 2.93 1.92-4.47 < 0.001 3.28 1.72-6.24 < 0.001 2.66 1.50-4.70 0.001 
Altitude 1.004 1.002-1.007 0.001 1.004 1.001-1.008 0.022 1.004 1.001-1.007 0.017 
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Modification of the effect of air pollution exposure by anemia
Fifteen of the 22 hospitalized children were anemic. The presence of anemia increased 
the OR for pneumonia hospitalization in children with high air pollution expo- sure from 3.68 
to 6.82 (Table 3). In the absence of anemia, higher air pollution exposure was not predictive 
of pneumonia hospitalization (OR 1.04; 95% CI 0.08- 13.93). In contrast, anemia status did 
not change the influence of air pollution exposure on ARI events that required consultation 
with a physician (Table 4). 
DISCUSSION
Our most important result is that anemic children exposed to relatively high levels of 
ambient air pollution are at increased risk of pneumonia hospitalization com- pared to 
children exposed to lower levels of air pollution. In addition, we found that children (both 
anemic and non-anemic) who were exposed to higher levels of air pollution were significantly 
more likely to have received a physician consultation for acute respiratory illness compared 
to children exposed to lower levels of air pollution. We also found evidence that anemia 
and higher air pollution exposure may interact to increase the odds of hospitalization in 
children with pneumonia. The strongest evidence of the potential interaction effect is that 
anemia increased the OR for the association between higher air pollution exposure and 
pneumonia hospitalization from OR (3.68, 95% CI 1.09-12.44; P =0.036) for all children to OR 
6.82 (95% CI 1.45-32.00; P = 0.015) for anemic children. In non-anemic children, the OR for 
hospitalization with pneumonia in children exposed to higher levels of air pollution dropped 
from 3.68 (noted above) to 1.04 (95% CI 0.08-13.9; P = 0.98). These results suggest a possible 
interaction between anemia and ambient air pollution exposure as risk factors. This result 
is important as these risk factors have not been examined concurrently before, however, 
our study did not have the statistical power to formally assess the potential interaction 
between pneumonia hospitalization and anemia status. Larger studies specifically designed 
to examine this finding are required.
The central pathophysiological deficit in pneumonia is poor tissue oxygenation (23). 
Anemia and low hemoglobin oxygen saturation independently decrease oxygen delivery. 
Hypoxia increases mortality during pneumonia two to five-fold (23,24). The association 
between anemia and pneumonia has been recognized since at least 1925 (25). Anemic 
children have less oxygen carrying capacity and suffer greater hypoxia during pneumonia-
than normal children (26). Oxygen saturation was significantly lower (P < 0.001) in children 
with high air pollution exposure. It is biologically plausible that anemia, and the lower 
hemoglobin oxygen saturation of higher air pollution exposure children, could additively or 
Chapter 4
72
multiplicatively decrease tissue oxygenation during pneumonia, especially at high altitude, 
resulting in more severe disease and more hospitalizations.
Reasons for differential oxygen saturations in normal populations are limited to only two 
possibilities: either marked differences in altitude, which was not the case in our study (127 
m difference), or dyshemoglobinemia (26). Carbon monoxide (CO) and NOx (particularly 
NO), produced by vehicular engine combustion, reduce oxygen saturation through formation 
of the dyshemoglobins carboxyhemoglobin and methemoglobin (27). Vehicular engine 
combustion is the major source of air pollution in Quito (12, 16, 17).
Previously, Estrella et al. (12) documented elevated carboxyhemoglobin levels in primary 
school children in Quito. Carboxyhemoglobin levels were 2.52% ± 1.12 in a northern Quito 
school adjacent to our lower pollution neighborhood, and 5.09% ± 1.7 (P < 0.05) in a central city 
school, adjacent to our higher air pollution neighborhood. Carboxyhemoglobin levels above 
2.5% are abnormal; 43% of children living in northern Quito and 92% of the children living in 
central Quito exceeded this threshold (12). Rare causes of dyshemoglobinemia (anesthetic 
or dapsone use, high-nitrate water ingestion), are unlikely alternative explanations since 
few children in this study would have undergone anesthesia or dapsone treatment, and all 
children shared a low-nitrate municipal water supply. Therefore, the most likely explanation 
for the marked SpO2 difference between the higher and lower air pollution exposure children 
is their differential exposure to common, combustion-related, air pollutants that bind to 
hemoglobin.
One potential limitation of our O2 saturation data was that we used non-invasive pulse 
oximetry rather than directly measuring carboxyhemoglobin and methemoglobin levels, 
as the latter would have required venous blood sampling, potentially decreasing study 
participation. However, oximetry underestimates carboxyhemoglobin-related oxygen 
saturation deficits (26,27), suggesting the deficits we found are conservatively estimated.
This study supports interaction between ambient air pollution levels, anemia, and 
hospitalization for pneumonia because (1) the OR increased in the setting of both risk 
factors, and (2) a biologically plausible pathophysiological mechanism for synergy can be 
identified. However, our study was designed for a straightforward comparison and sample 
size was too small to conclusively test for significant interaction in either tabular analysis 
using the Breslow-Day approach or by using an interaction term in the logistic regression 
model. Mauderly and Samet (2009) noted the difficulty of establishing synergism in air 
pollution studies because sample sizes of people with impaired health are generally too low 
for rigorous statistical testing (28). This study, however, is informative for the design of larger 
studies looking specifically for evidence of this interaction.
 The study children resided in impoverished neighbor- hoods (Table 1) which were carefully 
chosen to minimize differential nutritional status secondary to family socioeconomic status. 
We hypothesize that the incrementally worse nutritional status (HAZ, WAZ, and anemia) of 
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the higher exposure children (Table 2) was due to their incrementally higher incidence of 
respiratory infections related to higher air pollution (Tables 3 and 4). Higher rates of infection 
are known to worsen nutritional status, including anemia, in children (1,2,10,11,29).
It could be argued that the increased pneumonia hospitalization of the higher air 
pollution exposure children was due to their greater malnutrition, and not their air pollution 
exposure. However, in the entire study population, children with and without a history of 
respiratory illness did not differ by age, gender, or any nutritional parameters (HAZ, WAZ, 
MUAC, hemoglobin). The only significant difference between ill and healthy children was the 
lower oxygen saturation level seen in children with a pneumonia hospitalization or physician 
consultation (93.6 ± 3.0% vs. 94.5 ± 3.0%; P<0.001). We believe this difference in SpO2 
represents air pollution-related dyshemoglobinemia.
Data from a retrospective study must be interpreted cautiously. First, although the 
site populations did not differ by SES metrics, we did not collect household SES data that 
potentially could have provided additional insight into the role(s) of various socioeconomic 
factors. Second, families had to recall health information regarding their children over the 
previous 12 months. Although we inquired about events that were likely to be remembered 
(indeed, specific diagnoses were recalled for all (100%) hospitalizations and 495 of 512 (97%) 
physician consultations), we could not independently verify that all recalled diagnoses were 
accurate. Third, we did not correct for some potential confounding variables such as biofuel 
smoke in indoor air or cigarette smoking, however, ~ 98% of households in both sites used 
gas and not biofuels (Table 1), and therefore it is unlikely that biofuel smoke introduced a 
major source of bias. Also, in a tobacco-use survey (Harris et al, unpublished data), 30% 
of adults in LP and JR stated that they smoked cigarettes but 96% of users smoked ≤5 
cigarettes per day because of cost. Furthermore, Estrella et al (12) found no difference in 
carboxyhemoglobinemia in children from households with and without tobacco use. These 
factors suggest that smoking was not a major source of bias in our study. We used data for 
2005 from CORPAIRE, which monitors ambient air pollution using accepted methods (17,30) 
and we assumed that living in  a more polluted neighborhood was linked to higher personal 
exposure to ambient air pollution, a widely accepted assumption (6). Lastly, it is possible 
that unknown confounding factors we did not measure accounted for the higher rates of 
pneumonia, rather than the combination of air pollution and anemia.
In summary, we found evidence of possible synergy between a common manifestation of 
malnutrition-anemia-and ambient air pollution as risk factors for pneumonia hospitalization 
in a high-altitude setting. Their effects on oxygen delivery could plausibly mediate this 
association. We suspect air pollution-related dyshemoglobinemia reduces oxygen saturation, 
while anemia decreases oxygen carrying capacity. Our study suggests that both improving 
nutrition, and controlling air pollution, could most rapidly decrease hospitalizations for 
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pneumonia, the leading cause of death in children. Further study is needed to confirm our 
finding of synergy between air pollution and anemia.
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ABSTRACT
Outdoor air pollution is associated with respiratory infections and allergies, yet the role 
of innate lymphoid cells (ILCs) in pathogen containment and airway hyperresponsiveness 
relevant to effects of air pollutants on ILCs is poorly understood. We conducted a systematic 
review to evaluate the available evidence on the effect of outdoor air pollutants on the lung 
type 1 (ILC1) and type 2 ILCs (ILC2) subsets. We searched five electronic databases (up to 
Dec 2018) for studies on the effect of carbon monoxide (CO), sulfur dioxide (SO2), nitrogen 
dioxide (NO2), diesel exhaust particles (DEP), ozone (O3), and particulate matter (PM) on 
respiratory ILCs. Of 2209 identified citations, 22 full-text papers were assessed for eligibility, 
and 12 articles describing experimental studies performed in murine strains (9) and on human 
blood cells (3) were finally selected. Overall, these studies showed that exposure to PM, DEP, 
and high doses of O3 resulted in a reduction of interferon gamma (IFN-γ) production and 
cytotoxicity of ILC1. These pollutants and carbon nanotubes stimulate lung ILC2s, produce 
high levels of interleukin (IL)-5 and IL-13, and induce airway hyperresponsiveness. These 
findings highlight potential mechanisms by which human ILCs react to air pollution that 
increase the susceptibility to infections and allergies.
Keywords:  lung innate lymphoid cells; ILC; air pollutants; airway hyperresponsiveness
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1. INTRODUCTION
Air pollution exposure is associated with an array of respiratory problems, particularly in 
children because their lungs and immune system are still maturing [1,2,3,4]. Development 
of lung infections and exacerbation of allergic airway diseases are more frequently found in 
people living in highly polluted areas [5,6,7,8]. In fact, we found that Ecuadorian children 
highly exposed to CO, NO2, fine particulate matter with diameters no greater than 2.5µm 
(PM2.5) or volcanic ashes presented increasedsusceptibility to respiratory infections [7], high 
rates of hospitalization for pneumonia [8], and elevated rate of emergency room visits due to 
acute upper and lower respiratory infections and asthma-related conditions [9].
PM, DEP, O3, and other chemicals and polluting compounds have been shown to have 
deleterious effects on the respiratory function of humans [3,5,6,7,8,10,11,12,13]. Exposure 
to these outdoor environmental pollutants can result in acute airway inflammation [14,15], 
increased mucosal secretions [16], oxidative lung damage [17,18,19], and loss of antibacterial 
functions [20,21,22,23,24]. These conditions may be mediated by a harmful effect of the 
pollutants on lung immune cells.
The effects of specific air pollutants on certain classic lung innate immune cells including 
alveolar macrophages (AM), polymorphonuclear (PMN), and dendritic cells (DC) have 
been recently gaining the attention [25,26,27,28]. For instance, it has been reported that 
particulate matter alters the anti-mycobacterial function of human respiratory epithelium 
[29] and that DEP impairs antibacterial immunity by suppressing the nucleolar factor NF-kβ 
pathway in human blood monocytes [30]. Also, concentrated urban particles have been 
shown to hamper bacterial clearance by AMs and PMNs in mice [31], whereas DEP induces 
activation of inflammatory signaling molecules and cytokine synthesis in AMs [32]. However, 
not much is known about the effects of air pollutants on newer sets of immune cells, so-called 
innate lymphoid cells (ILCs), which play an essential role in lymphoid tissue formation, tissue 
remodeling, tissue homeostasis [33,34], inflammation, and regulation of host responses to 
infection [34,35]. These cells are involved in the initiation, modulation, and resolution of lung 
diseases [36].
ILCs are derived from a bone marrow common lymphoid progenitor [37], have a 
lymphoid morphology, and lack both antigen-specific receptors and myeloid phenotypic 
markers. They populate barrier surfaces, including skin, intestine, lung, and some mucosal-
associated lymphoid tissues [36]. Three major groups of ILCs have been defined based on 
the transcription factors needed for their development and the cytokines they produce 
[37,38,39]. Figure 1 summarizes the current understanding of ILC types, functions and 
activation pathways. The ILC1 group includes classical natural killer (NK) and non-NK cells, 
which are cytotoxic and produce interferon gamma (IFN-γ) [40,41]. The ILC2 group expresses 
interleukin (IL) IL-5 and IL-13 [41]. The type 3 (ILC3) group comprises of LTi cells, NKp46− ILC3, 
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and NKp46+ ILC3, which produce IL-17 and/or IL-22 [41]. Due to their cytokine production, 
ILCs 1, 2, and 3 resemble the adaptive T helper (Th) 1, Th2, and Th17 cells respectively 
[42]. In addition, human ILCs are highly heterogeneous among patients, tissues, and health 
conditions because they exhibit diversity in the expression of their surface markers [43,44].
In this paper, we systematically appraised all available studies to date that examined the 
effect of PM, O3, and DEP on lung ILC subsets in in vivo and in vitro models. While the 
role of ILCs in inflammation and the effects of air pollutants on classic innate immune cells 
are recognized, the effects of air pollutants on the lung ILCs remains scarce. Defining such 
 
 
 
Figure 1. Summarizes the understanding of innate lymphoid cell (ILC) types, activation pathways and functions. 
Innate lymphoid cells are derived from a common lymphoid progenitor, have a lymphoid morphology, and lack 
antigen-specific receptors. Based upon the transcription factors needed for their development and the cytokines 
they produce, ILCs are divided in three groups which mainly populate barrier surfaces. ILC1 includes classical nat-
ural killer (NK) and non-NK cells and depends on the transcription factor T-bet. ILC2 depends on the transcription 
factors GATA3 and RORα. ILC3 requires the transcription factor ROR-γt and comprises a heterogeneous subset of 
cells. After external antigen contact, respiratory epithelial cells and classical innate immune cells produce several 
cytokines which stimulate different ILCs groups. IL-12, IL-15, IL-18 prime ILC1s to produce IFN-γ and other cytokines 
involved in microbe elimination, Th1 activation, and tumor eradication. ILC2s are activated by IL-4, prostaglandin 
D2 (PGD2), IL-33 and IL-25 to produce amphiregulin involved in tissue repair, IL-5 to recruit eosinophils, and IL-13 
to stimulate mucus production by epithelial cells. ILC3s are primed by IL-18, IL-23, and IL-1β to produce principally 
IL-17 and IL-22 which participate in lymphoid tissue formation, Th cell regulation, B cell activation, and epithelium 
activation and repair. EC, epithelial cell; MØ, macrophage; DC, dendritic cell; PGD2, prostaglandin D2; TSLP, Thymic 
Stromal Lymphopoietin.
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relationships may help to understand how air pollutants affect respiratory infections and 
allergies. These investigations may also provide insights on potential strategies for improving 
diagnosis and treatment for these diseases.
2. MATERIALS AND METHODS
The systematic review was conducted using the general principles of the PRISMA-P 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [45] aimed to 
facilitate the development and reporting of systematic review protocols. The study protocol 
is available online [46]. 
2.1. Search Strategy
For the literature search, no limits were set on study designs, language or year of 
publication. We searched five electronic databases: Embase (via Embase.com), Medline 
(via Ovid), Web of Science, Cochrane Central, and Google Scholar from their inception 
until May 2018 for studies that measured the effect of air pollution exposure on number, 
viability, or function of any of the ILCs. The search strategy was constructed in cooperation 
with a medical information specialist (Wichor M Bramer, Medical Library, Erasmus MC) 
and combined terms related to air pollution (e.g., “air pollution”, “CO”, “DEP”, “PM2.5”, 
or “O3”) with those related to ILCs (e.g., “innate lymphoid cells”, “ILC1”, “ILC2”, “ILC3”, or 
“NK”), respiratory health (e.g., “asthma”, “respiratory infections”), or immunity (e.g., “innate 
immunity” or “cytokines”). We additionally checked references cited in selected articles and 
hand searched the PubMed engine database to retrieve additional articles. The full search 
strategy is provided in the Supplementary material, Resource S1: Search terms, and Figure 2.
2.2. Screening and Eligibility Criteria
Article titles and abstracts were initially screened for eligibility by two authors 
(B.E., M.C.). We included all studies based on cohorts, cross-sectional, experimental, 
in vitro, or in vivo designs in either animals or humans, that examined the effect of 
air pollutants exposure (measured by either pollution measurements or serologic 
markers of exposure) on lung ILCs and/or cytokines. We excluded systematic 
reviews, comments, consensus reports, editorials, guidelines, and protocols. 
2.3. Study Selection
First, we read the abstract of the retrieved references and selected those that included 
any of the specified respiratory health (e.g., asthma, airway hyperreactivity, and respiratory 
infection), as well as ILCs cell number and viability, cytokine production and activity, 
infection susceptibility and allergen-induced response, and airway hyperresponsiveness. 
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Second, we read the full paper of the selected abstracts to confirm if they fulfilled all 
selection criteria. Disagreements were resolved by consensus and in consultation with a 
third independent reviewer (Josje Schoufour, Department of Epidemiology, Erasmus MC). 
2.4. Data Extraction
Extracted data from each article were registered in a predesigned form 
to record study design, analysis unit, and type of exposure, route and 
doses of exposure, experimentation arm/groups, findings, and conclusions 
(Supplementary Material Resource S2: Methodological details of the studies). 
2.5. Quality Assessment of the Evidence
The quality of each study was assessed in terms of reproducibility of experimental 
methods and results, using a modified version of the Animal Research Reporting in vivo 
Experiments (ARRIVE) guidelines [47], and an adapted scale for in vitro experiments in human 
cells (Supplementary Material, Resource S3: Modified ARRIVE guidelines, and Resource 
S4: Adapted scale from ARRIVE guidelines for experimental studies in human cells). 
2.6. Synthesis of the Evidence
The diversity in study designs, models, doses, and ways of assessing exposure and 
outcomes, did not allow us to carry out comparative quantitative analysis. Instead, we 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References identified through 
data base searching = 2198 
Full-text papers assessed for 
eligibility = 22 
References 
identified through 
hand searching 
= 11 References after removing 
duplicates = 1521 
References excluded 
 = 1499 
Full-text papers  
excluded = 10 
- Organic pollutants = 9 
- Not lung ILC = 1 
Papers included in the 
systematic review = 12 
  
Figure 2. Flow diagram of study selection.
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provided a qualitative overview of the extracted data and characterized the studies, 
exposures, outcomes, and the main findings.
3. RESULTS
The search of electronic databases and hand searching provided 2209 citations. After 
removing duplicates, 1521 unique titles remained. Of these, 1499 studies were excluded 
based on the initial screening criteria. For the remaining 22 references, full-text papers were 
retrieved and further assessed for eligibility. From these, ten studies were not considered 
for the purpose of this review because one study did not measure lung ILCs and nine did 
not include the inorganic pollutants as the study objective. These studies were designed 
to induce allergic airway inflammation and observe how ILCs interact with the adaptive 
immune system, particularly Th2. (Supplemental Material, Resource S5) (For flow diagram 
see Figure 2). Out of the 12 remaining articles selected for the final evaluation, six studies 
investigated the effects of different pollutants on NK cells and six studies examined the 
effects on various other ILCs (Table 1). There were nine studies based on in vivo and in vitro 
murine experimental models [48,49,50,51,52,53,54,55,56], and three studies based on ex 
vivo and in vitro human cell models [57,58,59].
Regarding the quality of the experimental procedures, experimental animals, and 
experimental outcomes, all murine model studies met at least 75% of requirements stipulated 
by the modified ARRIVE guidelines. Experimental procedures and experimental outcomes 
of the human cell studies met at least 89% of requirements stipulated by the adapted 
scale (Supplementary Material, Resource S3: Modified ARRIVE guidelines, and Resource 
S4: Adapted scale from ARRIVE guidelines for experimental studies in human cells). These 
percentages ensure the reliability of the in vitro experimental procedures.
Table 1 lists the 12 selected studies and their main findings, and Table 2 integrates the 
main findings per cell type, focusing first on ILC1-NK cells and then summarizing the effects of 
air pollutants on ILC2 cells. Overall, the studies show the diversity in study designs, models, 
doses, and ways of assessing exposure and outcomes. They were:
(a)  3 studies on the effects of O3 on ILC2 (all in mice) [51,52,55],
(b)  3 studies on the effects of O3 on NK cells (1 in mice and 2 in humans) [54,58,59],
(c)  1 study on the effects of carbon nanotubes on ILC2 (in mice) [48],
(d)  1 study on the effects of DEPs on ILC2 (in mice) [49],
(e)  2 studies on the effects of DEPs on NK cells (1 in mice and 1 in humans) [50,57],
(f)  1 study on the effects of PM2.5 on ILC2 (in mice) [56],
(g) 1 study on the effects of PM2.5 on NK cells (in rats) [53].
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Table 1. Characteristics and main findings of the studies.
 
 
Authors, Year  
Type of Exposure 
(Doses; Method of 
Administration) 
Outcome Summary of Findings/Observed Effects of Exposure on the Outcome 
Type of Cell: Mice ILCs 
Beamer, et al. 
2013 [48] 
Multi-walled carbon 
nanotubes (50 μg; 
oropharyngeal)  
IL-33 function on 
ILC2 
 Epithelial cells (type II pneumocytes) in the 
lavage fluid induce secretion of IL-33  
 Elevated levels of IL-33 induce recruitment of 
ILCs in the airways 
 ILCs acting in response to IL-33 stimulate AHR 
and eosinophil recruitment through the release 
of IL-13  
Type of Cell: Mice ILC2 
De Grove, et al. 
2016 [49]  
DEP  
(25 mg on days 1, 8, 
and 15; intranasal) 
Function and 
cytokine production 
 DEP alone has little effect but enhances the 
effects of house dust mite (HDM) exposure 
 Marked increase in epithelium-derived cytokines 
IL-25 and IL-33 
 Increased numbers of DCs, neutrophils, ILC2s, 
CD41 T cells, CD81 T cells, and eosinophils. 
 ILC2s marginally contribute to DEP-enhanced 
allergic airway inflammation 
 Dysregulation of ILC2s and Th2 cells attenuated 
DEP-enhanced allergic airway inflammation. 
 A crucial role for the adaptive immune system on 
concomitant DEP plus HDM exposure 
Mathews, et al. 
2017 [51] 
O3 (2 ppm for 3 
hours; inhaled) 
IL-33 action on ILC2 
and γδ T 
 Interaction between Obesity and O3  
 Increased lung IL-13+ innate lymphoid cells type 
2 (ILC2) and IL-13+ γδ T cells in obese mice  
 Increased ST2+γδ T cells, indicating that these 
cells can be targets of IL-33, 
 O3 induced type 2 cytokine expression in ILC2s 
and γδ T cells in obese mice 
  Little or no effect of O3 on IL-33 in lean mice. 
 ILC2s and γδ T appear to contribute to the effects 
of IL-33 
Yang, et al. 2016 
[52] 
 
O3  
(3 ppm for 2 hours on 
day 16; inhaled) 
 
 
Il5 and Il13 RNA 
expression 
 O3 exposure increased airway levels of IL-33, a 
potent activator of lung ILC2s 
 Lung-resident ILC2s were the predominant early 
source of the Th2 cytokines IL-5 and IL-13 in O3-
exposed mice 
 No ILC2 influx or proliferation within 12 hours 
after O3 exposure  
 ILC2s from the lungs: greater increased 
activation of Il5 and Il13 mRNA 12 hours after O3  
Kumagai, et al. 
2017 [55] 
  
O3  
(0.8 ppm on 
day 1 or for 9 
consecutive 
weekdays; inhaled) 
ILC2 in airway 
inflammation, 
mucus cell 
metaplasia, and 
Type 2 immunity 
 O3 induced pulmonary esosinophilic 
inflammation in ILC sufficient mice 
 O3 induced mucus cell metaplasia in proximal 
airway epithelium 
 O3 increased mRNA transcripts of type 2 
immunity in lung 
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Lu, et al. 2018 
[56] 
  
PM2.5 
(25 mL/kg of a 
suspension of 15 g/L 
on days 1, 8, 15, and 
21; intranasal) 
ILC2-related 
transcription factors 
 Increased expression of RORα and GATA3 
transcription factors, which are vital factor for 
ILC2. 
 Increased IL33-levels which activates ILC2s 
Type of Cell: Rats NK 
Burleson, et al. 
1989 [54] 
O3  
(1.0 ppm for 23.5 
hours /day on 1, 3, 7, 
or 10 consecutive 
days; ambient)  
Number and 
function of NK, and 
function of 
adherent cells 
 O3 induced suppression of pulmonary NK activity 
 Cell/products involved in NK activation mediate 
the immunosuppression  
 O3 decreased number but not viability of NK 
Zhao, et al. 2014 
[53] 
 
PM2.5 
(1, 5, or 10mg/kg 
body weight; 
intratracheal) 
 
 
Number and 
bacterial response  
 PM2.5 increases susceptibility to respiratory 
infection by S. aureus. 
 PM2.5 decreases the number of NK cells in the 
lung and suppress AM phagocytosis, which 
provides a potential mechanism to explain that 
association between ambient air pollution and 
pulmonary bacterial infections 
Type of Cell: Mice NK 
Finkelman, et al. 
2004 [50] 
 
DEP 
(2 mg once; injected 
i.p.)  
INF gamma 
production 
 DEP potently inhibits IFN-γ production by NK and 
NKT cells, which is rapid in onset, long lasting, 
and dose-related 
 DEP induces an inhibitory effect on steady-state 
INF-γ mRNA levels and may also suppress INF-γ 
production through posttranscriptional 
mechanisms 
Type of Cell: Human NK 
Müller, et al. 
2013 [57] 
  
DEP  
(10 μg/mL; direct 
exposure of cell) 
Function and 
cytokine release 
 DEP reduced expression of the cytotoxic NK cell 
surface marker CD16, gene and protein 
expression of granzyme B and perforin, and the 
ability to kill target cells  
Kucuksezer, et 
al. 2014 [58]  
 
 O3 
(1, 5, 10, and 50 
mg/mL cRPMI; direct 
exposure of cell) 
Number, function  
 O3 increased number of CD16 cell and 
cytotoxicity of NK 
 
Müller, et al. 
2013 [59]  
 
 
O3 
(0.4 ppm; direct 
exposure of cell) 
Effect of O3 exposed 
epithelial cells on 
natural killer cells 
function, cytokine 
release. 
 O3 reduced markers of activation, INF-γ 
production, and cytotoxic function. 
 O3 upregulated ligands for NK in epithelial cells. 
 
 
Table 1. Characteristics and main findings of the studies (continued).
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3.1. Effects of Air Pollutants on ILC1-NK Cells
NK cells play a fundamental role in the immunity against intracellular infections and 
tumor immune surveillance (Figure 1). Overall, the summary showed that exposure to air 
pollutants results in decreased or impaired NK cell number, and modified cell function and 
cytokine release (Table 2).
Table 2. Effects of air pollutants on NK cells and ILC2: integration of findings.
  NK cell features a   
Exposure PM 2.5 DEP O3 CN 
Model Rats Mice Human Rats Human Mice 
 
Number 
 
↓NK BALF 
↓Influx into 
airways 
↓NK in 
spleen  
 
↓ % lung 
lymphocyt
es 
 
Low doses: ↑ 
number 
 
 
Cytokine  
 
↓IFN-γ 
 
 
 
 
↑IL-1β 
↑ IL-8 
↑ TNF-α 
no changes in 
INF- γ 
  
↓ IFN-γ  
 
Activity 
 
↑ 
Susceptibility 
to respiratory 
infection by S. 
aureus 
 
 
 
↓ 
Cytotoxicity 
↓ CD16 
expression 
↓ Granzyme 
B levels 
↓ Perforin 
levels 
 
↓ 
Pulmonary 
NK activity 
 
 
↓ 
Cytotoxicity 
↓ Granzyme 
B levels 
↓ Markers of 
cytotoxicity 
Low doses: ↑ 
cytotoxicity 
 
 
ILC2 cell features b 
 
Exposure PM 2.5 DEP O3 CN 
Model Rats Mice Human Mice Human Mice 
Number  
↑ in alveolar 
space but not 
in lungs 
 
No effect in 
lean mice 
↑IL-5+ and 
IL-13+ ILC2s 
in BAL in 
obese mice 
 ↑ in lung 
 
Cytokine   
 
↑IL-5 
↑IL-13 
 
 
↑IL-5 
↑IL-13 
  
↑IL-13 
 
Air way 
hiperrespon
siveness 
(AHR) 
 
Enhances 
AHR: 
 
↑ RORα and 
GATA3 
transcription 
factors 
related to 
ILC2 
 
Enhances 
AHR: 
Accumulation 
of ILC2s and 
Th2 cells and 
type 2 
cytokine 
production 
 
 
Induces 
AHR: 
↑ 
expression 
of lung 
mRNA 
transcripts 
associated 
with type 2 
immunity 
 
 
Induces 
AHR: 
↑ IL-13 
from 
ILC2 
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3.1.1. Cell Number and Viability
Studies in murine strains demonstrated that PM2.5 exposure decreases significantly both 
the absolute NK cell number in broncho-alveolar lavage fluid (BALF) and the NK cell influx into 
the airway lumen at 24 h post S. aureus infection [53]. Similarly, DEP exposure decreased the 
number of NK cells in spleen in mice [50]. Concerning O3 exposure, this pollutant decreases 
the percentage of lung lymphocytes in mice, although without effect on their viability [54]. In 
contrast, in human cells, 3–5 days of low dose (1mg/mL) O3 exposure significantly increased 
the total NK cell population defined as CD3-CD16+/56+ without significant changes among 
the expression levels of other surface molecules [58].
3.1.2. Cytokine Production 
NK cells stimulated by IL-12 or IL-18, secreted from dendritic cells and macrophages, 
produce several cytokines, principally IFN-γ, IL-1β, IL-8, IL-17A, and tumor necrosis 
factor alpha (TNF-α), which are involved in lung inflammatory processes and infection 
resistance (Figure 2). DEP exposure caused strong, rapid in onset, long-lasting, and dose-
related suppression of IFN-γ production in murine NK following lipopolysaccharide (LPS) 
stimulation; this suppression was due to the inhibition of the IL-12, and IL-18 response to 
LPS by accessory cells as well as by a direct inhibitory effect on IFN-γ mRNA levels, partly 
through post-transcriptional mechanisms [50]. In NK cells from healthy non-smoking non-
asthmatic volunteers, DEP produced a modest increase of IL-1β, IL-8, and TNF-α release with 
no changes in IFN- γ [57]. O3 exposure also reduces the expression of IFN-γ on human NK 
cells by affecting the direct cell-cell interactions between epithelial and NK cells, and it is 
dependent on UL16 binding protein 3 (ULBP3) and major histocompatibility complex class I 
chain-related protein A and B (MICA/B) on epithelial cells [59].
3.1.3. Activity
Cytotoxic activity of the NK cell is achieved through the release of granzyme B and perforin 
once the activating receptors have recognized their ligands (Figure 1). Activating receptors 
include NKp46, NKp44, CD16, CD69, and NKG2D. The murine experiments with the preceding 
PM2.5 exposures have demonstrated that: (a) exposure triggers a significant increase in 
bacterial load in the lung of rats infected by S. aureus; and (b) adoptive NK cell transfer to 
the lung of those rats markedly reduces the bacterial load to a level comparable to control 
rats that were infected with S. aureus, but not exposed to PM2.5. A potential mechanism 
explaining these observations is that alveolar macrophages, cultured with NK cells, have a 
high rate of phagocytosis of S. aureus, and suggests that interactions between NK cells and 
lung macrophages facilitate better control of bacterial infection by innate phagocytic cells 
[53]. In vitro and ex vivo experiments in human blood cells showed that exposure to DEP 
alone significantly reduces the cytotoxic potential of NK cells as compared to controls. At 
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the same time, exposure to DEP, in the context of stimulation with the viral mimetic polyI:C, 
decreases the expression of CD16, granzyme B, and perforin, and suppresses the ability of 
NK cells to kill target cells without affecting the percent of NKG2D+ and NKp46+ cells [57]. 
In murine strains, continuous exposure to 1.0 ppm O3 for 1, 5, and 7 days had a significant 
immunosuppressive effect on pulmonary NK cell activity compared to controls, but this 
effect was reversed after 10 days of continuous O3inhalation [54]. Furthermore, it has been 
demonstrated that the effect on pulmonary NK cells involved several cell types and/or their 
products that stimulate NK cells [54].
Similarly, studies on the interrelation between O3-exposed human epithelial cells and NK 
cells showed that direct exposure to O3 reduces, although non significantly, the expression 
of NK cell receptors (NKG2D and NKp46), the intracellular levels of granzyme B, and 
cytotoxicity function [59]. Yet, in another study, low doses of O3 exposure (1 mg/mL and 5 
mg/mL) induced an increase in human NK-cell cytotoxicity without a significant difference 
between doses [58].
3.2. Effects of Air Pollutants on ILC2
ILC2 play critical roles in immune protection, tissue repair, brown fat biogenesis, and in 
the regulation of the inflammatory process (Figure 1). Air pollutants stimulate or inhibit ILC2 
as shown in experiments in mouse models (Table 2).
3.2.1. Cell Number and Viability
ILC2s (nuocytes) represent approximately 1% of the total number of cells in the whole 
lung lavage in mice [48]. Exposure to DEP plus house dust mite (HDM) increased the number 
of cytokine-expressing ILC2s along with Th2 T cells in the alveolar space of mice, but not in 
the lung tissue itself [49]. O3 exposure did not affect the total number of pulmonary ILC2 in 
non-obese mice [52,55], suggesting no influx or proliferation within 12 h after O3 exposure 
in such mice [52]. However, in obese mice O3 increased the number of IL-5+ and IL-13+ ILC2s 
[51]. Conversely, exposure to carbon in a multi-walled carbon nanotube experiment in two 
strains of mice resulted in a significant increase of ILC2 numbers [48].
3.2.2. Cytokine Production and Activity
Exposure to DEP plus HDM also increased IL-5 and IL-13 levels in the BALF ILC2 compared 
with DEP alone and saline exposed groups, but this increase was also seen in Th2 cells, 
which was the principal source of those cytokines [49]. Experimental studies in mice showed 
that O3 [51,52] and multi-walled carbon nanotube [48] exposure induced the production 
of IL-33 by lung tissue which in turn activated several cells in the lung including Th2 T cells 
and ILC2 cells to produce IL-13 [48,51,52] and IL-5 [51,52]. In fact, it was reported that 12 
h of O3 exposure significantly increased the transcription of IL-5 and IL-13 mRNA with the 
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consequent increase of IL-5 and IL-13 production [52]. Additionally, it was confirmed that 
ILC2s were the principal source of IL-5 and IL-13 since O3 exposure of CD4+ Thy1+ Th cells 
isolated from the lungs did not induce those cytokines 12 h after exposure [52], and that 
bronchoalveolar lavage type 2 cytokines were not significantly reduced in O3-exposed obese 
mice when CD4+ T cells were depleted by treating mice with a depleting anti-CD4 antibody 
[51].
3.2.3. Allergen-Induced Response and Airway Hyperresponsiveness (AHR)
IL-33, IL-5 and IL-13 are critical for AHR since they induce granulocyte infiltration and 
changes in airway epithelia (Figure 1). In an ovalbumin murine asthma model, exposure to 
PM2.5 exacerbated the asthma symptoms by significantly increasing the expression of RORα 
and GATA3 levels in peripheral blood mononuclear cell, transcription factors related to ILC2, 
suggesting that ILC2s play a crucial role in serious asthma induced by PM2.5 [56].
AHR was significantly enhanced by DEP exposure in HDM exposed mice due to 
accumulation of ILC2s and Th2 cells and type 2 cytokine production (IL5 and IL-13); however, 
the contribution of ILC2 after DEP exposure was marginal since ILC2 deficient mice exposed 
to DEP showed AHR depending on Th2 cells activation [49].
ILC-sufficient mice exposed for 9 days to ozone showed significantly greater BALF 
eosinophils, mucous cell metaplasia with more mucins in the proximal airway epithelium, 
and increased expression of lung mRNA transcripts associated with type 2 immunity than air-
exposed mice [55]. Additionally, mice treated with anti-Thy1.2 antibodies, which significantly 
reduce a total number of both ILCs and T cells, dramatically lost the O3-induced influx of 
eosinophils and mucous cells metaplasia [55]. Importantly, intra-tracheal transfer of ILC2s to 
mice treated with anti-Thy1.2 showed that O3-exposed mice stimulated with methacholine 
present dramatically enhanced AHR compared to air-exposed mice [52].
Concerning carbon nanotube exposure, this regimen also induced AHR in mice through 
IL-13 action. The mechanism was via activation of epithelial cells to produce IL-33, which in 
turn recruits and stimulates ILC2 to produce IL-13 [48].
3.3. Effects of Air Pollutants on ILC3
No studies were identified that explored the effects of air pollutants on ILC3 numbers, 
viability, or cytokine production.
4. DISCUSSION
In this systematic review, we showed that PM, DEP, O3, and carbon nanotubes affect ILCs in 
the respiratory system in two ways. The pollutants generally inhibit ILC1 (NK cell) cytotoxicity 
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and cytokine (IFN-γ) production, thereby increasing the susceptibility to infections and 
allergies. The pollutants also stimulate ILC2 to produce IL-5 and IL-13, thereby increasing 
airway hyperresponsiveness.
With regard to mechanism of action, the reviewed studies suggest that exposure to 
particulate contaminants (DEP and PM2.5) and high doses of O3 impair lung NK cell activity 
directly by decreasing expression of the activating receptors CD16 and CD69, granzyme 
B and perforin levels, and also indirectly by dampening the activity of neighboring cells 
implicated in NK cell activation. In addition, these same pollutants decrease IFN-γ secretion 
of NK cells, an important cytokine responsible for stimulating macrophages [60,61,62] and 
for inducing adaptive Th1 differentiation and function [63,64,65]. These alterations of NK 
cells jointly lessen the ability of the organism to fight against intracellular pathogens, viruses 
in particular, and may thereby result in increased susceptibility to respiratory infections.
With regard to ILC2 cells, experimental studies in murine strains indicate that DEP, 
O3, and multi-wall carbon nanotubes activate ILC2 to produce IL-5 and IL-13, via a larger 
production of IL-33. As IL-5 and IL-13 are also produced by Th2 cells and are responsible for 
IgE class switching on B cells and the recruitment and activation of eosinophils [66,67,68,69], 
ILC2s stimulated by air pollutants likely act synergistically with Th2 cells to mount allergic 
respiratory processes, such as rhinitis and asthmatic episodes associated to air pollutants.
This review contributes to our understanding of the role that ILCs play in the effect 
of environmental air pollutant exposure on respiratory infections and allergic disease. 
Our findings may be useful to identify potential intervention strategies, targeting the key 
molecules which enhance pulmonary NK cell function to protect against infections or to 
control an excessive activation of ILC2, thus decreasing the production of allergy-related 
cytokines and minimizing airway allergic inflammation. With respect to the development of 
preventive strategies, a comprehensive solution against harmful effects of air pollution on 
the respiratory health should require the implementation of and compliance with a broad 
range of policies to improve air quality [70].
We excluded nine studies that addressed the crosstalk between ILCs, particularly ILC2, and 
adaptive type 2 immune response during a natural airborne allergen-induced allergic airway 
inflammation, but not included any of the inorganic pollutants. The general conclusion is that 
both type of cells work together in a bidirectional way to maintain airway hyperreactivity. In 
the supplementary material we provided the list of the excluded studies.
This is the first comprehensive systematic review that builds a general picture of how 
ILCs are affected by different air pollutants and how respiratory health is affected. Since 
most of the evidence included in this review is based on in vitro and in vivo studies, thus 
the extrapolation of our findings to general population may be difficult. The experimental 
models could also underestimate or overestimate the effects of contaminants on the ILCs 
because a) the animal studies use inbred strains, which may differ in immune responsiveness 
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to the heterogeneous responses found in the general population; b) the doses and duration 
of the exposure used in the experimental conditions may not represent real-life exposures; 
and c) the relationship between a dose of exposure and number of exposed cells may not 
accurately represent reality. Therefore, it would be important that future studies examine 
the effects of air pollution on human ILCs, for example in sputum samples and, preferably, in 
combination with reliable exposure measurements. These studies should help to understand 
the role and mechanisms underlying the participation of these cells in infections and airway 
hyperreactivity associated with air pollutants exposure.
5. CONCLUSIONS
This systematic review of available studies on air pollution and ILCs shows that air pollution 
impairs the function of ILCs, increasing the susceptibility to infections and allergies. Exposure 
to key air pollutants, including PM, DEP, and O3 stimulate lung ILC2s to produce high levels 
of IL-5 and IL-13 and generally inhibit the cytotoxicity and IFN-γ production by ILC1-NK cells. 
These processes most likely play an essential role in the airway hyperresponsiveness and 
increased susceptibility to respiratory infections triggered by exposure to air pollution. Our 
findings also highlight substantial gaps in knowledge and the need to better understand the 
mechanisms by which human immune systems react to air pollution.
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SUPPLEMENTARY MATERIAL
Resource S1. Search terms 
Five databases were searched in cooperation with a medical information specialist to 
identify relevant studies: Embase.com, Medline Ovid, Web of science, the Cochrane Library, 
Google scholar)
Embase.com 1118
(‘air pollution’/de OR ‘air pollutant’/exp OR ‘air pollution indicator’/de OR ‘environmental 
exposure’/de OR ‘exhaust gas’/de OR acetylene/de OR benzene/de OR ‘1, 3 butadiene’/de 
OR ‘carbon monoxide’/de OR dust/de OR ethane/de OR ethylbenzene/de OR ethylene/de OR 
‘airborne particle’/de OR ‘nitrogen dioxide’/de OR ‘particulate matter’/de OR toluene/de OR 
xylene/de OR ‘polycyclic aromatic hydrocarbon’/exp OR combustion/de OR ‘black carbon’/de 
OR ‘volatile organic compound’/de OR ‘tobacco use’/exp OR ‘smoking and smoking related 
phenomena’/exp OR ‘carbon nanotube’/de OR ((air NEAR/3 (clean*)) OR ((environment* OR 
personal) NEAR/6 (expos* OR toxican*)) OR pollut* OR microenvironment* OR exhaust* OR 
emission* OR acetylene* OR benzene* OR butadiene* OR (carbon NEXT/1 monoxide*) OR 
co OR carbonmonoxide* OR Coarse OR dust OR ethane OR ethylbenzene* OR ethylene* OR 
ethene* OR particle* OR (particul* NEAR/3 matter*) OR (nitro* NEXT/1 dioxide*) OR pm1 
OR ‘pm2 5’ OR pm10 OR ‘pm 1’ OR ‘pm 2 5’ OR ‘pm 10’ OR soot OR toluene* OR xylene* OR 
ufp* OR ‘black carbon’ OR (polycyclic NEAR/3 (hydrocarbon* OR carbon*)) OR pah OR pahs 
OR combust* OR (volatile NEAR/3 compound*) OR VOCs OR voc OR tVOCs OR tvoc OR btex 
OR smoke OR smoking OR tobacco OR (carbon NEAR/3 nanotube*)):ab,ti) AND (‘lymphoid 
cell’/exp OR ‘cytokine’/exp OR ‘cytokine response’/exp OR (((lymphoid ) NEAR/3 cell*) OR 
lymphocyte* OR ilc OR ilcs OR (natural* NEAR/3 killer*) OR cytokine* OR interferon* OR ifn 
OR interleukin*):ab,ti) AND (asthma/exp OR ‘respiratory tract infection’/exp OR ‘respiratory 
tract inflammation’/exp OR (asthma* OR (airway* NEAR/6 (hyperreactiv* OR allerg* OR 
inflammat* OR immun*)) OR ((respiratory* OR airway*) NEAR/3 infect*)):ab,ti) AND (‘innate 
immunity’/de OR (innate* OR non-specific* OR nonspecific* OR in-born OR inborn ):ab,ti) 
NOT ([Conference Abstract]/lim OR [Letter]/lim OR [Note]/lim OR [Editorial]/lim)
MedlineOvid 1118
(“air pollution”/ OR exp “Air Pollutants”/ OR “environmental exposure”/ OR “Vehicle 
Emissions”/ OR acetylene/ OR benzene/ OR “Benzene Derivatives”/ OR “butadienes”/ 
OR “carbon monoxide”/ OR dust/ OR ethane/ OR ethylenes/ OR “nitrogen dioxide”/ OR 
“particulate matter”/ OR toluene/ OR “Polycyclic Hydrocarbons, Aromatic”/ OR ((air ADJ3 
(clean*)) OR ((environment* OR personal) ADJ6 (expos* OR toxican*)) OR pollut* OR 
microenvironment* OR exhaust* OR emission* OR acetylene* OR benzene* OR butadiene* 
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OR (carbon ADJ monoxide*) OR co OR carbonmonoxide* OR Coarse OR dust OR ethane 
OR ethylbenzene* OR ethylene* OR ethene* OR particle* OR (particul* ADJ3 matter*) OR 
(nitro* ADJ dioxide*) OR pm1 OR “pm2 5” OR pm10 OR “pm 1” OR “pm 2 5” OR “pm 10” OR 
soot OR toluene* OR xylene* OR ufp* OR “black carbon” OR (polycyclic ADJ3 (hydrocarbon* 
OR carbon*)) OR pah OR pahs OR combust* OR (volatile ADJ3 compound*) OR VOCs OR voc 
OR tVOCs OR tvoc OR btex OR smoke OR smoking OR tobacco OR (carbon ADJ3 nanotube*)).
ab,ti.) AND (exp “Lymphocytes”/ OR exp “Cytokines”/ OR (((lymphoid ) ADJ3 cell*) OR 
lymphocyte* OR ilc OR ilcs OR (natural* ADJ3 killer*) OR cytokine* OR interferon* OR ifn 
OR interleukin*).ab,ti.) AND (asthma/ OR “respiratory tract infection”/ OR “respiratory tract 
inflammation”/ OR (asthma* OR (airway* ADJ6 (hyperreactiv* OR allerg* OR inflammat* 
OR immun*)) OR ((respiratory* OR airway*) ADJ3 infect*)).ab,ti.) AND (“Immunity, Innate”/ 
OR (innate* OR non-specific* OR nonspecific* OR in-born OR inborn ).ab,ti.) NOT (letter OR 
news OR comment OR editorial OR congresses OR abstracts).pt.
Cochrane 3
(((air NEAR/3 (clean*)) OR ((environment* OR personal) NEAR/6 (expos* OR toxican*)) OR 
pollut* OR microenvironment* OR exhaust* OR emission* OR acetylene* OR benzene* OR 
butadiene* OR (carbon NEXT/1 monoxide*) OR co OR carbonmonoxide* OR Coarse OR dust 
OR ethane OR ethylbenzene* OR ethylene* OR ethene* OR particle* OR (particul* NEAR/3 
matter*) OR (nitro* NEXT/1 dioxide*) OR pm1 OR ‘pm2 5’ OR pm10 OR ‘pm 1’ OR ‘pm 2 5’ OR 
‘pm 10’ OR soot OR toluene* OR xylene* OR ufp* OR ‘black carbon’ OR (polycyclic NEAR/3 
(hydrocarbon* OR carbon*)) OR pah OR pahs OR combust* OR (volatile NEAR/3 compound*) 
OR VOCs OR voc OR tVOCs OR tvoc OR btex OR smoke OR smoking OR tobacco OR (carbon 
NEAR/3 nanotube*)):ab,ti) AND ((((lymphoid ) NEAR/3 cell*) OR lymphocyte* OR ilc OR ilcs 
OR (natural* NEAR/3 killer*) OR cytokine* OR interferon* OR ifn OR interleukin*):ab,ti) 
AND ((asthma* OR (airway* NEAR/6 (hyperreactiv* OR allerg* OR inflammat* OR immun*)) 
OR ((respiratory* OR airway*) NEAR/3 infect*)):ab,ti) AND ((innate* OR non-specific* OR 
nonspecific* OR in-born OR inborn ):ab,ti) 
Web of science 481
TS=((((air NEAR/2 (clean*)) OR ((environment* OR personal) NEAR/5 (expos* OR 
toxican*)) OR pollut* OR microenvironment* OR exhaust* OR emission* OR acetylene* 
OR benzene* OR butadiene* OR (carbon NEAR/1 monoxide*) OR co OR carbonmonoxide* 
OR Coarse OR dust OR ethane OR ethylbenzene* OR ethylene* OR ethene* OR particle* 
OR (particul* NEAR/2 matter*) OR (nitro* NEAR/1 dioxide*) OR pm1 OR “pm2 5” OR pm10 
OR “pm 1” OR “pm 2 5” OR “pm 10” OR soot OR toluene* OR xylene* OR ufp* OR “black 
carbon” OR (polycyclic NEAR/2 (hydrocarbon* OR carbon*)) OR pah OR pahs OR combust* 
OR (volatile NEAR/2 compound*) OR VOCs OR voc OR tVOCs OR tvoc OR btex OR smoke 
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OR smoking OR tobacco OR (carbon NEAR/2 nanotube*))) AND ((((lymphoid ) NEAR/2 cell*) 
OR lymphocyte* OR ilc OR ilcs OR (natural* NEAR/2 killer*) OR cytokine* OR interferon* 
OR ifn OR interleukin*)) AND ((asthma* OR (airway* NEAR/5 (hyperreactiv* OR allerg* OR 
inflammat* OR immun*)) OR ((respiratory* OR airway*) NEAR/2 infect*))) AND ((innate* OR 
non-specific* OR nonspecific* OR in-born OR inborn )) ) AND DT=(article)
Google scholar
Pollution|pollutant|pollutants|exhaust|”particulate matter”|pah|pahs|combustion|
”black carbon”|vacs “lymphoid cell|cells”|lymphocyte|lymphocytes|cytokine|cytokines| 
interferon| interferons|asthma innate|”non-specific”|nonspecific|inborn
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Resource S3. Modified ARRIVE guidelines, and adapted scale from ARRIVE 
guidelines for experimental studies in human cells 
 
 
      FULFILLMENT % 
TITLE 1 Provide as accurate and concise a description of the content of the article as possible. 100 
ABSTRACT 2 
Provide an accurate summary of the background, research objectives, 
including details of the species or strain of animal used, key methods, 
principal findings and conclusions of the study. 
94 
INTRODUCTION   
Background 3 
a. Include sufficient scientific background (including relevant 
references to previous work) to understand the motivation and 
context for the study, and explain the experimental approach and 
rationale. 
100 
    
b. Explain how and why the animal species and model being used can 
address the scientific objectives and, where appropriate, the study's 
relevance to human biology. 
50 
Objectives 4 Clearly describe the primary and any secondary objectives of the study, or specific hypotheses being tested. 100 
METHODS   
Ethical statement 5 
Indicate the nature of the ethical review permissions, relevant 
licences (e.g. Animal [Scientific Procedures] Act 1986), and national or 
institutional guidelines for the care and use of animals, that cover the 
research. 
88 
Study design 6 For each experiment, give brief details of the study design including the number of experimental and control groups. 50 
Experimental 
procedures 
7 For each experiment and each experimental group, including controls, provide precise details of all procedures carried out. For example:   
  
a. How (e.g. drug formulation and dose, site and route of 
administration, anaesthesia and analgesia used [including 
monitoring], surgical procedure, method of euthanasia). Provide 
details of any specialist equipment used, including supplier(s). 
94 
  b. When (e.g. time of day). 100 
  c. Where (e.g. home cage, laboratory, water maze). 100 
In vitro 
procedures 
7a a. Describe in  detail all  the in vitro procedures 100 
  b. Describe in detail  all the reagents, cells,  kits including manufacturer  used (manufacturer)  100 
Experimental 
animals 
8 
a. Provide details of the animals used, including species, strain, sex, 
developmental stage (e.g. mean or median age plus age range) and 
weight (e.g. mean or median weight plus weight range). 
88 
  
b. Provide further relevant information such as the source of animals, 
international strain nomenclature, genetic modification status (e.g. 
knock-out or transgenic), genotype, health/immune status, drug or 
test naïve, previous procedures, etc. 
100 
Housing and 
husbandry 
9 Provide details of:   
  
a. Housing (type of facility e.g. specific pathogen free [SPF]; type of 
cage or housing; bedding material; number of cage companions; tank 
shape and material etc. for fish). 
77 
Modified ARRIVE: Average score for 9 studies carried out in animals
Chapter 5
110
  
b. Husbandry conditions (e.g. breeding programme, light/dark cycle, 
temperature, quality of water etc for fish, type of food, access to food 
and water, environmental enrichment). 
50 
Sample size 
10 a. Specify the total number of animals used in each experiment, and the number of animals in each experimental group. 50 
  b. Explain how the number of animals was arrived at. Provide details of any sample size calculation used.   
Allocating 
animals to 
experimental 
groups 
11 a. Give full details of how animals were allocated to experimental groups, including randomisation or matching if done. 50 
Experimental 
outcomes 12 
Clearly define the primary and secondary experimental outcomes 
assessed (e.g. cell death, molecular markers, behavioural changes). 100 
Statistical 
methods 13 a. Provide details of the statistical methods used for each analysis. 72 
    
b. Specify the unit of analysis for each dataset (e.g. single animal, 
group of animals, 
single neuron). 
16 
    c. Describe any methods used to assess whether the data met the assumptions of the statistical approach. 100 
RESULTS   
Baseline data 14 
For each experimental group, report relevant characteristics and 
health status of animals (e.g. weight, microbiological status, and drug 
or test naïve) prior to treatment or testing. (This information can 
often be tabulated). 
0 
Numbers 
analysed 15 
a. Report the number of animals in each group included in each 
analysis. Report absolute numbers (e.g. 10/20, not 50%) (Schulz et al., 
2010). 
0 
Outcomes and 
estimation 16 
Report the results for each analysis carried out, with a measure of 
precision (e.g. standard error or confidence interval). 66,5 
DISCUSSION   
Interpretation/sci
entific 
implications 
18 
a. Interpret the results, taking into account the study objectives and 
hypotheses, current theory and other relevant studies in the 
literature. 
100 
Generalisability/t
ranslation 19 
Comment on whether, and how, the findings of this study are likely to 
translate to other species or systems, including any relevance to 
human biology. 
70 
Funding 20 
List all funding sources (including grant number) and the role of the 
funder(s) 
in the study. 80 
TOTAL      74,9 
 
 
Effects of air pollution on lung innate lymphoid cells
111
Resource S4. Adapted scale for in vitro experiments in human cells (From 
ARRIVE guidelines). 
Average score for 3 studies carried out in human cells 
      FULFILLMENT % 
TITLE 1 Provide as accurate and concise a description of the content of the 
article as possible. 
100 
ABSTRACT 2 
Provide an accurate summary of the background, research objectives, 
including details of the species or strain of animal used, key methods, 
principal findings and conclusions of the study. 
100 
INTRODUCTION   
Background 3 
a. Include sufficient scientific background (including relevant 
references to previous work) to understand the motivation and 
context for the study, and explain the experimental approach and 
rationale. 
100 
Objectives 4 Clearly describe the primary and any secondary objectives of the 
study, or specific hypotheses being tested. 
100 
METHODS   
Ethical statement 5 Indicate the nature of the ethical review permissions, written 
informed consent 
100 
Study design 6 For each experiment, give brief details of the study design including 
the number of experimental and control groups. 
75 
In vitro 
procedures 
7 a. Describe in  detail all  the in vitro procedures 100 
  
b. Describe in detail  all the reagents, cells,  kits including 
manufacturer  used (manufacturer)  
100 
Sample size 
10 a. Specify the total number of  subjects  100 
  
b. Explain how the number of animals was arrived at. Provide details 
of any sample size calculation used. 
 0 
Experimental 
outcomes 12 
Clearly define the primary and secondary experimental outcomes 
assessed (e.g. cell death, molecular markers, behavioural changes). 
100 
Statistical 
methods 13 a. Provide details of the statistical methods used for each analysis. 
75 
 
    
b. Describe any methods used to assess whether the data met the 
assumptions of the statistical approach. 
100 
RESULTS   
Baseline data 14 For each experimental group, report relevant characteristics and 
health status of human subjects 
0 
Outcomes and 
estimation 16 
Report the results for each analysis carried out, with a measure of 
precision (e.g. standard error or confidence interval). 
100 
 
DISCUSSION   
Interpretation/sci
entific 
implications 
18 
a. Interpret the results, taking into account the study objectives and 
hypotheses, current theory and other relevant studies in the 
literature. 
100 
Funding 20 List all funding sources (including grant number) and the role of the 
funder(s) in the study. 
75 
TOTAL      89.1 
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ABSTRACT
Outdoor air pollution is associated with respiratory infections and allergies, yet the role 
of innate lymphoid cells (ILCs) in pathogen containment and airway hyperresponsiveness 
relevant to effects of air pollutants on ILCs is poorly understood. We conducted a systematic 
review to evaluate the available evidence on the effect of outdoor air pollutants on the lung 
type 1 (ILC1) and type 2 ILCs (ILC2) subsets. We searched five electronic databases (up to 
Dec 2018) for studies on the effect of carbon monoxide (CO), sulfur dioxide (SO2), nitrogen 
dioxide (NO2), diesel exhaust particles (DEP), ozone (O3), and particulate matter (PM) on 
respiratory ILCs. Of 2209 identified citations, 22 full-text papers were assessed for eligibility, 
and 12 articles describing experimental studies performed in murine strains (9) and on human 
blood cells (3) were finally selected. Overall, these studies showed that exposure to PM, DEP, 
and high doses of O3 resulted in a reduction of interferon gamma (IFN-γ) production and 
cytotoxicity of ILC1. These pollutants and carbon nanotubes stimulate lung ILC2s, produce 
high levels of interleukin (IL)-5 and IL-13, and induce airway hyperresponsiveness. These 
findings highlight potential mechanisms by which human ILCs react to air pollution that 
increase the susceptibility to infections and allergies.
Keywords:  lung innate lymphoid cells; ILC; air pollutants; airway hyperresponsiveness
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INTRODUCTION
Traffic-related air pollution has been associated with harm to respiratory health worldwide 
(1–11). Children are highly prone to harmful effects of air pollutants on lung function 
(12–14) due to the small size of their airways and immaturity of defense mechanisms (12, 
15). Reduction of several pollutants, especially particulate matter (PM2.5 and PM10), nitrogen 
dioxide (NO2), and ozone (O3) has been associated with improvement of lung function (16, 
17) plus the reduction of respiratory symptoms, bronchitis, allergic disorders in children 
with and without asthma, and in the number of daily asthma events (18–22). In contrast, 
some stud- ies have demonstrated that the reduced exposure to traffic-related air pollutants 
has little effect on lower respiratory symptoms (23) and did not affect the prevalence of 
respiratory/allergic symptoms in school children (24). The reasons for such discrepancies 
are not clear, but might be attributed to effects of several con- founding factors such as 
exposure misclassification, temporal, and spatial trends  in exposure, health, socioeconomic 
status, and smoking (25), as well as population susceptibility, life style changes, or the use 
of statistical methods that bypass the link-by-link approach of classical accountability in 
evaluating the regulatory impacts (26).
In several Latin American countries, including Brazil (6, 27), Mexico (2, 28), Chile (29, 30), 
Colombia (31), and Ecuador (32–34) researchers have demonstrated associations between 
respiratory problems and urban air pollution. These countries have created programs for air 
pollution management and control. Studies are lacking on the effects of such programs on 
respiratory health in children.
The city of Quito is the most polluted city in Ecuador, due to the number of cars contributing 
to air pollution and to the mountain range that impedes airflow to reduce contamination 
(35, 36). From January through April of 2000, we studied 616 children, aged 6–12 years, 
attending schools located in areas with different traffic intensities—moderate in the North 
and high in the Center. We found that 90% of school-aged children in the high-traffic area of 
Quito, and 43% of children in the city area with moderate traffic had blood concentrations of 
COHb higher than the safety level of 2.5% (33). Trained pediatricians identified ARI episodes 
in about 70% of children in the high-traffic area and 30% of children in the moderate-traffic 
area. Children with COHb > 2.5% were 3.25 (95% CI 1.65, 6.38) times more likely to present 
with ARIs than children with COHb ≤ 2.5% (33). Our study served as the foundation for city-
wide public policies: creation of the Metropolitan Atmospheric Monitoring Network Quito 
(REMMAQ), plus vehicular emissions control in Quito with technical inspection of vehicles 
in 2002 (34). By 2007, the annual average concentrations of sulfur dioxide (SO2), CO, and 
PM10 decreased to acceptable levels. CO was reduced by 35% (from 1.29 to 0.83 μg/m3) 
(37). Such drastic reduction in air pollution seemed likely to lead to improvements in the 
respiratory health of city residents.
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Was the reduction of traffic-related pollutant levels, specifically in CO exposure between 
2000 and 2007, associated with both the incidence of ARI and COHb levels in school-aged 
children? We conducted a 15-week prospective study of 730 children attending elementary 
schools in the North and Center areas of Quito and compared the findings with results of the 
2000 study of ARI and the COHb levels in children attending schools in the same locations 
(33).
METHODS
Study design and participants
The design and methods followed in the 2007 study, described in this section, were 
similar to those in the 2000 study (33) with the additional analysis of associations of ARI 
incidence and ambient CO measurements. In both studies, a pediatrician visited each child 
in the school twice weekly to examine the child’s respiratory signs and symptoms and to 
determine the presence of upper acute respiratory illnesses and lower acute respiratory 
illnesses.
Out of 736 recruited children attending public elementary schools in the two areas of 
Quito, 6 (< 1%) children withdrew from their school for various reasons (change of address or 
presence of varicella). Between February and June 2007, we measured the incidence of ARI 
and COHb levels in remaining 730 children. To ensure comparability between the studies, 
we conducted the 2007 study in the winter season (see   https:// nutrition.tufts.edu/  sites/ 
default/ files/ documents/ ENaumova- SupplementalMaterialCOHbARIpaper_09-24-18.pdf) 
(1) and in two schools located in the immediate vicinity of the previously studied schools 
(Center and North areas). The selected schools had similar characteristics: building, number 
of children, and socioeconomic status of the children.
During the screening period, we delivered detailed information about the study to 
teachers and parents of each child. We excluded three children due to presence of asthma (n 
= 1), congenital cardiopathy (n = 1), and major chest deformity (n = 1). A total of 736 children 
met the inclusion criteria: 6–11 years of age (age was confirmed by birth certificate), formal 
written consent freely signed by parents, and child assent.
Carboxyhemoglobin status
Before starting the follow-up period, we obtained a 5-mL venous blood sample 
from each child using a plastic syringe and placing the sample in a collecting tube with 
Ethylenediaminetetraacetic acid (EDTA). These tubes were refrigerated until transported 
for the analysis to a laboratory at Universidad Católica del Ecuador. (This laboratory also 
measured COHb in the 2000 study.) We measured COHb levels by spectrometry (38) within 
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24 h, and expressed results as a percentage of plasma hemoglobin. COHb concentration of 
2.5% was considered the reference value, the level below which no symptoms would be 
found (39).
Acute respiratory illness measurements
Trained practitioners visited each child weekly at her/his school by to monitor res- 
piratory symptoms and signs, and to determine the presence of acute upper and lower 
respiratory illnesses. Children who presented with respiratory illness were treated, but not 
necessarily removed from school, and followed until the resolution of the episode. A new 
case could be identified after 2 weeks free of respiratory ill- ness. Acute upper respiratory 
illness was defined as the presence of two or more of the following signs/symptoms: cough, 
nasal secretion, fever > 37.5 °C (axillary temperature), inflammation of pharynx, and anterior 
cervical lymphadenitis. Presence of otitis (local pain, aural pus, and eardrum congestion) was 
also considered as acute upper respiratory illness. Acute lower respiratory illness was defined 
by tachypnea (respiratory rate > 20) and/or lower respiratory tract secretions (alveolar or 
bronchoalveolar) assessed by thoracic auscultation, plus one or more of the following: fever, 
cough, and chest retractions (40).
Anthropometric measurements
We measured each child’s weight and height by standard procedures (41) using 
instruments calibrated by the Ecuadorian Institute of Normalization. Weight was measured 
with a DETECTO balance (New York), that included a height gage graduated in cm. Weight was 
recorded to the nearest 0.1 kg. Height was recorded to the nearest 0.1 cm.
Nutritional status
Weight-for-age Z-score (WAZ) and height-for-age Z-score (HAZ) were determined for each 
child using Nutstat software (Epi Info(TM) CDC, 2004). Children having a WAZ < –2 SD were 
classified as underweight. Children having a HAZ < − 2 SD were classified as stunted.
Exposure to pollution
Household survey
To determine the indoor CO contamination, we sent a survey to the parents of study children 
in the first 3 weeks of the study. It asked about the type of fuel used for cooking (kerosene, gas, 
alcohol, firewood), and the presence of smokers. Ninety- four % of the surveys were completed. 
Air quality measurements
In 2004, 4 years after the 2000 study was completed, Quito started city-wide routine air 
quality monitoring. To provide CO proxies for both time intervals, we obtained from two 
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monitoring stations located in the Center and North areas all available monthly records for 
CO levels during the period 2004–2007. Using monthly records, we interpolated CO average 
values from 2004 for COHb measurements in 2000 by direct assignment of the closest available 
monthly measurements in 2004 (4.5 mg/m3 for CO level). We used these interpolated values 
in our analysis. For 2007, we obtained daily records of environmental CO, SO2, and PM2.5 levels, 
collected now as part of the automatic network of passive monitoring maintained by Quito 
Air Corporation (CORPAIRE). We supplemented the analysis with daily records for ambient 
temperature and precipitation from the National Institute of Meteorology and Hydrology 
(INAMHI), Quito, Ecuador (42).
Statistical analysis
We compared descriptive statistics about children from the 2000 and 2007 studies. 
Continuous variables were described as the mean and standard deviation; categorical 
variables as absolute frequency and percentages. We compared the distributions of the 
studied parameters with t Student and chi-squared tests for continuous and categorical 
variables, respectively.
We calculated the incidence rates (episodes/1000 child-weeks (CW) for the fol- low-up 
period) of acute respiratory illness and the annual frequency of ARI episodes/ child in both 
2007 and 2000 study groups. We estimated the average concentrations for the selected 
environmental air pollutants measured during the 15-week study.
The relationships between COHb levels and environmental CO were assessed by 
several regression models, using the CO values from the day of and the day prior to the 
COHb measurement. The models were gradually adjusted for individual characteristics 
(age, sex, underweight, stunting), variables for the household sources of indoor air 
pollution (indoor firewood use and smoking), and meteorological characteristics 
(see   https:// nutrition.tufts.edu/  sites/ default/ files/ documents/ ENaumova- 
SupplementalMaterialCOHbARIpaper_09-24-18.pdf) (2). To evaluate the association of 
COHb, as a marker for CO exposure, with the presence of respiratory illness, we used two 
logistic regression models. In the first model, the explanatory variable, COHb, was used as 
a continuous variable (concentrations) and in the second as a binary variable (0, if COHb ≤ 
2.5%; and 1, if COHb > 2.5%). We expressed the results in Adjusted Odds Ratios (AOR) with 
95% confidence intervals.
To allow for multiple episodes of ARI in a child, we applied the Generalized Estimating 
Equation (GEE) for Poisson regression models to evaluate the association between COHb 
level and the incidence of ARI (ARI/1000 child-weeks). We applied the same model to 
examine the relationship between ambient CO concentrations and ARI incidence. We 
also explored the relationship between ARI incidence and COHb levels and between 
ARI incidence and ambient CO concentrations, using the classic Poisson regression 
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model (see   https:// nutrition.tufts.edu/  sites/ default/ files/ documents/ ENaumova- 
SupplementalMaterialCOHbARIpaper_09-24-18.pdf)  (3). The results are expressed in rate 
ratios with 95% confidence intervals.
Logistic and GEE regression models were adjusted for age, sex, nutritional status (underweight 
and stunted), fire wood use for cooking, and presence of smokers in the households. Regression 
coefficients for study parameters were considered statistically significant if the corresponding 
two-sided p value was equal to or below 0.05.
Finally, we constructed a Poisson regression model for ARI occurrence for 2007 with CO, SO2, 
and PM2.5 concentration values (same day of COHb measurements) and adjusted for individual 
covariates.
We entered and managed data using the ACCESS program (version 11.5614.5602, 2003). 
We analyzed these data using the SPSS program (Version 22. 0, Lead Technologies Inc., SPSS Inc., 
Chicago, Illinois, USA). The complete database contained information from both 2007 and 2000 
study.
Ethics approval and consent to participate
We obtained ethical approval for the study from the Ethical Committee of the Corporación 
Ecuatoriana de Biotecnología (CEB). We obtained voluntary formal written consent from 
parents, plus assent from each child.
RESULTS
General characteristics of participants
In 2000, 616 children aged 6–12 years were studied (33). Thirty-one percent (196/616) 
of the children had COHb measured, and 87.5% completed the survey. There were a total 
of 7337 weekly visits. In 2007, we enrolled 730 children aged 6–12 years in the study. All 
children had COHb measured and 98% completed the survey. A total of 10,683 child-weeks 
of observation were accumulated in the 2007 study. As compared to 2000, average age, the 
proportion of females, stunted, and underweight children were significantly higher in the 2007 
study. Between the two study years, there were no significant differences in the percentage of 
home smokers and the use of firewood in households (Table 1).
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Environmental contaminants
In the study of year 2000, there was no systematic monitoring of contaminants by areas in 
the city of Quito. Ambient CO levels were steadily declining over the period, based on city-wide 
routine monitoring, from 4.5 mg/m3 in 2004 to 0.78 mg/m3 in 2007 (Fig. 1a). During the study 
period in 2007, the maximum daily concentration of consecutive 8-h moving averages for CO 
and O3 and the maximum daily concentration of consecutive 24-h moving averages for PM2.5, 
NO2, and SO2 in north and center monitoring stations were within desirable and acceptable 
limits, as permitted by Ecuadorian Air Quality Standards (NECA) (37, 43) (Fig. 1b).
ARI incidence and carboxyhemoglobin levels
While there was no difference in the percentage of children who presented with ARI in 
2007 and 2000, the number of ARI episodes and the annual frequency of ARI per child were 
significantly lower in 2007 as compared to 2000 (Table 2). Similarly, the incidence rate of ARI 
in 2007 was significantly lower than in 2000 (43.52 per 1000 CW vs. 83.14 per 1000 CW), 
equivalent to a 48% lower rate of ARI (RR 0.52; 95% CI 0.45–0.62, p ≤ 0.0001).
In 2007, the average level of COHb was below 2.5%, in contrast to 2000, when it exceeded 
that safety level. Furthermore, in 2007, the fraction of children with COHb > 2.5% was 
significantly lower as compared to the 2000 study (4.9% vs. 64.9%) (Table 2).
 
Study parameters 
 
2000 
(n =616) 
 
2007 
(n = 730) 
 
p value 
Baseline characteristics 
 Age (years) 8.64 ± 1.01 9.39 ± 1.53 < 0.0001 
 Females (%) 242 (39.4) 388 (53.2) < 0.0001 
 Weight (kg) 27.38 ± 5.6 28.05 ± 7.71 0.074 
 Underweight1  17 (2.8) 95 (13.1) < 0.0001 
 Height (cm) 127.5 ± 8.15 126.34 ± 12.42 0.067 
 Stunted 2 56 (9.1) 233 (31.9) < 0.0001 
 BMI (kg/m2)3 16.74 ± 2.42 17.25 ± 2.42 < 0.0001 
Survey    
 Completed surveys  539 (87.5) 718 (98.4) < 0.0001 
 Households with kerosene use  11 (2.17) 0 (0.0)  
 Households with ﬁre wood use 5 (0.9) 2 (0.2) 0.111 
 Households with smokers  128 (25.2) 159 (22.2) 0.22 
 
Data are mean ±SD or n (%).
1 Underweight was defined as weight for age Z score <–2SD. 
2 Stunted was defined as Height for age Z score < –2SD.
3 BMI - Body Mass Index
Table 1: Baseline characteristics of children in 2000 and 2007 studies.
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Fig. 1 Air quality in Quito (2004–2007).
a Declining trend in the outdoor CO ambient concentration (mg/m3) measured at the North and Center stations; b 
Maximum daily concentration of consecutive 8-h moving averages for CO and O3, and maximum daily concentration 
of consecutive 24-h moving averages for PM2.5, NO2, and SO2 in Center and North monitoring stations in 2007
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Table 2: Incidence of acute respiratory illness and exposure measurements for children in 2000 and 2007 studies.
Data are mean ±SD or n (%)
ARI - Acute Respiratory Illness
1 COHb: Carboxyhemoglobin as percentage of CO fixed to hemoglobin
2 COHb over the safe level of 2.5%
 
Study parameters 
 
 
2000 
(n = 616) 
 
2007 
(n = 730) 
 
p value 
Outcome    
Children with ARI  308 (50.0) 357 (48.9) 0.689 
ARI episodes 610 465 < 0.0001 
Annual frequency of ARI/child 4.35 2.33 < 0.0001 
Incidence rate of ARI/1000 child weeks  83.14 43.52 < 0.0001 
Blood tests (n) 196 730  
 COHb levels (%)1 3.88 ± 1.93 1.90 ± 0.39 < 0.001 
 COHb > 2.5%2  136 (69.4) 36 (4.9) < 0.001 
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ARI incidence, carboxyhemoglobin, and CO
In 2007, neither ambient CO concentrations (Table 3) nor levels of COHb (Table 4) were 
associated with the risk of having ARI as compared to 2000 study. In 2007, having COHb 
levels > 2.5% was not associated with ARI (adjusted OR 1.29; 95% CI 0.65–2.53, p = 0.468), 
in contrast to 2000 when AOR was 5.44 (95% CI 2.38–12.42, p < 0.0001) (Table 5). Similarly, 
in 2007, levels of COHb were not associated with presence of ARI (adjusted OR 1.30; 95% CI 
0.89–1.91, p = 0.187), in contrast to 2000 when AOR was 1.57 (95% CI 1.28–1.93, p < 0.0001).
 
All 
RR (95% CI) 
 
p value 
2000 
RR (95% CI) 
 
p value 
2007 
RR (95% CI) 
 
p value 
CO (mg/m3)1 1.23 (1.13,1.34) <0.0001 10.65(4.66,24.37) <0.0001 1.12 (0.91,1.35) 0.290 
Age (year) 0.93 (0.86,0.97) 0.017 1.06(0.848,1.13) 0.585 0.95 (0.89,1.00) 0.097 
Female 1.04 (0.87,1.36) 0.657 1.10 (0.72,1.67) 0.641 1.07 (0.89,1.28) 0.446 
Underweight2 1.02 (0.79,1.33) 0.832 0.59(0.215,1.66) 0.325 1.06 (0.81,1.39) 0.654 
Stunted3 1.21 (0.98,1.50) 0.066 1.30 (0.68,2.51) 0.422 1.18(0.97,1.45) 0.096 
Indoor ﬁre wood use 1.46 (0.42,5.05) 0.544 1.89(0.86,4.13) 0.110 0.66(0.16,2.72) 0.566 
Indoor smokers 1.07 (0.88,1.30) 0.466 1.04 (0.64,1.58) 0.950 1.13(0.92,1.39) 0.234 
 
Table 3. Risk factors associated with acute respiratory illness incidence in 2000 and 2007 studies and overall.
Rate Ratio (RR) - results from the Log-linear Poisson Generalized Estimating Equation model
1 CO, Carbon monoxide as continuous variable on the day of COHb measurement
2 Underweight was defined as weight for age Z score <-2SD 
3 Stunted was defined as height for age Z score < -2SD 
 
All 
RR (95% CI) 
 
p value 
2000 
RR (95% CI) 
 
p value 
2007 
RR (95% CI) 
 
p value 
COHb levels1 1.26 (1.17,1.34) <0.0001 1.24 (1.10,1.38) <0.0001 1.13(0.94,1.36) 0.165 
Age (year) 0.94 (0.89,1.00) 0.059 0.89 (0.72,1.09) 0.285 0.95 (0.89,1.04) 0.129 
Female 1.06 (0.89,1.26) 0.472 1.48 (0.66,1.66) 0.842 1.07(0.89,1.29) 0.434 
Underweight2 1.48 (0.80,1.36) 0.729 0.75(0.22,2.04) 0.578 1.08 (0.82,1.42) 0.570 
Stunted3 1.17 (0.95,1.45) 1.200 1.33 (0.67,2.64) 0.403 1.18(0.96,1.45) 0.099 
Indoor ﬁre wood use 1.72 (0.48,6.18) 0.402 3.13(0.72,12.72) 0.110 0.65(0.16,2.54) 0.528 
Indoor smokers 1.23 (0.92,1.36) 0.245 1.02 (0.64,1.75) 0.799 1.13(0.92,1.39) 0.241 
 
Table 4. Risk factors associated with acute respiratory illness incidence in 2000 and 2007 studies and overall.
Rate Ratio (RR) - results from the Log-linear Poisson Generalized Estimating Equation model
1 COHb, as continuous variable 
2 Underweight was defined as weight for age Z score <-2SD 
3 Stunted was defined as height for age Z score < -2SD 
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ARI incidence in center and north areas of Quito
In 2007, the number of episodes of ARI, the percentage of children with ARI, and the 
annual frequency of ARI per child were comparable across the schools in the North and 
Central areas. The percentage of children with COHb > 2.5% was significantly lower in the 
Center school. The percentage of underweight children was significantly higher in the Center 
area school. While most characteristics of the study children in two schools were comparable, 
children at the Center area school were, on average, 1 year older as compared to those from 
the North area and there were more girls (Table 6).
In the Center area of Quito in 2007 as compared to 2000, there were significantly lower 
values for the percentage of children with ARI, the number of acute respiratory illnesses, 
annual rate of respiratory illness, COHb levels, and percentage of children with COHb > 2.5%. 
The children in 2007 were also significantly older, with more females, stunted children, and 
underweight children than those in the 2000 study (Table 6). The North area of Quito had a 
significantly higher percent of children with ARI, more ARI episodes, and a higher annual ARI 
rate, yet significantly lower values for COHb levels. The percentage of children with COHb > 
2.5% observed in 2007 was low compared to 2000. Again, children in 2007 were significantly 
older and the percentage of stunted and underweight children was higher as compared to 
2000.
For indoor CO contamination factors, the use of firewood as fuel was comparable across 
the time and locations, while the use of kerosene declined (Table 6). For the 2007 study, in 
a multi-pollutant model, daily CO and SO2 levels were significantly associated with number 
of episodes of ARI (see   https:// nutrition.tufts.edu/  sites/ default/ files/ documents/ 
ENaumova- SupplementalMaterialCOHbARIpaper_09-24-18.pdf) (Table S7).
 
2000 
AOR (95% CI) 
 
p value 
2007 
AOR (95% CI) 
 
p value 
COHb >2.5%1 5.44 (2.38–12.42) <0.0001 1.29 (0.65–2.53) 0.468 
Age/year 0.91 (0.61–1.34) 0.626 0.95 (0.86–1.05) 0.278 
Female 1.76 (0.82–3.79) 0.146 1.13(0.84–1.52) 0.431 
Underweight2 2.53(0.37–17.17) 0.342 0.92 (0.57–1.49) 0.743 
Stunted3 1.94 (0.62–6.06) 0.254 1.21(0.85–1.73) 0.278 
Indoor ﬁre wood use 1.30 (0.07–25.76) 0.865 0.83(0.05–13.52) 0.865 
Indoor smokers  0.85 (0.36–1.96) 0.696 1.14(0.79–1.64) 0.484 
 
Table 5: Risk factors associated with the presence of acute respiratory illness in children in 2000 and 2007 studies.
Adjusted odds ratios (AOR) result from binary logistic regression model
1COHb, Carboxyhemoglobin over the safe level of 2.5%, as binary variable 
2Underweight was defined as weight for age Z score <–2SD
3Stunted was defined as Height for age Z score < –2SD
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DISCUSSION
Five years of vehicle emissions control effectively and significantly decreased mean COHb 
levels, percent of children with COHb above the safety level > 2.5%, and incidence of ARI. 
The strongest evidence of the relation between declining of CO air pollution and respiratory 
health is that the RR for the association COHb > 2.5% and incidence of ARI decreased by 
67.5% in this period. In 2007, the average value of COHb in blood of study children was below 
the safety level of 2.5%, in contrast to 2000 study when the average exceeded the safety 
level. Furthermore, the percentage of children with COHb > 2.5% decreased by 92%, and the 
annual frequency of ARI/ child declined 46% compared to the year 2000 study. We suggest that 
reduced ambient levels of CO resulted in reduced COHb concentration and increased number 
Table 6: Incidence of ARI and exposure measurements for children at Center and North in 2000 and 2007 studies.
ARI Acute respiratory illness
1 p–value < 0·05: a (Center 2000 vs. Center2007), b (Center 2000 vs. North 2000), c (Center 2000 vs. North 2007), d 
(North 2000 vs. North 2007), e (North 2000 vs. Center 2007), f (North 2007 vs. Center 2007). 
2 Underweight was defined as weight for age Z score <–2SD 
3 Stunted was defined as Height for age Z score < –2SD
4 COHb, as continuous variable
5 COHb, Carboxyhemoglobin over the safe level of 2.5% 
Variables  
Center 2000  (n 
= 313) 
Center 2007 
(n = 359) 
North 2000 
(n = 303) 
North 2007 
(n = 371) 
 p value1 
 
Outcome 
     
 Children with ARI  219 (70.0) 169 (47.0) 90 (29.7) 189(50.9) a, b, c, d, e 
 No. of ARI episodes 496 224 114 241 a, b, c, d, e 
 Annual rate of ARI 6.89 2.25 1.63 2.41 a, b, c 
Baseline characteristics 
 Age (years) 8.36 ± 1.08 9.56 ± 1.56 8.94 ± 0.84 9.23 ± 1.49 a, b, c, d, e, f 
 Females 92 (29.5) 204 (56.8) 150 (49.5) 184 (49.6) a, b, c 
 Weight (kg) 27.0 ± 5.97 28 ± 8.12 27.75 ± 5.21 28.04 ± 7.30   
 Underweight2 10 (3.2) 61 (17.0) 7 (2.31) 34 (9.16) a, c, d, e, f 
 Height (cm) 126.46 ± 8.5 126.79 ± 11.7 128.57 ± 7.65 125.89 ± 13.1 d 
 Stunted3 27 (8.26) 116 (32.31) 29 (9.57) 117 (31.53) a, c, d, e 
BMI (kg/m2) 16.75± 2.3 17.11 ± 2.5 16.7 ± 2.4 17.3 ± 2.3 c, d  
Survey       
Completed surveys  238 (76) 348 (96.93) 301 (99.34) 370 (99.73) a, b, c 
Households with  kerosene use  7 (2.94) 0 (0.0) 4 (1.68) 0 (0.00) a, c 
Households with ﬁre wood use 1 (0.42) 1 (0.29) 4 (1.34) 1 (0.27)   
Households with smokers  37 (15.14) 74 (21.26) 91 (30.54) 85(22.97) b, d 
Blood tests  106 359 90 371  
 COHb levels (%)4 5.09 ± 1.7 1.88 ± 0.29 2.55 ± 1.20 1.91 ± 0.46 a, b, c, d, e  
COHb > 2.5%5 97 (91.50) 12 (3.34) 39 (43.33) 24 (6.47) a, b, c, d, e 
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of children with the safe COHb level. Did this environment lead to decreased susceptibility to 
ARIs in children residing in areas with high micronutrient and oxygen deficiency?
This evidence is consistent with other limited trials that have demonstrated bene- fits in 
child respiratory health from air pollution reduction policies, and other actions implemented 
to improve air quality. Although those studies were not specific for CO reduction, overall 
declining trends in several air pollutants were associated with a decrease of medical visits 
for asthma and lower respiratory infections (44), decrease of bronchitis symptoms (19), 
improvements in lung function (16–18), less pulmonary inflammation (45), and reduction 
in asthma prevalence (20). School bus retro- fits—used to reduce tailpipe and engine 
emissions—are associated with large reductions in bronchitis, asthma, and pneumonia 
incidence among children (46).
It is important to mention that some studies did not show definite effects of air pollution 
regulation on respiratory illnesses in children (23, 24). We believe that changes might 
better be attributed to the difference in pollutant exposure between subjects, the type 
of the policy that was implemented, or differences in study designs. Some studies on air 
pollution and health suggest that the variability in the relationship between decreases in 
pollution and respiratory symptoms may be due to unexplored heterogeneity between and 
within communities (18), measurement errors associated with instrument precision, spatial 
variability of pollutants (47, 48), and the lack of direct measurements of how emissions are 
changing and/or how they are responding to specific regulations (26).
Although lessening of both outdoor CO and COHb levels were seen in both study areas in 
2007, the large reduction (67%) in the annual rate of IRA/child was detected only in the school 
located at the Center. This reduction was related to a marked decrease in the average of COHb 
levels in those children (63% reduction seen in Table 6). Other risk factors for acute respiratory 
infection, such as underweight and stunting (49–52) were not related to ARI (Tables 3 and 4). 
Potentially, this could indi- cate that ambient CO levels affect children independently of the 
nutritional status.
In the North area, the annual rate of ARI/child was 32% higher than in 2000 despite a 25% 
reduction of COHb levels observed in 2007 (Table 6). It is possible that other factors, such as 
immune status or other outdoor pollutants, which were not evaluated in this study, explain 
this finding. In fact, in the 2004–2007 period, the CO levels recorded in the North area were 
within desirable limits, and the pollutants of greatest concern were O3 and PM2.5 because 
they increased annually albeit within acceptable levels. Our hypothesis that the increase of 
PM in the north of Quito in 2007 may explain the rise in the incidence of respiratory illness 
becomes more plausible because of other factors that could influence the presence of such 
illness. Those factors that were not associated with the increase in ARIs include male sex, 
younger age, presence of underweight, or stunting.
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Even if overall air quality showed improvement from January to April 2007, PM2.5 levels had 
an increasing trend in the North of Quito. During February, levels were above the maximum 
levels allowed by the national standard (19.67 µg/m3) (37). Such increases reflect a significant 
increase in the car fleet with which the city of Quito has experimented across the years (7% per 
year or ~ 30,000 vehicles per year) (35).
It is worth mentioning that in the peripheral areas of Quito, such as in the north, the 
residential population has grown as has the number of commuters, with a resulting increase 
in heavy vehicular circulation, especially diesel buses (43). Diesel combustion is known to 
generate approximately ten times more nanoparticles than the combustion of gasoline (53). 
Even low levels of PM cause asthma and other respiratory diseases (46). Diesel exhaust 
particles induce alveolar macrophages to produce nitric oxide which can combine with 
superoxide anions to produce peroxynitrite, a potent oxidizing compound that alters body 
cells, any somatic cells (54). As indicated by a multi-pollutant model in 2007, CO and SO2 
levels were associated with the number of episodes of ARI. The high rate of respiratory 
illness in 2007 in neighborhoods charged with nanoparticles, suggests that control of CO 
emission and other pollutants, like SO2, were not sufficient to prevent illnesses associated 
with chronic respiratory inflammation.
Due to the differences in study designs and measurements of both ambient pollutants 
and respiratory outcomes, direct comparisons of our findings with studies addressing the 
benefit for respiratory health of short- or long-term air pollution reduction are not completely 
feasible. Nevertheless, our findings support those studies, demonstrating that improvements 
in respiratory health can be expected when there are significant reductions in environmental 
pollution, even for the short periods.
The 48% reduction in the incidence of ARI (RR = 0.52, 95% CI 0.45, 0.62, p < 0.0001) that 
we found after 5 years of vehicle emission control might be com- parable to the 37–40% 
drop in pneumonia cases due to reduced emissions of diesel- related toxics particulates 
from school buses reported by Beatty and Shimshack in 2011 (46). Similarly, the reduced 
prevalence of common cold (OR = 0.78; 95% CI 0.68, 0.89) in children aged 6–15 years 
related to the decline in PM10 levels that was found by Bayer et al. in 2015 (21); and with 
the decreased prevalence of respira- tory symptoms (bronchitis, cough, and phlegm) in 
adolescents with asthma due to decreases of NO2, PM2.5, PM10, and O3 that Gilliland et al. 
demonstrated in 2017 (18). Those studies were carried out in developed countries where 
children are less exposed to environmental risks than children in developing countries, such 
as Ecuador. Our findings are needed if we are to alert developing countries to the importance 
of having healthy environments to prevent respiratory problems.
Ecuador has been listed as a country with a high level of air pollution, but there are others 
whose populations are also at risk: Peru, Colombia, Venezuela, Mexico, Honduras, Chile, and 
Guatemala comprise the top Latin American countries with the worst air pollution (55). Our 
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findings suggest that policies intended to abate vehicle air pollution may be appropriate in 
other parts of the developing world with similar geographic conditions and where the impact 
of air pollution on respiratory health is severe. In addition, such control strategies are likely 
to be sustainable, as Quito has already demonstrated feasibility in a developing country.
Taken together, these findings show a strong relationship between CO, COHb, and 
ARI, explained by biologically plausible mechanisms. They indicate a benefit of the lower 
concentration of environmental CO on the respiratory health of children achieved by vehicle 
exhaust control. CO, one of the principal polluting gases from vehicular emissions (56), affects 
respiratory mucosae from the nose to the alveoli, causing respiratory infections—from colds to 
bronchospasm and pneumonia (4, 57); and these infections increase hospitalizations (4, 57–59). 
When CO enters the blood stream it reacts with hemoglobin to form COHb. This compound does 
not allow an adequate supply of oxygen to reach tissues and organs of the human body in a dose-
dependent manner (60, 61). Thus, an increase in ambient CO could lead to a potential increase 
in an individual’s COHb level indicative of a condition that poses a risk for respiratory illness.
The major strengths of our study include (a) the representative sample size for Quito 
city, making the results relevant to other Andean countries, (b) the objective measure of 
CO exposure through COHb levels, (c) the direct detection of ARI cases by experienced 
pediatricians who examined each child every week, and (d) the inclusion of factors important 
for the development of acute respiratory illness. Furthermore, we compared our findings 
with the results of a 2000 study to determine whether a policy change had a long-term 
effect on a similar population. These strong points are responsible for robust analyses and 
trustworthy results.
The study has several limitations. Because CO monitoring was not available in 2000, it 
was not possible to evaluate directly the change of CO concentrations. For the analysis, we 
used conservative estimates based on the observed trend in measurements collected after 
2004, when routine monitoring started. We compensated for the lack of measurements 
in 2000 with a more detailed analysis of CO lagged by 1 day with data available for 2007. 
We chose the lag of 1 day because during expo- sure to a fixed CO concentration, COHb 
levels increase rapidly over the first 2 h, and then begin to plateau at around 3 h, reaching an 
equilibrium steady state at 4–6 h. To maintain COHb below 2.5%, CO exposure cannot exceed 
10 ppm (62). In blood samples collected in tubes containing EDTA or heparin and stored at 
room temperature or at 4 °C, COHb concentrations were stable for at least 5 days (38). The 
analysis of the CO concentration from the same day and a day prior COHb measurements 
reached similar conclusions.
We reconstructed the time series of CO measurements and demonstrated a trend in CO levels 
over time in two city areas. We have demonstrated that the ambient CO levels were strongly 
associated with the individual’s COHb concentration (see   https:// nutrition.tufts.edu/  sites/ 
default/ files/ documents/ ENaumova- SupplementalMaterialCOHbARIpaper_09-24-18.pdf) 
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(2–3). Reduction of COHb levels observed in 2007 might indicate the effect of the reduced 
outdoor CO level. In addition, CORPAIRE reported that the annual average concentrations of 
CO was reduced by 35% in the period 2004–2007 (from 1.29 to 0.83 μg/m3), while the traffic 
density of light vehicles increased by approximately 47% (250,000 vs. 368,000 vehicles) (35).
Although we selected children from the same schools studied in 2000, the 2007 
population had slightly different mean ages and nutritional status. Our multivariate models 
demonstrated that these variables were not associated with ARI occurrence. Unfortunately, 
we did not consider other factors that could have influenced ARI occurrence, such as physical 
activity, the use of transportation, or socioeconomic status. We did not evaluate what 
changes in lifestyle or immune status of each child that could have influenced the respiratory 
health status of the children.
While Quito’s population increased from ~ 1,820,000 (63) to ~ 2,120,000 (64) during the 
period 2000–2007, there was no evidence that other factors affected the health outcomes, 
such as substantial changes in healthcare, or whether children stayed home when sick. 
Perhaps the same number of children developed ARIs, but less frequently or there was a 
dramatic improvement in indoor air quality.
In September 2006, the National Congress approved a law to regulate the use and 
consumption of tobacco and its derivatives; however, the law was never enforced. In July 
2011, the National Congress banned smoking in public places, but not within households 
(65).
Over the study period, no specific emission control measures were implemented and it is 
unlikely that other sources of CO (industry, smoking) were reduced. As expected, the vehicle 
fleet increased in the city and in the northern area there were more buses fueled by diesel 
than in the downtown area. This might have increased ARI episodes in the North school area.
In light of these findings, we believe that broad policies should be implemented to 
improve air quality throughout our city to reduce the health problems due to environmental 
contaminants. Sustainable community-wide campaigns to raise awareness of the need for 
systematic controls of public and private motor vehicles can be useful preventive health 
actions. Our findings suggest that local pollution policies, such as control of exhaust emission 
from gasoline engine vehicles, and the gradual removal of old-fashioned carburetor vehicles 
from the circulation can contribute to the reduction of respiratory illnesses in children. 
These policies are likely to decrease the risk of school absenteeism and to reduce health care 
costs (45, 46). A comprehensive policy analysis may further demonstrate the benefits of the 
improved catalytic converters, the reduction of diesel emissions, and the use of biofuel in 
rapidly growing Latin American cities.
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CONCLUSIONS
Our findings show that a substantial decline in ambient carbon monoxide level that 
resulted from a city-wide 5-year vehicular emission control program is associated with 
reduction of both incidence of respiratory illnesses and carboxyhemoglobin levels in school-
aged children. Our study, along with others, supports the value of implementing preventive 
policies, and the need for sustained long-term programs in countries with poor air quality.
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SUPPLEMENTAL MATERIAL 
Weather description  
While the general climate of Ecuador is hot and subtropical, the climate of Quito, the 
national capital, is defined by its mountainous location. The city is situated 2850m above 
the sea level in the Andean Region. While the monthly temperatures are stable throughout 
the year averaging ~15°C, the season are defined by precipitation. The dry (summer) season 
generally extends from June to September with the rest of the months reserved for rainy 
(winter) season (Table S1).
Model building for the relationship between ambient CO and COHb levels
The relationship between COHb levels and air quality on the day of and the day prior the 
blood draw was assessed by linear regression model. We included in the model individual 
characteristics (age, sex, underweight, stunting) and variables for the household sources 
of indoor air pollution (indoor firewood use and smoking). We developed the model in a 
sequential manner, starting with the simple analysis of relationship between log(COHb) and 
CO (Table S2). We then gradually increased the model complexity by adding the individual 
covariates (Table S3), and two meteorological characteristics (Table S4). Table S4 is limited to 
 2000 2007 
Month 
 
Monthly 
Precip 
sum 
Monthly 
Average Shade 
air temperature 
(oC) 
Monthly 
Precip 
sum 
Monthly Average 
Shade air 
temperature (oC) 
Jan 177.3 13.6 62.2 16.0 
Feb 165.8 13.4 67.5 15.4 
Mar 149.5 13.9 177.2 15.0 
Apr 187.6 14.1 188.1 14.8 
May 123.8 14.1 101.0 15.3 
Jun  66.4 14.6 22.2 15.3 
July 22.1 14.6 12.5 15.6 
Aug 9.7 15.3 33.4 15.2 
Sep 67.3 14.2 3.0 16.1 
Oct  43.6 15.5 160.1 14.5 
Nov 16.7 14.6 197.4 14.9 
Dec 0.0 13.8 0.0 14.0 
 
Table S1. Monthly average meteorological characteristics for 2000 and 2007.
Data from:  National Institute of Meteorology and Hydrology (INAMHI). Anuario Climatológico 2007. Quito, Ecuador. 
Available at  www.serviciometeorologico.gob.ec/wp-content/uploads/anuarios/.../Am%202007.pdf
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the ambient measurements for the day prior to COHb measurements. Please note, that in 
absence of actual measurements for air quality in 2000 we use interpolated values of 4.5mg/
m3 for daily CO level (Tables S2-S4). 
Table S2. Regression models for log (COHb) measurement and CO ambient concentration for 2000 and 2007.
 Beta SE p-value 
The day of COHb measurements 
Constant 0.506 0.017 <0.0001 
CO (mg/m3)  0.145 0.007 <0.0001 
The day prior to COHb measurements 
Constant    0.511    0.017    <0.0001 
CO (mg/m3)    0.144    0.007    <0.0001 
 
Table S3. Adjusted regression models for log(COHb) measurement and CO ambient concentration for 2000 and 
2007.
 Beta SE p-value 
The day of COHb measurements 
Constant   0.787 0.076 <0.0001 
CO (mg/m3)   0.127 0.008 <0.0001 
Age (year) -0.024 0.008   0.002 
Female -0.037 0.021   0.082 
Underweight1 -0.009 0.036   0.800 
Stunted2 -0.025 0.026   0.346 
Indoor ﬁre wood use   0.016 0.157   0.920 
Indoor smokers  -0.058 0.026   0.027 
R2 = 0.288    
 
The day prior to COHb measurements 
 
Constant  0.787 0.076 <0.0001 
CO (mg/m3)  0.127 0.008 <0.0001 
Age (year) -0.023 0.008 0.002 
Female -0.039 0.021 0.067 
Underweight1 -0.004 0.036 0.919 
Stunted2 -0.031 0.026 0.232 
Indoor ﬁre wood use  0.007 0.156 0.964 
Indoor smokers  -0.063 0.008 <0.0001 
 
 
R2 = 0.292
1 Underweight was defined as weight for age Z score < -2SD
2 Stunted was defined as height for age Z score < -2SD
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We then run a regression model for only 2007, which included actual measurements 
for available air pollutant (except for NO and O3 due to incomplete records) as well as 
for temperature and precipitation for the day prior to COHb measurements (Table S5). In 
contrast to model presented in Table S4, where the effect of CO is driven by the substantial 
decline of CO concentration, the relationship between COHb measurements and ambient CO 
levels were not significant.  
Table S4. Adjusted regression adjusted Model for log(COHb) measurement and CO ambient concentration for 
2000 and 2007.
   Beta        SE     p-value 
The day prior to COHb measurements 
 
Constant  -5.590 1.224 <0.0001 
CO (mg/m3)  0.049 0.026 0.058 
Age (year) -0.021 0.007 0.005 
Female -0.021 0.021 0.317 
Underweight1 0.009 0.035 0.788 
Stunted2 -0.028 0.025 0.276 
Indoor ﬁre wood use  0.002 0.150 0.988 
Indoor smokers  -0.057 0.002 0.023 
Ambient Temperature (oC) 0.358 0.710 <0.0001 
Precipitation (mm) 0.011 0.002 <0.0001 
 
R2 = 0.345
1 Underweight was defined as weight for age Z score < -2SD
2 Stunted was defined as height for age Z score < -2SD
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 Beta SE p value 
Constant  1.670 0.734 0.002 
CO (mg/m3)  -0.016 0.021 0.451 
SO2 (μ/m3) -0.003 0.004 0.396 
PM2.5 (μ/m3) 0.002 0.002 0.173 
Age (year) 0.003 0.005 0.577 
Female 0.018 0.014 0.190 
Underweight1 -0.003 0.022 0.904 
Stunted2 -0.013 0.016 0.404 
Indoor ﬁre wood use  0.158 0.126 0.212 
Indoor smokers  -0.012 0.017 0.472 
Ambient Temperature (oC) -0.037 0.046 0.425 
 
Table S5. Adjusted regression model for log (COHb) measurement and ambient concentration for CO, SO2 and 
PM2.5 measured on a day prior the COHb measurements for the 2007 study.
R2 = 0.012
1 Underweight was defined as weight for age Z score < -2SD 2 Stunted was defined as height for age Z score < -2SD
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Model building for the relationship between ambient CO and COHb levels 
and respiratory illness
We constructed a Poisson regression model for ARI occurrence for 2000 and 2007 with 
COHb level and CO concentration values (same day) and adjusted for individual covariates. 
Only COHb levels are significant associated with number of episodes of ARI (Table S6).
Table S6. Adjusted Poisson regression model for ARI (number of episodes) and COHb concentration for 2000 and 
2007.
 Exp (Beta) 95 CI p value 
The day of COHb measurements 
 
Constant  0.645 0.344-1.208 0.170 
COHb (%) 1.215 1.125-1.314 < 0.0001 
CO (mg/m3)  0.992 0.923-1.065 0.821 
Age/year 0.947 0.892-1.005 0.073 
Female 1.060 0.900-1.249 0.488 
Underweight1 1.060 0.813-1.382 0.669 
Stunted2 1.188 0.976-1.447 0.086 
Indoor ﬁre wood use  1.648 0.678-4.003 0.270 
Indoor smokers  1.102 0.908-1.337 0.326 
 1 Underweight was defined as weight for age Z score < -2SD
2 Stunted was defined as height for age Z score < -2SD
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Model building for the relationship between ambient CO, SO2 and PM2.5 
levels and respiratory illness in 2007.
We constructed a Poisson regression model for ARI occurrence for 2007 with CO, SO2 and 
PM2.5 concentration values (same day of COHb measurements) and adjusted for individual 
covariates. CO, SO2 levels are significant associated with number of episodes of ARI (Table 
S7).
Table S7. Adjusted Poisson regression model for ARI (number of episodes) and air pollutants in 2007.
 
        
RR (95% CI) 
 
P-value 
CO (mg/m3) 1 1.56 (1.17–2.08) 0.002 
SO2 (μg/m3) 1 1.10 (1.04–1.16) >0.0001 
PM2.5 (μg/m3)1 0.98 (0.95–1.01) 0.060 
Age/year 0.91(0.85–0.09) 0.007 
Female 1.06 (0.89–1.27) 0.469 
Underweight2 1.20 (0.98–1.47) 0.472 
Stunted3 1.17 (0.96–1.44) 0.066 
Indoor ﬁre wood use  0.62 (0.14–2.76) 0.539 
Indoor smokers  1.14 (0.93–1.39) 0.186 
 
 Rate Ratio (RR) - results from the Log-linear Poisson Generalized Estimating Equation model
1 Continuous variable on the day of COHb measurement
2 Underweight was defined as weight for age Z score <-2SD 
3 Stunted was defined as height for age Z score < -2SD 
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GENERAL CONCLUSIONS
The body of work presented in this thesis on air pollution exposure and respiratory health 
in Ecuadorian children shows the following:
With regard to carbon monoxide exposure we found that:
1. Children attending primary schools in high traffic polluted areas present acute 
respiratory infection episodes more frequently than children in less polluted areas.
2. Carboxyhemoglobin (a biomarker of carbon monoxide exposure) above the safe 
level of 2.5% is associated with a 3-fold increase in the annual rate of ARI incidence 
in children as compared to COHb < 2.5%.
3. The average concentrations of blood carboxyhemoglobin in the studied population 
of children living in Quito exceeded a safe level of 2.5% mostly due to elevated COHb 
in children from the area with high traffic volume.
4. Hematocrit (a measure of a compensatory oxygen-delivery function) level did not 
affect the observed relationship between individual COHb concentration and ARI 
occurrence.
These data imply that exposure to a high level of CO, the primary reason for increased 
COHb concentration, may lead to increased susceptibility to ARIs.
We assume the following hypothetical immunological mechanisms are present depending 
on a hypoxic environment caused by COHb:
1. A disruption of cytoskeleton integrity and apoptosis of alveolar epithelium could 
permit the entrance of microorganisms.
2. Inhibitory effect on the recruitment and differentiation of AMs as well as low phagocytic 
activity of AMs and immature DC would allow the survival of microorganisms.
3. Upregulation of monocyte/macrophage and mature DC pro-inflammatory cytokines 
and chemokines would aggravate the inflammatory process and delay the recovery 
of respiratory tissue and further lead to recurrent infections.
With regard to volcanic ash exposure we found that:
1. Volcanic ash exposure increased the rate of emergency room visits due to acute 
respiratory infections and asthma in children less than 15 years of age.
2. The rate of asthma and asthma-related diagnoses was two times higher during the 
period of fumarolic activity of Pichincha.
3. Children under 4 years were more affected by volcanic ash exposure than older 
children. 
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These data imply that there is a strong relationship between ash exposure and respiratory 
health in children.
We assume the following hypothetical immunological mechanisms:
1. At the beginning of the volcanic ash exposure, there is a first wave of ramifications 
with a transient acute irritant effect on the mucous membrane of the upper 
respiratory tract which can explain the increased number of asthma cases. 
2. Later, when volcanic ash reaches the alveoli it may impair macrophage-mediated 
removal of particles and bacterial killing which could explain the development of 
respiratory infections. 
3. Furthermore, a functional activation of the NLRP3 inflammasome by volcanic can 
occur in macrophages which aggravates the inflammatory process.
4. Finally, youngest children appear to have been affected the most, due to a) the 
anatomic and functional characteristics of their respiratory system which permit 
faster access of the pollutants to the lung, and b) the immaturity of their immune 
system. 
These hypotheses suggest that volcanic ash exposure, while not seriously compromising 
lung cell function, may be able to impair innate immunity responses in exposed individuals.
With regard to PM and NOx exposure we found that:
1. Children under 36 months of age exposed to higher levels of PM and NOx had a 
higher risk of pneumonia-related hospitalizations, total respiratory illnesses and 
anemia than children exposed to lower levels of air pollution.
2. Anemic children under 36 months of age exposed to higher levels of pollution 
presented a risk of pneumonia-related hospitalization six times higher compared to 
non-anemic children in the same polluted neighborhood. 
These data imply that anemic children exposed to relatively high levels of PM and NOx 
present increased susceptibility to lower respiratory infections, including pneumonia, and 
that a possible synergy exists between a common manifestation of nutritional anemia and 
ambient air pollution as risk factors for pneumonia-related hospitalization in a high-altitude 
setting.
We assume the following hypothetical immunological mechanisms:
1. Loss of integrity of the respiratory epithelia allows greater exposure to pathogens.
2. Impairment of NK cells cytotoxicity could increase susceptibility to infections.
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3. Excessive production of proinflammatory cytokines by NK, AMs, DC could threaten 
lung gas exchange, especially in anemic children, and aggravate any respiratory 
episode.
4. Hypoxia due to anemia and methemoglobin formation could alter the function of 
some innate cells and delay recovery.
With regard to the effects of air pollution on lung ILCs we found that: 
1. Exposure to key air pollution, including PM, DEP, and O3 stimulates lung ILC2s to 
produce high levels of IL-5 and IL-13. 
2. Exposure PM, DEP, and O3 inhibits in general the cytotoxicity and IFN-γ production by 
lung ILC1 (NK) cells (apart of low doses of O3). 
We assume the following hypothetical participation of ILCs on respiratory problems 
associated with exposure to pollutants: 
1. ILC2s would be involved in airway inflammation through production of IL-5 which 
recruits and activates eosinophils in the respiratory mucosa, causing inflammation 
through their cytotoxic proteins. 
2. ILC2s through production of IL-13 could stimulate airway smooth muscle contraction 
by modulating Ca2+ responses and stimulating innate immune cells to secrete 
chitinase. 
3. ILC1 NK cells would aggravate inflammatory process by secreting proinflammatory 
cytokines (IL-1β, IL-8 and TNF-α) which in turn elicit innate immune cells to produce 
inflammatory proteins.
4. ILC1 NK cells exposed to air pollutants could be involved in increased susceptibility 
to respiratory infections since they present low cytotoxicity capacity and reduced 
production of IFN-γ, two key mechanism to fight against pathogens . 
With regard to air pollution policy control we found that:
1. Local air pollution control policies, such as the control of exhaust emissions by 
gasoline-engine vehicles, and the gradual removal of outdated carburetor–vehicles 
from the circulation significantly reduces the frequency of respiratory illnesses in 
children.
2. A decline in ambient carbon monoxide levels resulting from vehicular emission 
control programs is associated with a reduction of carboxyhemoglobin levels in 
school–age children. 
3. Reduction of carboxyhemoglobin levels results in a reduction of respiratory illness.
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In conclusion, these data taken together indicate that exposure to high levels of outdoor 
CO, PM, NO2 and volcanic ashes is associated with increased susceptibility to respiratory 
illness, and supports the benefit of a policy aimed at lowering the concentration of 
environmental pollutants to decreased susceptibility to ARIs in children residing in areas with 
high micronutrient and oxygen deficiencies.
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DISCUSSION
Environmental pollution is a critical growing public health problem especially in developing 
countries (1). According to the WHO, 570,000 children under the age of five die every year as 
a result of respiratory infections caused by indoor and outdoor air pollution and exposure to 
environmental tobacco smoke (2). Therefore, there is a continuing demand for improving air 
quality to avoid those deaths. The studies presented in this thesis support the relationship 
between air pollution and respiratory infection in children (3-5), focus the effect of the main 
air pollutants (PM, O3, and DEP) on the lung immune system, and emphasize the importance 
of establishing policies to reduce environmental pollution (6), Overall, these findings show 
that children exposed to CO, PM, NOx from traffic exhaust fumes or volcanic ash are at 
risk of developing respiratory illness and that this risk could be exacerbated by the child’s 
nutritional and health (anemia) status. Besides, the results provide a general picture of how 
immune cells, and particular ILCs, are involved in the airway hyperresponsiveness and in the 
increased susceptibility to respiratory infections when exposed to different contaminants. 
Our results also demonstrate that the decline in traffic-air pollution due to vehicle emissions 
control is associated with a reduction in respiratory illness incidence in school-aged children.
Interpretation of the results 
1. Carbon monoxide exposure and respiratory infections 
The toxic effects of CO in different human tissues are due principally to its ability to bind to 
the heme complex within hemoglobin capturing oxygen and forming COHb, a compound that 
prevents hemoglobin from delivering oxygen throughout the body (7) causing a hypoxemic 
status on the tissues. The lowest level of COHb, at which adverse effects are observed, ranges 
from 2.9 to 3%, and a concentration of < 2.5% is considered safe (8). Possibly, long-term CO 
exposure could damage the lung tissue, resulting in respiratory problems. 
Although CO is one of the main environmental pollutants, few studies have been 
conducted regarding its effects on respiratory infections. For example, it has been reported 
that higher levels of CO increase the risk of hospital admissions for total respiratory 
conditions (9) and pneumonia (10, 11). Also, the prevalence of bronchitis symptoms 
among children with asthma increase as the concentration of CO increases (12). Our results 
confirm the existing literature that exposure to CO is associated with an increased risk of 
respiratory events in children (Chapter 2). However, it is important to note that our study 
measured individual concentrations of COHb, as a quantifiable proxy for CO exposure and 
likely render more accurate results as compared to the aforementioned studies that used 
environmental measurements of several pollutants, including CO, and examined associations 
with respiratory outcomes in a cross-sectional manner. 
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There are no studies yet on the plausible immunological mechanisms for CO to cause 
respiratory infections. Hypothetically, the mechanism could be attributed to the hypoxic 
status caused by high concentrations of CO. Hypoxemia impairs the cytoskeleton and induces 
apoptosis of the epithelial cells (13) causing broad uncovered respiratory surfaces through 
which microorganisms can enter. After crossing the epithelial barrier, pathogens should be 
eliminated by phagocytic cells; however, this does not happen because a) hypoxia impedes 
optimal recruitment of alverolar macrophages (14, 15) while permitting high migration levels 
of immature DCs towards the secondary lymphoid organs (16) and b) the few remaining 
alveolar macrophages (MAs) and immature dendritic cells (DCs) exhibit a reduced phagocytic 
activity (14, 15, 17). Besides, hypoxic MAs and DCs which are unable to phagocytize, secrete 
proinflammatory cytokines and chemokines that would aggravate the inflammatory process 
and delay the recovery of respiratory tissues leading to recurrent infections in those children. 
Consequently, children with COHb above the safe level of 2.5% would have a higher 
hypoxemic status that puts them at an increased risk of infection. Precisely, we found that 
low COHb concentrations (< 2.5%) were associated with a low rate of ARI (0.6 episodes per 
child per 12 weeks) while a greater exposure to CO was related to a higher frequency of acute 
respiratory episodes. Furthermore, our study revealed that with one percent increase in 
COHb above the safety level, children are 1.15 (95% CI, 1.03–1.28) times more likely to have 
an additional case of ARI, meaning that minor increases in COHb concentration would lead to 
a greater risk of respiratory illness. In light of this evidence, cities with growing urbanization 
rates, and a subsequent increase in their number of circulating vehicles, should build up their 
public health efforts to control exhaust emissions to lower the risk of respiratory infections.
2. PM and NOx exposure and respiratory infections
Several pieces of scientific evidence show that PM and NOx have harmful respiratory 
effects in children in both developed and developing countries. Exposure to PM has been 
associated with an increase in respiratory symptoms (18) as well as an increased risk of 
upper and lower respiratory infections and pneumonia (19-21). A higher risk of emergency 
room visits, hospital admissions, health care utilization for respiratory infections has also 
been reported (22-28). At the same time, some studies have shown no significant effects of 
PM on the risk of pneumonia (29, 30) or on hospitalization due to respiratory infection (9, 
22). It is likely that the effects depend on the PM concentration, air temperature, weather, 
wind, age and sex of subjects or even on the type of respiratory pathogen. A relationship 
between NOx and increased respiratory symptoms (12), respiratory infections (29, 30), 
and risk of emergency room visits or hospital admissions for respiratory infections (10, 31) 
has also been found. Our study in young children living in areas with different air pollution 
conditions adds to the evidence that exposure to higher outdoor air pollution (PM and NOx), 
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is associated with higher numbers of total respiratory illnesses and increased respiratory-
related hospitalizations (chapter 4).
Few studies have examined the mechanisms by which PM can contribute to an increase 
in acute respiratory infections, but the most likely explanation lies in the adverse impact that 
high concentrations of these pollutants have on the innate immune cells. First, PM exposure 
would provoke a loss of integrity of the respiratory epithelia because it induces oxidative stress 
(32) and impairs the mitochondrial structure and DNA biogenesis (33) resulting in activation 
of multiple cell death pathways allowing greater exposure to pathogens. In addition, PM 
reduces the production of antimicrobial peptides by epithelial cells, which limit the capacity 
to clear or remove pathogens from the respiratory tract (32). Second, pathogens that go 
beyond the epithelial barrier can easily proliferate because the PM exposed macrophages 
are unable to display their phagocytic activity (34) and anti-microbicidal function (35). The 
intracellular pathogens can also survive since PM suppresses the ability of ILC1s (NK) to 
secrete perforin and granzyme B to kill infected cells (36) (chapter 5). Third, a sustained 
inflammatory state would be generated because epithelial, dendritic, and NK cells are 
elicited by PM to secrete IL-6, TNF-α, IL-6, IL-8 and IL-12 among others (36-39), with the 
consequent PMN infiltration of the lung where they are permanently activated and produce 
superoxide radicals that may contribute to lung tissue injury (40). Finally, PM stimulated DCs 
may potentiate T-lymphocyte cytotoxic responses by increasing the damage to the airways 
and the severity of the infection (41).
NOx exposure also contributes to causing lung tissue injury through a) formation of 
reactive oxygen and nitrogen species causing the death of epithelial cells (42), b) increasing 
the inflammatory process by attracting PMN cells (43), and c) causing a hypoxic state by 
binding to hemoglobin and forming methemoglobin.
Taken together, PM and NOx create an imbalance of inflammatory mediators and 
suppress the microbial ability of innate cells. These effects possibly are more pronounced 
in young children, which might explain why the study children (< 36 months of age) living 
in highly polluted areas were at three times more risk of respiratory illness including severe 
pneumonia and required four times more hospitalizations compared to children exposed to 
a lower level of pollution (chapter 4). Therefore, strategies for ambient air quality control are 
needed to improve the respiratory health conditions of Ecuadorian children living in areas of 
poor air quality and of others in similar situation. 
3. The triad of anemia, air pollution, and respiratory infections
Several studies have demonstrated the relationship between anemia and respiratory 
infections (44-48), others have shown that air pollution causes anemia (49-51), or respiratory 
infections (3, 10, 11, 20, 21, 26, 29, 31, 52), and a few others have revealed that bacterial 
infections can decrease iron levels and cause anemia (53, 54). However, in the reviewed 
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scientific literature there are no studies displaying the relationship between anemia, air 
pollution, and respiratory infections in a population group, except for our study showing that 
anemic children under 36 months of age exposed to higher PM and NOx pollution presented 
six times more risk of pneumonia-related hospitalization compared to non-anemic children 
in the same polluted areas (presented in chapter 4).
Anemia and air pollution separately account for several cases of respiratory infections, 
but both factors acting together likely involve a higher risk for infections. There seems to be 
an intricate synergism among air pollution, anemia (iron deficiency), and infection. These 
interlaced effects could have as a common denominator for an impaired immune system 
(Figure1).
Anemia and respiratory infections: Iron-deficiency anemia is the most common 
micronutrient disorder worldwide. Women of childbearing age and children under 5 years of 
age are the most vulnerable groups. In Ecuador 26% of preschool children suffer from iron-
deficiency anemia (Hb levels <11g/dL), and the percentage is higher in children under 1 year 
of age (62%) (55). Consumption of iron-poor diets is the main cause for anemia, especially in 
the Andean region where Quito is located (55). 
Iron deficiency has been related to an impairment of cell-mediated immunity (56) and 
bactericidal activity of phagocytic cells (57, 58). These deleterious effects can be explained 
by the critical role that iron has on proliferation, differentiation and activation of monocytes, 
macrophages, and T lymphocytes (59) as well as on the modulation of cytokines production 
and the oxidative process of the innate immune cells (57). Clinical and experimental studies 
have shown that iron deficiency decreases serum IL-6 (58) and IL-2 levels (60); reduces 
phagocytic activity of monocytes, and oxidative burst activity of neutrophils and monocytes 
Figure 1. This figure shows a diagram of the triad “anemia, respiratory infections, and immune system”. 
Anemia and pollution impair the immune system and cause infections. Infection reduces iron in the body causing 
transitory anemia. Air pollution causes anemia by reducing red blood cells and hemoglobin.
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(58, 61); lowers the levels of CD4-T cells and decreases CD4:CD8 ratio,(56); but does not alter 
humoral immunity (56, 62). 
An impaired immunity related to iron deficiency possibly makes children more vulnerable 
to both viral and intracellular bacterial infections. In fact, some studies have reported that 
anemic children were more susceptible to lower respiratory tract infections compared to 
non-anemic children (47, 48, 63, 64). This evidence supports in part our findings on the 
higher risk of pneumonia hospitalization in anemic children living in Quito, and leads us to 
think that nutritional programs to diminish the rates of anemia on the population could also 
be beneficial to lower the risk of respiratory infections in those children.
Air pollution as a cause of anemia and respiratory infections: Some studies have shown 
that long-term exposure to air pollution is associated with presence of anemia, and that 
ambient PM and NO2 are the main pollutants implicated in this association (50, 51). It has 
been shown that high concentrations of air pollutants alter iron metabolism in the body 
resulting in iron-deficient anemia, with low values of hematocrit, hemoglobin, and red blood 
cell count (RBC) without changes in RBC indices (42, 49, 51, 65). One of the main proposed 
mechanisms explaining these findings is the inflammatory status triggered by PM and NO2 
exposure, which in turn, decreases erythropoietin secretion and induces erythropoietin 
resistance in the bone marrow (42). Additionally, studies show that NO2 can produce RBC 
membrane peroxidation, (65), formation of methemoglobin (42, 66). 
The possible mechanisms by which PM and NO2 impair immunity and cause respiratory 
infections have been described earlier in this chapter, and in Chapters 1 and 5.
In conclusion, ambient air pollution and anemia appear to synergistically increase 
respiratory infections due to an impairment of the immune system. On the one hand, 
PM and NO2 induce innate immune cells (EC, NK, AMs, and DC) to produce excessive 
proinflammatory cytokines which could threaten lung tissue integrity leaving it exposed 
to respiratory pathogens, and may also cause anemia. On the other hand, hypoxia due to 
anemia and methemoglobin would alter cell-mediated immunity and the bactericidal activity 
of phagocytic cells, worsening the infectious episode. 
This evidence supports our finding that children living in highly polluted areas of Quito 
were 1.5 times more likely to be anemic and had four times more pneumonia-related 
hospitalization rates compared to children living in less polluted areas (chapter 4). Optimal 
control of air pollution as well as the prevention of anemia in young children should be 
implemented in developing countries to decrease hospitalizations for pneumonia, the 
leading cause of death in children. Definitely, additional studies are needed to confirm our 
findings of synergy between air pollution and anemia. 
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4. Volcanic eruptions and respiratory infections
Volcanic eruptions and respiratory problems have been well established. The magnitude 
and severity of the respiratory problems depend on numerous factors including the intensity 
of the eruption, the physical and chemical characteristics of the emissions, the weather 
conditions, and the characteristics of the affected people(67-70). Children, the elderly, 
and people with previous respiratory problems are at higher risk of presenting respiratory 
illnesses. It is known that the range of respiratory affections can vary from mild (i.e. throat 
irritation), to severe such as asthma or respiratory infections, but neither the behavior of 
these problems during the phases of a volcanic eruption nor the involved immunological 
mechanisms have been explored in depth.
In chapter 3, we described the variation in pediatric ER visits for respiratory conditions 
before, during, and after volcanic ash falls in Quito, Ecuador, due to Guagua Pichincha volcano 
eruption which occurred in April of 2000. We showed that during the eruption, the rate of 
emergency room visits due to acute respiratory infections and asthma in children under 15 
years of age increased (Figure 2). We also posited that the rate of asthma and asthma-related 
diagnoses was two times higher during the period of fumarolic activity of the volcano (Figure 
2); and that children under 5 years were more affected by volcanic ash exposure. These 
data are in accordance with some other studies showing an increase of ER/hospital visits for 
cardiorespiratory causes (71), acute respiratory diseases (72), and asthma(68)in adults and 
children during a volcanic eruption.
Figure 2. Relative risks associated with Guagua Pichincha´s volcanic activity for three respiratory diagnostic 
groups. 
ALRI -Acute lower respiratory infection; AURI-Acute upper respiratory infection; Period 1- Fumarolic; Period 2-one 
week after 1; Period 3-two weeks after 1; Period 4-three weeks after 1.
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In order to explain this behavior from an immunological standpoint, we assume the 
following hypothetical immunological mechanisms elicited by the gases and particles of the 
volcanic emission.
During the fumarolic period, a transient acute irritant effect on the epithelial membrane 
of the upper respiratory tract takes place due to volcanic gases, especially SO2 reacting with 
the epithelial fluid to produce bisulfite and sulfite agents (73). These metabolites induce 
the respiratory epithelium to express two asthma related genes: mucine 5, subtypes A and 
C (MUC5AC) responsible for mucus secretion and airway obstruction, and the IL-13 gene, 
responsible for production of IL-13 (74). IL-13 is a pro- inflammatory cytokine involved 
in the pathogenesis of human allergic asthma by inducing contractility of airway smooth 
muscle cells (73), IgE switching in B cells, infiltration of inflammatory cells and mucus 
hypersecretion (75, 76). In addition to SO2, particles of volcanic ash trapped by mucus can 
cover the airway epithelium and worsen the asthma (68). Although there are no studies 
in humans, it is plausible that ILC2s and their cytokines (IL-5 and IL-13) can contribute to 
the allergic inflammation since murine experimental studies demonstrated that particulate 
matter produces accumulation of ILC2s in the lungs (Chapter 5). In summary, the first contact 
with volcanic gases and PM <4μm may induce airway inflammation through the activation of 
epithelial cells (Figure 3A). 
Later, when volcanic particles <4 μm reach the alveoli, macrophages try to phagocytose 
them without success since either toxic crystalline silica particles or excess of inert particles 
may impair macrophage-mediated removal of particles, and bacterial killing (68, 77). 
Likewise, iron-rich crystalline silica particles induce macrophages to produce large amounts 
of ROS (78) that can cause macrophages to die. Besides, inhalation of crystalline silica can 
activate the NLRP3 inflammasome in macrophages which worsens the inflammatory process 
(79). In conclusion, these detrimental effects of volcanic particles on macrophages and NK 
cells could explain the development and persistence of respiratory infections beyond the 
fumarolic period of a volcanic eruption (Figure 3B). 
Finally, younger children could have been affected the most, due to the anatomic and 
functional characteristics of their respiratory system which may facilitate the access of the 
pollutants to the lung (80, 81) as well as the limitations given by the immaturity of their 
immune system (82, 83).
Our findings together with those of others studies document the damage that volcanic 
eruptions can produce on the respiratory health of the population, and highlight the necessity 
of countries surrounded by active volcanoes being prepared to protect people, especially 
young children, from the harmful effects of volcanic eruptions.
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Figure 3. A) Asthma in volcanic fumarolic period. SO2 , acting with epithelial fluids produces sulfite and bisulfite 
metabolites that stimulate epithelial cells (EC) to produce both mucine-5 AC (MUC5AC) responsible for mucus se-
cretion, and IL-13 responsible for smooth muscle contraction, neutrophil (PMN) recruitment, and IgE switching in B 
cells. Particulate matter (PM) induces innate lymphoid cell type 2 (ILC2) to produce IL-13 and IL-5 related to allergic 
inflammation. B) Respiratory infections post-fumarolic period. Silica particulates (PM silica) reach the alveoli and 
induce alveolar macrophages (MØ) to a) activate the inflammasome system causing an inflammatory process, b) 
increase the production of reactive oxygen species (ROS) causing DNA damage, and c) decrease both phagocytosis 
and bacterial killing.
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5. The participation of ILCs in respiratory illness associated with air 
pollution 
Innate lymphoid cells (ILCs), a novel group of the innate immune system, populate barrier 
surfaces, including skin, intestine, lung, and some mucosal-associated lymphoid tissues (84). 
ILCs do not have antigen specific receptors and their activation depends on the surrounding 
cytokines. Once activated, ILCs perform their functions through cytokine production which 
varies according to the type of ILC (85-87). ILC1s include classical NK and non-NK cells that 
principally produce IFN-γ (86, 88). ILC2s secrete IL-5, IL-13, IL-9(89, 90), and amphiregulin 
(90). ILC3s produce mainly IL-17 and IL-22(91). In general, these cells coordinate the innate 
immune response, contribute to inflammation, modulate adaptive immunity (84), and 
regulate wound repair and tissue regeneration (92), but in some situations they can cause 
tissue injury (93).
The role of ILCs in the human lung tissue is not well studied due to the limited access 
to human lung samples (93, 94). Some studies have shown that the three ILC subsets are 
scattered within the lung tissue and probably concentrate in different places only after 
damage or inflammation. In the lung, ILC3s are more frequently found (60%) (93), and 
play an important role in antibacterial immunity, lymphoid organogenesis, recruitment of 
neutrophils, and protection of the epithelial barrier. ILC2s, which correspond to 30% of the 
ILCs (93), produce airway inflammation, bronchial hyperreactivity, increases the effects 
of allergic asthma (95), and also participate in airway homeostasis and lung tissue repair 
(96, 97). ILC1 NK cells represent only 10% of the ILCs (93), and mainly control infections by 
cytotoxicity, but also induce lung tissue injury(98). 
Summarizing, lung ILCs are crucial for lymphoid tissue formation, respiratory tissue 
remodeling, airway homeostasis, they are important to fight against pulmonary infections, 
and contribute to inflammation. But what happens to these cells when they are subjected 
to air pollutants? 
The systematic review presented in chapter 5, offers in vitro and in vivo experimental 
evidence of the deleterious effects of PM, diesel exhaust particle (DEP), and O3 on the 
number, cytokine production, and activity of ILC1s (human and mice) and ILC2 (mice). With 
this information we propose the following hypothetical immunological mechanisms elicited 
by pollutants in the respiratory system:
Although there are no studies on the effect of pollutants in human ILC2s, from the 
studies in murine species it could be inferred that these cells would be involved in airway 
inflammation and hyper-responsiveness associated with exposure to pollutants (Figure 4A). 
Exposure to DEP, carbon nanotubes, and O3 induces respiratory epithelial cells to secrete 
IL-33 (99, 100) which in turn elicits ILC2s to increase mRNA expression of IL5 and IL-13 (101) 
and secretion of these cytokines (99-102). On the one hand, IL-5 has several functions in the 
adaptive and innate responses, but preferentially recruits eosinophils from blood vessels in 
Chapter 8
162
the respiratory mucosa, and triggers them to degranulate cytotoxic proteins (103), and to 
generate ROS (104), substances responsible for airway inflammation. On the other hand, 
IL-13 could participate in airway hyper-responsiveness by modulating Ca2+ dependent 
responses of airway smooth muscle (105) and stimulating macrophages and epithelial cells 
to secrete chitinase, an enzyme that seems to induce smooth muscle contraction (106, 107).
Studies on human ILC1 NK cells showed that exposure to air pollutants results in impaired 
cell number, function and cytokine release, which could be related to both the establishment 
of airway inflammatory pathology and susceptibility to respiratory infections (Figure 4B). 
Once pollutants are inhaled, they stimulate epithelial cells, macrophages, and dendritic cells 
to secrete IL-12 (37, 108) and IL-18 (37, 109) which trigger human ILC1 NK cells to carry out 
several complex and diverse effects. In presence of DEP, IL-12 and IL-18 induce ILC1s NK 
cells to produce a modest increase of pro-inflammatory cytokines (IL-1β, TNF-α, and IL-8) 
(36, 110), which in turn induce recruitment and activation of neutrophils, monocytes, and 
eosinophils that establish an inflammatory process in the respiratory tissue. In addition, DEP 
and high doses of O3 have an immunosuppressive effect on the pulmonary NK cells´ cytotoxic 
activity. These pollutants showed to decrease the expression of the activating marker CD16 
(111), and the production of granzyme B, and perforin (36). Finally, high doses of O3 prime 
human NK cells to decrease the expression and secretion of IFN-γ (112), a key cytokine 
that enhances the microbicidal and tumoricidal activity of macrophages (113). Accordingly, 
the abatement of ILC1 NK cell along with the impairment of other immune processes not 
mentioned here could contribute to the high incidence of lung infection associated with air 
pollution exposure. 
As a conclusion, it seems that different air pollutants have specific, deleterious effects 
in the respiratory tissue through effects on innate immune cells including those ILCs 
subsets reviewed here. Certain pollutants, such as DEP and O3 have opposite effects on 
the same cell, sometimes producing pro-inflammatory responses, while on others causing 
immunosuppressive effects. As a result, the first one is associated with enhancement of 
hyperresponsiveness, and the latter with an increased risk of infection.
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Figure 4. A) Effects of pollutants on ILC2s. Particulate matter (PM), diesel exhaust particles (DEP) and ozone (O), 
elicit epithelial cells to produce IL-33 that stimulate ILC2. ILC2s produce a) IL-5, a cytokine that recruit and activate 
eosinophils that degranulate cytotoxic proteins and reactive oxygen species (ROS), that result in airway inflamma-
tion, and b)IL-13, a cytokine that makes macrophages and epithelial cells produce chitinase, an enzyme related to 
smooth muscle contraction and airway hyperresponsiveness. B) Effects of pollutants on NK cells. DEP and high 
doses of O3, decrease IL-12 and IL-18 secretion by epithelial cells. These reduced concentrations of IL-12 and IL- 18 
plus DEP and O3 produce opposite effects on NK cells: a) stimulate pro inflammatory cytokines (IL-1β, IL-8 and TNFα) 
secretion which induce monocytes, neutrophils and eosinophils to produce inflammatory proteins, and b) impair 
the capacity of killing infected cells by reducing granzyme and perforine secretion, but also reduce interferon gam-
ma (IFNγ) secretion which alters the phagocyte capacity of macrophages.
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6. The experience of a policy to reduce environmental pollution
Environmental pollution poses continuing risks to the health of human beings worldwide. 
For several decades, developed countries have developed strategies to limit its impact and 
have implemented control measures with favorable results both on the air quality and on the 
respiratory health of children (114-120). However, in developing countries such as those in 
Latin America, where pollution is a raising concern due to the rapid growth of transportation 
and manufacturing industries, awareness of the dangers of pollution on the large number 
of people exposed has not been a main concern. Few countries have applied measures for 
air pollution abatement (121-123), but studies of the implications of such measures on the 
respiratory health of children are scarce. 
In Quito, the most polluted city in Ecuador, only when the problematic and the magnitude 
of its health consequences were demonstrated, it was possible to mobilize consciences and 
generate programs for the improvement and control of pollution. The study presented in 
chapter 2, shows a positive correlation between CO exposure (measured through COHb) 
and occurrence of acute respiratory infections in children attending schools located in areas 
with different traffic intensities in Quito in 2000. These findings were the foundation for 
implementing the first local policy for traffic-related pollution abatement. In 2002, the 
municipality of Quito issued a municipal ordinance that made passing a vehicular technical 
inspection mandatory. This was implemented in order to verify the compliance of vehicle 
safety standards including concentration of CO, CO2, HC’s and O2 in the gases emitted from 
the exhaust pipe of vehicles fueled by gasoline(124). Two years later, this ordinance became 
the purview of the “CORPAIRE” or “Corporation for the Improvement of the Air of Quito”, 
which assumed the vehicular technical revision process and air quality monitoring, through 
the Atmospheric Monitoring Network (124). 
According to CORPAIRE, during the 2004-2007 period the annual average concentrations 
of SO2, CO and PM10 had significantly decreased. CO, specifically, presented a 35% reduction 
(from 1.29 to 0.83 μg/m3) (125) as a result of a tighter fume emissions control by the 
vehicular technical inspection process and to the gradual phasing out of outdated, heavily 
polluting vehicles from circulation (126). In the year 2007, we could evaluate whether the 
improvement of air quality had influenced the respiratory health in school children. The 
study presented in chapter 6 describes the magnitude of benefits from a modest five-year 
air pollution control policy on the incidence of acute respiratory illness in school-age children 
of Quito. The exposure of interest was CO, which was measured as blood COHb levels in 
children. The strongest evidence of the relationship between declining CO air pollution 
and respiratory health was the fact that the relative risk for the association COHb > 2.5% 
and incidence of ARI decreased by 67.5% in this period. Our results suggest that polices 
aimed to abate vehicle-caused air pollution may be appropriate in developing countries with 
similar geographic conditions and where the impact of air pollution on respiratory health 
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is severe. Additionally, these findings are a valuable contribution to the scientific literature 
on effectiveness of accountability studies as they provide a stronger basis for public health 
policy development.
Limitations of the study
Exposure to pollutants
A limitation of our analysis during the studies process carried out in 2000 (chapters 2 
and 3) was the absence of direct measures of exposure. Regrettably, in Quito, systematic 
monitoring of air quality for critical air pollution was initiated only after 2000, so we could 
only rely on indirect proxies such as traffic intensity, limited satellite imagery records of ash 
emissions, and daily records of seismic activity of the Pichincha volcano to establish the 
timing of high exposure to pollutants. Since CO monitoring was not available in 2000, the 
comparative study evaluating the effect of air pollution control on respiratory illness (chapter 
6) was not able to assess the actual change of CO concentrations. Therefore, for the analysis 
we used the most conservative estimates based on the observed trend in measurements 
collected after 2004, when the routine monitoring started. We compensated the lack of 
measurements in 2000 with a more detailed analysis of CO lagged by one day with data 
available for 2007. 
Furthermore, in our studies carried out after 2004 (chapters 4 and 6) when the air 
monitoring system started in Quito, we used as reference for pollutant exposure the CO, PM 
and NOX measurements from the urban monitoring stations close to the study areas. These 
exposure data may not faithfully represent the true exposure levels of each individual given 
that possible difference in inhalation and exposure mechanisms among subjects were not 
taken into account. It is also important to consider that urban monitoring may possibly not 
allow for measurements in spatial and temporal variation of the exposure. It would have 
been convenient to conduct personal monitoring of the exposure to make the estimates 
more reliable. However, in Quito there were no available measurements of biological 
markers of environmental pollution except for carbon monoxide. Obtaining such data would 
have required access to up to date laboratory facilities at a higher cost and with considerable 
delays. Nevertheless, there may still be a good correlation between the environmental and 
personal exposure estimates.
Risk estimates 
A common limitation for our epidemiological studies evaluating the risk of respiratory 
infection due to air pollution exposure, such as volcanic emission in chapter 3 and PM and NOX 
in chapter 4, is that the respiratory effects of each pollutant are difficult to separate due to a 
linear correlation among them. Therefore, the risks could have been under or overestimated 
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which puts our conclusions in caution. However, these estimates were prominent enough 
that the health authorities became aware of the environmental risks and decided to develop 
measures to reduce them. 
Diagnosis of acute respiratory infection
The determination of ARI episodes in the studies presented in chapter 2, 3 and 6, was 
based on a clinical case definition and therefore prone to subjective and observer bias. 
However, to minimize the bias, ARI diagnostics were made by a small group of trained 
pediatricians. It would have been important to determine the infectious etiology or measure 
some inflammatory biomarkers such as C reactive protein (CRP), but it would have been 
expensive, and the extra blood sample required for these markers could have potentially 
decreased the number of study participants. 
Innate Immunity 
Immunological studies are essential to better understand the role of air pollution in the 
respiratory illness, but we were not able to explore such role since this involves invasive 
methods to obtain immune cells in children. Such methods are not allowed in our country 
unless there is a higher risk to benefit ratio. The lack of specific findings in pediatric patients 
made us extrapolate findings from adults to reconstruct the possible events that may have 
occurred in the respiratory immune system of children to explain the high incidence of 
respiratory infections.
Future Studies
“More than 1 in 4 child deaths could be prevented by cleaning up the environment” 
(127).
If this is obvious, why is the problem becoming more pressing especially in developing 
countries? 
Possibly in Ecuador, the lack of public awareness about traffic-related pollution and its 
effect on health is one of the main problems. In the whole country, with the exception of 
Quito, no obvious connection has been made between the traffic-related pollution and 
health. Therefore, it is necessary to conduct studies exploring the effect of either individual 
pollutants or combined pollutants on the respiratory health in larger populations at urban 
and rural levels. After having the results, sustainable community–wide campaigns to raise 
awareness of the need for control of traffic-air pollution can be useful as a preventive health 
action. It is also important to carry out accountability studies, in cities that have implemented 
local air pollution policies, to provide meaningful information to decision makers to review 
the efficacy of current policies, and if necessary to develop effective new policies. Toward 
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a more complete understanding of the efficacy of air pollution policies, the accountability 
studies should incorporate assessments of air pollution impacts on relevant biomarkers of 
the clinical events under study so that an appropriate control of the confounding variables in 
the analysis would be guaranteed. These type of studies are feasible to carry out in Ecuador.
Other factor that aggravates the problem of pollution in developing countries is that the 
toxic effects of pollutants could be potentiated by the presence of malnutrition in children 
and the related immunological deficiencies. Regarding to malnutrition, specifically nutritional 
anemia, studies in larger population of children are required to confirm our findings of the 
synergy between air pollution and anemia to increase pneumonia hospitalizations. If these 
studies confirm the synergy, improvements in iron intake and controlling air pollution could 
decrease the severity of pneumonia.
Without any doubt, more studies are required to better understand the immunological 
mechanisms thrugh which an individual pollutant or multipollutants could cause and 
exacerbate respiratory infections or asthma. These studies would need ex vivo assays and 
sophisticated lab facilities and demand close collaboration with academic research centers.
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ENGLISH SUMMARY
Air pollution is an acute, cumulative, and chronic threat to human health and it is a growing 
problem in developing countries. Respiratory infections and allergic diseases associated with 
environmental contamination are more frequent in children and are more serious in children 
with malnutrition.
This thesis presents studies that show, a) the relationship of air pollution due to vehicular 
and volcanic emissions with respiratory diseases in children, b) the interaction of nutritional 
anemia and environmental pollution in respiratory diseases, c) the alterations that different 
air pollutants can produce in a new group of cells of the innate immune system, and d) the 
beneficial effect of a vehicle emission control policy on the incidence of respiratory infections 
in children.
Chapter one, the introduction, places us in the context of the problem of environmental 
pollution and respiratory illnesses in children of Quito-Ecuador as well as on the harmful 
effect of pollutants on respiratory health with an emphasis on the innate immune response, 
and the potential solutions and measures to improve air quality. In addition, it establishes 
the main objectives of this thesis.
In order to know about the Quito environment, a small description is important: the 
city of Quito, capital of Ecuador, is situated on the equatorial line at 2828 m above sea level 
in the Andean Region, and it is very sensitive to pollution due to its geographical location, 
topography and climatology. The city sits on a long narrow valley and is surrounded by high 
mountains that prevent the wind from dispersing the pollutants. The altitude of the city 
allows increased solar radiation that transforms the pollutants into oxidants. Its topography 
also favors the thermal inversions where of hot air roof traps and concentrates the pollutants 
within the city. Because it is a fast-growing city, it possesses a large number of circulating 
vehicles which are responsible for ~ 82% of the environmental pollution. Additionally, it 
is surrounded by active volcanoes that from time to time intensify their activity with the 
emission of large amounts of volcanic ash. This scenario exposes the population to excessive 
pollution and makes it be more prone to the health problems inherent to pollution, especially 
respiratory diseases.
The study presented in chapter 2, analyzes the effect of the exposure to carbon 
monoxide (CO) in the occurrence of acute respiratory infection (ARI) in school children, using 
carboxyhemoglobin (COHb) as a marker of chronic exposure to CO. It is known that CO binds 
tightly to hemoglobin to form COHb, a compound that prevents hemoglobin from delivering 
oxygen throughout the body, and that the concentration of COHb ≤ 2.5% is considered a safe 
level of oxygen supply. In the year 2000, we conducted a prospective study in 960 young 
children attending Quito’s public elementary schools located in three areas of different traffic 
intensity (high, moderate, and low-traffic areas). In a random subsample of 295 children, we 
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determined that average COHb concentrations were significantly higher in children attending 
schools in areas with high and moderate traffic, compared with the low-traffic area. The 
percentage of children with COHb concentrations above the safe level of 2.5% were 1, 43, 
and 92% in low-, moderate-, and high-traffic areas, respectively. Children with COHb above 
the safe level were 3.25 [95% confidence interval (CI): 1.65 – 6.38] times more likely to have 
ARI than children with COHb ≤2,5%. Furthermore, with each percent increase in COHb above 
the safety level, children were 1.15 [CI 95% 1.03-1.28] times more likely to have an additional 
case of ARI. All association analyzes were controlled by sex, age, indoor contamination, and 
nutritional status. Our findings provide strong evidence of the relation between CO exposure 
and susceptibility to respiratory infections, and they constituted a foundation for the creation 
of a local policy of control of vehicular emissions.
Chapter 3 presents the variation in rates of emergency room (ER) visits for acute upper 
and lower respiratory infections and asthma-related conditions in children, before, during 
and after the ashfall in Quito due to eruptions of the Pichincha volcano in April 2000. The city 
of Quito is located 13 km east of the Guagua Pichincha volcano in a long narrow valley that 
gives incomparable scenery: a dangerous setting created by nature and enhanced by humans. 
In April 2000, the Guagua Pichincha volcano became active after 340 years of dormancy 
and emitted volcanic ashes containing silica, sulfurs, and particulate matter. This study was 
conducted at the Baca Ortiz Children’s Hospital, Quito’s largest government-subsidized 
facility, which provides care to approximately 307,000 children under 15 years of age residing 
in the Quito Metropolitan area and surrounding communities. During 2000, 22,353 children 
were assisted at the hospital’s emergency room, and about 6% of children visited ER were 
treated for respiratory illnesses, mainly pneumonia. We abstracted 5169 (43% females) ER 
records with primary respiratory conditions treated from January 1 – December 27, 2000. 
The records were classified into three non-overlapping categories: acute upper respiratory 
infection (AURI), acute lower respiratory infection (ALRI), and asthma-related conditions. 
Information about Guagua Pichincha activity was collected, a timeline of exposure-related 
volcanic activity in January-April was created, and four period of analysis were defined: 
fumarolic activity (Period 1), one week (Period 2), two weeks (Period 3) and three weeks 
(Period 4) after the eruption. A Poisson regression model was adapted to time series of cases 
for AURI, ALRI, and asthma-related conditions in boys and girls for three age groups: 0–4, 5–9, 
and 10–15. The main findings were: a) The rate of emergency room visits due to respiratory 
conditions substantially increased in the three weeks after eruption for ALRI [RR = 2.22, IC 
95% 1.95-2.52] and AURI [RR = 1.72, IC 95% 1.49-1.97], respectively; b) The largest impact of 
eruptions on respiratory distress was observed in children younger than 5 years [RR = 2.21, 
IC 95% 1.79-2.73]; c) The rate of asthma and asthma-related diagnosis doubled during the 
period of volcano fumarolic activity [RR = 1.97, IC 95% 1.19-3.24]. This study documented 
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significantly increased levels of respiratory disease in Quito children after a volcanic eruption 
using hospitalization records.
Chapter 4 relates a study evaluating the synergistic relationship of two pneumonia 
risk factors in children: environmental contamination and nutritional anemia. In Ecuador 
25.78% of preschool children suffer iron deficiency anemia (Hb levels <11g/dL) mainly 
due to consumption of iron-poor diets, especially in the Andean region where Quito is 
located. The study was conducted in 825 children from 18 to 42 months of age, who lived 
in two socioeconomically similar neighborhoods but with different levels of environmental 
contamination (PM2.5 20.4 vs. 15.3 μg/m
3, and NO2 29.5 vs. 16.6 μg/m3). The history of 
medical visits and hospitalizations for respiratory problems during the year prior to the study 
were obtained from all the children. Anthropometric data, hemoglobin levels, and oxygen 
saturation (measured through oximetry) were recorded at the time of the consultation. 
The analyzes showed that in anemic children, the highest exposure to contamination was 
significantly associated with a higher number of hospitalizations for pneumonia [OR = 6.82, 
IC 95% 1.45-32.00], whereas in non-anemic children there was no difference in the number 
of hospitalizations according to exposure level. In addition, children exposed to higher levels 
of air pollution had significantly more hospitalizations for pneumonia [OR = 3.68, IC 95% 
1.09-12.44], total respiratory disease [OR = 2.93, IC 95% 1.92-4.47], stunting [OR = 1.88, IC 
95% 1.36-2.60], and anemia [OR = 1.45, IC 95% 1.09-1.93] compared to children exposed 
to lower levels of air pollution. Also, children exposed to higher levels of air pollution had 
significantly lower oxygen saturation (92.2% ± 2.6% vs. 95.8% ± 2.2%; P<0.0001), consistent 
with the formation of methaemoglobin related to NO2 exposure, as it has been described 
in some studies. Taking together these findings suggest that anemia may interact with 
environmental pollutants to increase hospitalizations for pneumonia, and that improving 
nutrition and reducing air pollution could reduce severe pneumonia, the leading cause of 
death in children.
Chapter 5 is a systematic review of 12 experimental studies on the effects of various 
environmental pollutants on lung innate lymphoid cells (ILCs) of murine and human species. 
Three major groups of ILCs have been defined on the basis of the transcription factors 
needed for their development and the cytokines they produce. The ILC1 group includes 
classical natural killer (cNK) and non-NK cells, which are cytotoxic and produce IFN gamma 
(IFN-γ). The ILC2 group expresses IL-5 and IL-13. The type 3 (ILC3) group comprises some cells 
which produce IL-17 and/or IL-22. Due to their cytokine production, ILCs 1, 2 and 3 resemble 
the adaptive T helper (Th) 1, Th2, and Th17 cells respectively. ILCs play an essential role in 
inflammation and in the regulation of host responses to infection. The experimental studies 
together show that lung NK cells exposed to particulate pollutants (diesel particles and 
PM2.5) and high doses of O3 present low cytotoxic capacity and reduced production of IFN-γ, 
an important cytokine responsible for stimulating macrophages and inducing differentiation 
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of Th1 cells. These same pollutants and carbon nanotubes stimulated lung ILC2s to produce 
high levels of IL-5 and IL-13 which are responsible for IgE class switching on B cells, and the 
recruitment and activation of eosinophils. In light of these findings, it can be concluded that 
air pollution would be related to greater susceptibility to intracellular infections due to the 
reduced activity of NK cells, and to the increase in respiratory allergic processes due to the 
action of ILC2.
Chapter 6 presents a study aimed to evaluate whether the reduction of traffic–related 
pollutant levels, specifically in CO exposure between 2000 and 2007, was associated with 
both the incidence of ARI and COHb levels in school–aged children. The study conducted in 
the year 2000, presented in chapter 4, was the basis for implementing the first local policy 
for the reduction of traffic-related pollution. In 2002, the municipality of Quito issued the 
municipal vehicle technical ordinance to verify compliance with vehicle safety standards, 
including the concentration of CO, CO2, O2, and hydrocarbons in the gases emitted by 
the exhaust pipe of gasoline vehicles. Five years after the establishment of this policy we 
carried out a methodological study similar to the 2000 study and compared them. Each 
study involved ~730 children aged 6–12 years observed for 12-15 weeks. The associations 
between COHb serum concentration, as an exposure proxy of carbon monoxide (CO), 
ambient CO, and ARI in both cohorts were examined. Compared to the 2000 study, the 2007 
study found a reduction of 48 % in the ARI incidence [RR = 0.52, 95% CI 0.45-0.62] and 92% 
reduction in the percentage of children with COHb> 2.5%; and no association between COHb 
concentrations above the safe level of 2.5% and the ARI incidence (p = 0.736). These results 
show that a substantial decrease in the level of environmental CO as a result of a citywide 
5-year vehicular emissions control program is associated with a reduction in the incidence 
of respiratory diseases and COHb levels in children in school age. This study supports the 
value of implementing preventive policies and the need for sustained long-term programs in 
countries with poor air quality.
Chapter 7 approaches the main findings of our studies on environmental pollution 
and delineates immunological hypotheses as an attempt to explain the effect of the main 
pollutants studied in the appearance of respiratory infections and allergic processes.
Finally, in chapter 8 that corresponds to the general discussion, the overall results of 
the studies are discussed and interpreted. At the same time, immunological hypotheses 
are developed to explain the possible mechanisms by which pollutants related to vehicular 
and volcanic emissions alter innate immunity and cause both susceptibility to respiratory 
infections and airway hyperreactivity related to asthma. An immunological discussion is 
made to explain the synergism between nutritional anemia and environmental pollution 
associated with respiratory infections. As final points, the inherent limitations of all the 
studies as a whole are presented, and future research possibilities are designed to help the 
understanding of the relationship between contamination and respiratory diseases and the 
improvement of air quality. 
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RESUMEN: SPANISH SUMMARY
La contaminación del aire es una amenaza aguda, acumulativa y crónica para la salud 
humana y es un problema creciente en los países en desarrollo. Las infecciones y los procesos 
alérgicos del sistema respiratorio asociados a contaminación ambiental son más frecuentes 
en niños y son más graves en niños con desnutrición. 
Esta tesis presenta estudios que evidencian a) la relación de la contaminación del aire 
debida a emisiones vehiculares y volcánicas con la presencia de enfermedades respiratorias 
en niños, b) la interacción de la anemia nutricional y la contaminación ambiental en las 
enfermedades respiratorias, c) las alteraciones que diferentes contaminantes del aire pueden 
producir en un grupo nuevo de células del sistema inmune innato, y d) el efecto benéfico 
de una política de control de emisiones vehiculares sobre la incidencia de infecciones 
respiratorias en niños.
El primer capítulo, que corresponde a la introducción, nos sitúa en el contexto del efecto 
nocivo de los contaminantes en eln sistema inmune innato pulmonar, del problema de 
la polución ambiental y las enfermedades respiratorias en niños de la ciudad de Quito, y 
de la eficacia de una política del control de la contaminación del aire en la reducción de 
enfermedades respiratorias en niños. 
El capítulo 1, la introducción, nos ubica en el contexto de la polución ambiental y las 
infecciones respiratorias en niños de Quito-Ecuador, así como también en los efectos 
daniños de los contaminantes ambientales sobre el sistema respiratorio con énfasis en la 
respuesta inmune y las medidas y soluciones potenciales para mejorar la calidad del aire. 
Adicionalmente, se establece los principals objetivos de la tesis.
 Para ubicarnos en el ambiente de Quito es importante una pequeña descripción: la 
ciudad de Quito, capital de Ecuador, está situada en la línea ecuatorial a 2828 m sobre el nivel 
del mar en la Región Andina, y es muy sensible a la contaminación debido a su ubicación 
geográfica, topografía y climatología. La ciudad se encuentra en un valle largo y angosto y 
está rodeada de altas montañas que impiden que el viento disperse los contaminantes. La 
altitud de la ciudad permite una gran radiación solar que transforma los contaminantes en 
oxidantes, y su topografía favorece las inversiones térmicas donde el techo de aire caliente 
atrapa y concentra los contaminantes dentro de la ciudad. Por ser una ciudad de rápido 
crecimiento posee un gran parque automotor que se estima es responsable del 82% de la 
contaminación ambiental. Adicionalmente, está rodeada de volcanes activos que de tanto en 
tanto intensifican su actividad con la emisión de grandes cantidades de cenizas volcánicas. 
Este escenario hace que la población esté expuesta a mucha contaminación y más propensa 
a los problemas de salud inherentes a la contaminación, especialmente las enfermedades 
respiratorias. 
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El estudio presentado en el capítulo 2, analiza el efecto de la exposición a monóxido 
de carbono (CO) en la ocurrencia de infección respiratoria aguda (IRA) en niños escolares, 
utilizando la carboxihemoglobina (COHb) como marcador de exposición crónica al CO. Se 
sabe que el CO se une fuertemente a la hemoglobina para formar COHb, un compuesto que 
evita que la hemoglobina entregue oxígeno por todo el cuerpo. La concentración de COHb 
≤ a 2.5% se considera un nivel seguro de suministro de oxígeno. El estudio fue realizado en 
el año 2000 y consistió en el seguimiento durante 12 semanas a 960 niños que asistían a 
escuelas primarias de Quito ubicadas en tres zonas de distinta intensidad de tráfico (alta, 
moderada y baja) para determinar la incidencia de IRA mediante diagnóstico clínico. En una 
submuestra aleatoria de 295 niños, se determinó que las concentraciones promedio de COHb 
fueron significativamente más altas en niños que asistían a escuelas situadas en las áreas de 
tráfico alto y moderado, en comparación con aquellos que estaban en el área de tráfico 
bajo. El porcentaje de niños con concentraciones de COHb por encima del nivel seguro de 
2.5%, fue de 1.43 y 92% en áreas de tráfico bajo, moderado y alto, respectivamente. Los 
niños con COHb por encima del nivel de seguridad fueron 3.25 [intervalo de confianza del 
95% (IC): 1.65 – 6.38] veces más propensos a tener IRA que los niños con COHb ≤2.5%. 
Además, se estableció que con cada incremento porcentual de COHb por encima del nivel 
de seguridad, los niños tuvieron 1.15 [IC: 95% 1.03-1.28] veces más probabilidades de tener 
un caso adicional de IRA. Todos los análisis de asociación fueron controlados por sexo, edad, 
contaminación intradomiciliaria y estado nutricional. Estos hallazgos proporcionaron una 
fuerte evidencia de la relación entre la exposición al CO y la susceptibilidad a las infecciones 
respiratorias y constituyeron una base para la formulación de una política local de control de 
emisiones vehiculares. 
El capítulo 3, describe el comportamiento del número de visitas a la sala de emergencia 
(SE) por afecciones respiratorias en niños, antes, durante y después de la caída de cenizas 
en Quito debido a las erupciones del volcán Pichincha ocurridas en abril de 2000. La ciudad 
de Quito, está asentada a 13 km al este del volcán Guagua Pichincha en un largo y estrecho 
valle que le da un escenario incomparable: una cámara peligrosa creada por la naturaleza 
y realzada por los humanos. En abril del 2000, después de 340 años de latencia, el volcán 
Pichincha se activó con emisiones de vapor y cenizas que contenían sílice, azufre y material 
particulado. Este estudio tuvo lugar en el Hospital Pediátrico Baca Ortiz, establecimiento 
público de referencia más grande de Quito que brinda atención a aproximadamente 
307000 niños menores de 15 años que residen en el área metropolitana de Quito y en 
las comunidades circundantes. Durante el año 2000, 22353 niños fueron atendidos en 
la SE y aproximadamente 6% de ellos fueron tratados por enfermedades respiratorias, 
principalmente neumonía. Se extrajeron 5169 registros por afecciones respiratorias 
primarias tratadas en la SE durante el período 1 de enero - 27 de diciembre de 2000. Los 
registros fueron clasificados en tres categorías no superpuestas: infección aguda de vías 
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respiratorias superiores (IRAA), infección aguda de vías respiratorias inferiores (IRAB), y 
afecciones relacionadas con el asma. Se recopiló información sobre la actividad del Guagua 
Pichincha, se creó una línea de tiempo de exposición a la actividad volcánica (enero-abril), 
y se definieron cuatro períodos de análisis: actividad fumarólica (Período 1), una semana 
(Período 2), dos semanas (Período 3) y tres semanas (Periodo 4) después de la erupción. Se 
aplicó un modelo de regresión de Poisson adaptado a series de tiempo de los casos para las 
tres categorías de enfermedades IRAB y IRAA y afecciones relacionadas con el asma en niños 
y niñas para tres grupos de edad: 0-4, 5-9 y 10-15 años. Los principales hallazgos fueron: 
a) la tasa de visitas a SE debido a afecciones respiratorias aumentó sustancialmente en las 
tres semanas posteriores a la erupción; para ALRI [Riesgo Relativo (RR) = 2.22, IC 95% 1.95-
2.52] y para AURI [RR = 1.72, IC 95% 1.49-1.97], b) el mayor impacto de las erupciones en 
los procesos respiratorios se observó en niños menores de 5 años [RR = 2.21, IC 95% 1.79-
2.73] y c) la tasa de asma y problemas relacionados con el asma se duplicaron durante el 
período fumarólico de la actividad volcánica (RR = 1.97, IC 95% 1.19-3.24). Con este estudio 
se documentan niveles significativamente más altos de enfermedad respiratoria en niños de 
Quito después de una erupción volcánica.
En el capítulo 4, el estudio evalúa la relación sinérgica  de dos factores de riesgo de 
neumonía en niños: la contaminación ambiental y la anemia nutricional. En Ecuador 25.78% 
de niños pre escolares tienen anemia por deficiencia de hierro (Hb levels <11g/dL), debido 
principalmente al consumo de dietas pobres en hierro, especialmente en la región Andina 
donde la ciudad de Quito es localizada. El estudio fue realizado en 825 niños de 18 a 42 meses 
de edad, que vivían en dos barrios socioeconómicamente similares pero con distinto nivel de 
contaminación ambiental (PM2.5 20.4 vs. 15.3 μg/m3, y NO2 29.5 vs. 16.6 μg/m3). De todos los 
niños se obtuvo el historial de visitas médicas y hospitalizaciones por problemas respiratorios 
durante el año previo al estudio, y los datos antropométricos, los niveles de hemoglobina y 
la saturación de oxígeno (medida a través de oximetría) en el momento de la consulta. Los 
análisis demostraron que en los niños anémicos, la mayor exposición a la contaminación 
se asoció significativamente con mayor número de hospitalizaciones por neumonía [Radio 
de Odds (OR) = 6.82, IC 95% 1.45-32.00], mientras que en los niños no anémicos no hubo 
diferencia del número de hospitalizaciones según nivel de exposición. Además, los niños 
expuestos a niveles más altos de contaminación del aire tuvieron significativamente más 
hospitalizaciones por neumonía [OR = 3.68, IC 95% 1.09-12.44], enfermedad respiratoria 
total [OR = 2.93, IC 95% 1.92-4.47], retraso en el crecimiento [OR = 1.88, IC 95% 1.36-2.60] 
y anemia [OR = 1.45, IC 95% 1.09-1.93] comparados con niños expuestos a más bajos de 
contaminación. También se encontró que los niños expuestos a alta contaminación tuvieron 
una saturación de oxígeno significativamente menor (92.2% ± 2.6% vs. 95.8% ± 2.2%; P 
<0.0001), consistente con formación de metahemoglobina relacionada con la contaminación 
de NO2, como ha sido descrito en algunos estudios. Estos hallazgos en conjunto sugieren que 
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mejorar la nutrición y disminuir la contaminación del aire podrían reducir rápidamente las 
hospitalizaciones por neumonía, la principal causa de muerte en los niños.
En el capítulo 5 se presenta una revisión sistemática de 12 estudios experimentales 
sobre los efectos de varios contaminantes ambientales en las células linfoides innatas (ILCs) 
pulmonares de especies murinas y humanas. Se han definido tres grupos principales de ILCs 
en base a los factores de transcripción necesarios para su desarrollo y a las citoquinas que 
producen. El grupo ILC1 incluye células asesinas naturales (cNK) clásicas y no NK, que son 
citotóxicas y producen IFN gamma (IFN-γ). El grupo ILC2 expresa IL-5 e IL-13. El grupo de 
tipo 3 (ILC3) comprende células que producen IL-17 y / o IL-22. Debido a su producción de 
citocinas, las ILC 1, 2 y 3 se asemejan a las células adaptativas T helper (Th) 1, Th2 y Th17, 
respectivamente. Las ILCs juegan un papel esencial en la inflamación y en la regulación de 
las respuestas del huésped a la infección. Los estudios experimentales en conjunto muestran 
que células NK pulmonares expuestas a contaminantes particulados (partículas de diésel y 
PM2.5) y altas dosis de O3 presentan baja capacidad citotóxica  y poca producción de gamma 
interferón, una citoquina importante responsable de estimular los macrófagos e inducir la 
diferenciación de las células Th1. La exposición a estos mismos contaminantes y a partículas 
de carbono estimulan a las ILC2 pulmonares para producir altos niveles de interleucina (IL) 5 
e IL-13 que son responsables de la generación de inmunoglobulina E (IgE) en los linfocitos B 
y del reclutamiento y activación de eosinófilos. A la luz de estos hallazgos se puede concluir 
que la contaminación del aire estaría relacionada con mayor susceptibilidad a las infecciones 
intracelulares por la disminución de la actividad de las células NK, y con el incremento de 
procesos alérgicos respiratorios debido a la acción de ILC2.
El capítulo 6 presenta un estudio cuyo objetivo fue evaluar si la reducción de los niveles de 
contaminantes relacionados con el tráfico, específicamente en la exposición al CO entre 2000 
y 2007, se asoció con la incidencia de los niveles de IRA y COHb en niños en edad escolar. El 
estudio en el año 2000, presentado en el capítulo 4, que muestra una relación positiva entre 
la exposición al CO y la ocurrencia de infecciones respiratorias agudas en niños escolares 
de Quito fue la base para implementar la primera política local para la reducción de la 
contaminación relacionada con el tráfico. En 2002, el municipio de Quito emitió la ordenanza 
municipal de revisión técnica vehicular para verificar el cumplimiento de las normas de 
seguridad de los vehículos, incluida la concentración de CO, CO2, O2, e hidrocarburos en los 
gases emitidos por el tubo de escape de los vehículos a gasolina. Cinco años después de la 
instauración de esta política  realizamos un estudio metodológicamente similar al estudio 
del 2000 y los comparamos. Cada estudio involucró ~ 730 niños de entre 6 y 12 años de 
edad que fueron observados durante 12-15 semanas. Se examinaron las asociaciones entre 
la concentración sérica de COHb, como un proxy de exposición de monóxido de carbono, con 
CO ambiental y ARI en ambas cohortes. En comparación con el estudio del 2000, en el 2007 
se encontró una reducción del 48% en la incidencia de IRA [RR = 0.52, IC 95% 0.45-0.62] y del 
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92% en el porcentaje de niños con COHb> 2.5%, pero no encontramos asociación entre las 
concentraciones de COHb por encima del nivel de seguridad de 2.5% y la incidencia de IRA (p 
= 0.736). Estos resultados muestran que una disminución sustancial en el nivel de monóxido 
de carbono ambiental como resultado de un programa de control de emisiones vehiculares 
de 5 años en toda la ciudad se asocia con la reducción de la incidencia de enfermedades 
respiratorias y niveles de COHb en niños en edad escolar. Este estudio respalda el valor de 
implementar políticas preventivas y la necesidad de programas sostenidos a largo plazo en 
países con mala calidad del aire.
En el capítulo 7 se presenta un sumario de los principales hallazgos de nuestros estudios 
sobre contaminación ambiental y se proponen hipótesis inmunológicas como intento de 
explicar el efecto de los principales contaminantes estudiados en el aparecimiento de las 
infecciones respiratorias y en procesos alérgicos.
Finalmente, en el capítulo 8 que corresponde a la discusión general, se comentan e 
interpretan los resultados generales de los estudios. Seguidamente, se desarrollan hipótesis 
inmunológicas para explicar los posibles mecanismos por los que ciertos polutantes 
relacionados con las emisiones vehiculares y volcánicas alteran la inmunidad innata y 
causan tanto susceptibilidad a las infecciones respiratorias como hiperreactividad de las 
vías aéreas relacionada con el asma. También se hace una discusión inmunológica para 
explicar el sinergismo entre anemia nutricional y polución ambiental asociado a infecciones 
respiratorias.  Finalmente, se presentan las limitaciones inherentes a todos los estudios en 
conjunto, y se bosquejan futuras posibilidades de investigación que ayuden al entendimiento 
de la relación contaminación-enfermedades respiratorias y al mejoramiento de la calidad del 
aire. 
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SAMENVATTING: SHORT DUTCH SUMMARY
Luchtvervuiling is een cumulatieve en chronische bedreiging voor de menselijke 
gezondheid en vormt een groeiend probleem in ontwikkelingslanden. Luchtweginfecties en 
allergische aandoeningen gerelateerd aan milieuvervuiling komen vaak voor bij kinderen 
en zijn ernstiger bij kinderen met ondervoeding. Dit proefschrift presenteert studies naar 
a) de relatie tussen luchtvervuiling als gevolg van voertuig- en vulkanische emissies en 
luchtwegaandoeningen bij kinderen, b) de interactie van voedingsanemie en milieuvervuiling 
bij luchtwegaandoeningen, c) de veranderingen die verschillende luchtverontreinigende 
stoffen kunnen veroorzaken in cellen van het aangeboren immuunsysteem, en d) het 
gunstige effect van een voertuigemissiecontrolebeleid op de incidentie van luchtweginfecties 
bij kinderen.
Hoofdstuk één, de inleiding, beschrijft de context van het probleem van milieuvervuiling 
en aandoeningen van de luchtwegen bij kinderen van Quito-Ecuador, evenals van het 
schadelijke effect van verontreinigende stoffen op de gezondheid van de luchtwegen, en 
potentiele oplossingen en maatregelen om de luchtkwaliteit te verbeteren. Bovendien 
worden de belangrijkste doelen van dit proefschrift beschreven.
De studie gepresenteerd in hoofdstuk 2 analyseert het effect van de blootstelling aan 
koolmonoxide (CO) bij het optreden van acute luchtweginfecties bij schoolkinderen, waarbij 
carboxy-hemoglobine (COHb) wordt gebruikt als een marker voor chronische blootstelling aan 
CO. In het jaar 2000 hebben we een prospectieve studie uitgevoerd bij 960 jonge kinderen op 
de openbare basisscholen van Quito in drie gebieden met verschillende verkeersintensiteit 
(gebieden met veel, matig en weinig verkeer). In een willekeurige deelsteekproef van 295 
kinderen hebben we vastgesteld dat de gemiddelde COHb-concentraties significant hoger 
waren bij kinderen die scholen bezoeken in gebieden met veel en matig verkeer, vergeleken 
met de gebieden met weinig verkeer. Het percentage kinderen met COHb-concentraties 
boven het veilige niveau van 2.5% was respectievelijk 1.43, en 92% in gebieden met weinig, 
matig en veel verkeer. Kinderen met COHb boven het veilige niveau hadden 3.25 keer meer 
kans op luchtweginfecties dan kinderen met COHb ≤2.5%. Bovendien hadden kinderen met 
elke procentuele toename van COHb boven het veiligheidsniveau, 1.15 [95%CI 1.03-1.28] keer 
meer kans op een extra luchtweginfectie. Onze bevindingen leveren sterk bewijs voor een 
verband tussen blootstelling aan CO en gevoeligheid voor luchtweginfecties, en ze vormden 
een basis voor het opstellen van een lokaal beleid voor de beheersing van voertuigemissies.
Hoofdstuk 3 presenteert de variatie in het aantal bezoeken aan spoedeisende hulp 
(SH) voor acute infecties van de bovenste en onderste luchtwegen en astma-gerelateerde 
aandoeningen bij kinderen, vóór, tijdens en na de as-val in Quito als gevolg van uitbarstingen 
van de Pichincha-vulkaan in april 2000. Deze studie werd uitgevoerd in het Baca Ortiz 
Kinderziekenhuis. In 2000 werden 22.353 kinderen geholpen op de eerste hulp van het 
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ziekenhuis en ongeveer 6% van de kinderen die SH bezochten, werd behandeld voor 
aandoeningen aan de luchtwegen (5169, 43% vrouw), voornamelijk longontsteking. Analyses 
naar typen aandoeningen en tijdsreeksen van blootstelling aan vulkanische activiteit toonden 
aan dat: a) Het aantal bezoeken aan de eerste hulp vanwege ademhalingsaandoeningen nam 
aanzienlijk toe in de drie weken na uitbarsting voor zowel bovenste [RR = 2.22, 95%CI 1.95-
2.52] als onderste luchtweginfecties [RR = 1.72, 95%CI 1.49 -1.97]; b) Het grootste effect van 
uitbarstingen op ademnood werd waargenomen bij kinderen jonger dan 5 jaar [RR = 2.21, 
IC 95% 1.79-2.73]; c) De snelheid van astma en astma-gerelateerde diagnose verdubbelde 
tijdens de periode van vulkaan fumarolische activiteit [RR = 1.97, IC 95% 1.19-3.24]. Deze 
studie documenteerde aanzienlijk verhoogde niveaus van luchtwegaandoeningen bij Quito-
kinderen na een vulkaanuitbarsting met behulp van ziekenhuisopname-records.
Hoofdstuk 4 heeft betrekking op een onderzoek naar de interactie tussen milieuvervuiling 
en voedingsanemie. In Ecuador lijdt 25.78% van de kleuters aan bloedarmoede door 
ijzertekort (Hb-waarden <11 g/dL), voornamelijk als gevolg van de consumptie van ijzerarme 
diëten, vooral in de Andesregio waar Quito zich bevindt. De studie werd uitgevoerd bij 
825 kinderen van 18 tot 42 maanden oud, die in twee sociaaleconomisch vergelijkbare 
buurten woonden, maar met verschillende niveaus van milieuvervuiling (PM2.5 20.4 versus 
15.3 μg/m3, en NO2 29.5 versus 16.6 μg /m3). De geschiedenis van medische bezoeken 
en ziekenhuisopnames voor ademhalingsproblemen in het jaar voorafgaand aan het 
onderzoek werd verkregen van alle kinderen. Kinderen die werden blootgesteld aan hogere 
luchtvervuiling hadden meer ziekenhuisopnames voor longontsteking (OR = 3.68, IC 95% 
1.09-12.44), luchtwegaandoeningen [OR = 2.93, IC 95% 1.92-4.47], stunting [OR = 1.88, IC 
95% 1.36-2.60] en bloedarmoede [OR = 1.45, IC 95% 1.09-1.93] in vergelijking met kinderen 
die werden blootgesteld aan lagere luchtvervuiling. We vonden dat bij anemische kinderen 
de hoogste blootstelling aan vervuiling significant geassocieerd was met een hoger aantal 
ziekenhuisopnames voor longontsteking [OR = 6.82, IC 95% 1.45-32.00], terwijl er bij niet-
anemische kinderen geen verband was voor luchtvervuiling. Deze bevindingen suggereren dat 
er interacties zijn tussen bloedarmoede en luchtvervuiling op het risico voor longontsteking, 
en dat zowel het verbeteren van voeding en het verminderen van luchtvervuiling ernstige 
longontsteking, de belangrijkste doodsoorzaak bij kinderen, kan verminderen.
Hoofdstuk 5 is een systematische review van 12 experimentele studies naar de effecten 
van verschillende stoffen van luchtvervuiling op lung innate lymphoid cells (ILCs) bij 
muizen en mensen. Drie hoofdgroepen van ILCs zijn gedefinieerd. De ILC1-groep omvat 
klassieke natural killer (cNK) en niet-NK-cellen, die cytotoxisch zijn en IFN-gamma (IFN-γ) 
produceren. De ILC2-groep brengt IL-5 en IL-13 tot expressie. De type 3 (ILC3) groep omvat 
enkele cellen die IL-17 en/of IL-22 produceren. Vanwege hun cytokineproductie lijken ILCs 
1, 2 en 3 respectievelijk op de adaptieve T-helper (Th) 1-, Th2- en Th17-cellen. ILCs spelen 
een essentiële rol bij ontstekingen en bij de regulatie van gastheerreacties op infectie. De 
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experimentele studies tonen aan dat NK-longcellen blootgesteld aan dieseldeeltjes en 
PM2.5 en aan hoge doses O3 een lage cytotoxische capaciteit en verminderde productie 
van gamma-interferon hebben. Dezelfde verontreinigende stoffen stimuleerden long-ILC2s 
om meer interleukine (IL) 5 en IL-13 te produceren. In het licht van deze bevindingen kan 
worden geconcludeerd dat luchtvervuiling verband houdt met een grotere gevoeligheid voor 
intracellulaire infecties als gevolg van de verminderde activiteit van NK-cellen en met de 
toename van allergisch processen als gevolg van de werking van ILC2.
Hoofdstuk 6 presenteert een evaluatiestudie naar vermindering van verkeersgerelateerde 
vervuiling, met name bij blootstelling aan CO tussen 2000 en 2007 en het verband met 
zowel de incidentie van luchtweginfecties als COHb-waarden bij schoolgaande kinderen. 
De studie gepresenteerd in hoofdstuk 4 was de basis voor de uitvoering van het eerste 
lokale beleid voor de vermindering van verkeersgerelateerde vervuiling. In 2002 heeft de 
gemeente Quito de technische verordening voor gemeentelijke voertuigen uitgegeven om 
de naleving van voertuigveiligheidsnormen te controleren, waaronder de concentratie van 
CO, CO2, O2 en koolwaterstoffen in de gassen die worden uitgestoten door de uitlaatpijp van 
benzinevoertuigen. Vijf jaar na de vaststelling van dit beleid hebben we een methodologische 
studie uitgevoerd vergelijkbaar met de 2000-studie en deze vergeleken. Bij elk onderzoek 
waren ~730 kinderen van 6-12 jaar gevolgd gedurende 12-15 weken. In vergelijking met de 
studie uit 2000 vond de studie uit 2007 een vermindering van 48% in de ARI-incidentie [RR = 
0.52, 95%CI 0.45-0.62] en 92% reductie van het percentage kinderen met COHb> 2,5%. Deze 
resultaten tonen aan dat een substantiële daling van het niveau van CO in het milieu gepaard 
gaat met een vermindering van de incidentie van ademhalingsziekten en COHb-waarden 
bij kinderen in de schoolleeftijd. Deze studie ondersteunt de waarde van de uitvoering van 
preventief beleid en de noodzaak van duurzame langetermijnprogramma’s in landen met 
een slechte luchtkwaliteit.
Hoofdstuk 7 vat de belangrijkste bevindingen van onze studies over luchtvervuiling 
samen. Ten slotte worden in hoofdstuk 8 de algemene resultaten van de studies besproken en 
geïnterpreteerd. Ook worden immunologische hypothesen beschreven die het effect van de 
bestudeerde stoffen in het optreden van luchtweginfecties en allergische processen zouden 
kunnen verklaren. Als laatste worden de beperkingen van de studies benoemd en worden 
aanbevelingen gedaan voor toekomstig onderzoek om de relatie tussen luchtvervuiling en 
aandoeningen van de luchtwegen beter te leren begrijpen.
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ABBREVIATIONS
AHR  Allergen-induced response and air way hyper 
AL  Adaptive lymphocytes
ALRI  Acute lower respiratory infection 
AM  Alveolar macrophages
AOR Adjusted Odds Ratios 
ARI  Acute respiratory infection
ARRIVE Animal Research Reporting in vivo Experiments
AURI Acute upper respiratory infection 
BAL Bronchoalveolar lavage
BALF  Broncho-alveolar lavage fluid
BMI  Body mass index.
CEB  Corporación Ecuatoriana de Biotecnología 
CI Confidence interval 
cNK  Classical natural killer 
CO  Carbon monoxide
COHb  Carboxihemoglobin 
CORPAIRE  Corporación Para el Mejoramiento del Aire de Quito ()
COX  Cyclooxygenase
CRP C reactive protein 
CW Child-weeks 
DC  Dendritic cells 
DEP  Diesel exhaust particles
EC Epithelial cell 
EDTA  Ethylenediaminetetraacetic acid 
EPA  Environmental Protection Agency 
ER Emergency room
GAM  Generalized additive model 
GEE  Generalized Estimating Equation 
HAZ  height-for-age Z-score 
HBD-2  human β-defensin 2
HBD-3 human β-defensin 3 
HDM  House dust mite 
HO. Hydroxyl radical 
HT  heavy-traffic (-school)
IFN-β  Interferon beta 
IFN-γ  Interferon gamma
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IL Interleukin 
ILC1  Innate lymphoid cells type 1
ILC2  Innate lymphoid cells type 2
ILC3  Innate lymphoid cells type 3
ILCs Innate lymphoid cells
INEC  Instituto Nacional de Estadistica Censos
JR  Jaime Roldos
LP Lucha de los Pobres
LPS Lipopolysaccharide
LT  Low-traffic area 
LTi Lymphoid tissue-inducer
MHC  Major histocompatibility complex 
MICA/B  Major histocompatibility complex class I chain-related protein A and B
MMP  Matrix metalloproteinase
MØ Macrophage 
MT moderate-traffic area of Quito (-school)
MWCNT  Carbon in a multi-walled carbon nanotube 
NK  Natural killer 
NKT Natural killer T
NO2 Nitrogen dioxide
NOX  Nitrogen oxides
O2- Ssuperoxide radical 
O3  Ozone 
OR  Odds ratio 
OVA  Ovalbumin
PBMC Peripheral blood mononuclear cell
PGD2   Prostaglandin D2 
PM  Particulate matter
PM0.1  Particulate matter < 0.1μM. 
PM10 Particulate matter < 10 μM. 
PM2.5  Particulate matter < 2.5µm 
PMN  Polymorphonuclear nuclear
PRISMA  Preferred Reporting Items for Systematic Reviews and Meta-Analyses
REMMAQ  Metropolitan Atmospheric Monitoring Network of Quito
ROS  Reactive oxygen species
RR  Relative Risk
SES  Socioeconomic status
SO2 Sulphur dioxide
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Th  T Helper 
TNF-α,  Tumor necrosis factor alpha
TSLP Thymic Stromal Lymphopoietin 
TT1 Alveolar type-1 like epithelial cells 
UFPM  Ultrafine PM 
ULBP3  UL16-binding proteins
VEGF  Vascular endothelial growth factor
VOC Volatile organic compounds 
WAZ  Weight-for-age Z-score 
WHO  World Health Organization 
μm  Micrometers
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